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Abstract
Biomolecule structural fluctuations determine function, regulating numerous biological processes My
research has shed light on several interesting cases in which structural fluctuations have been
identified to assess functional differences. Chapter 2 discusses the effects of structural rearrangement
of the β2-β3 loop on the DNA binding affinity of the type 6 human papillomavirus E2 protein. Chapter
3 investigates the effects of phosphorylation on the C-terminal domain of Cdc37, a protein important
in the Hsp90 chaperone cycle. Chapter 4 studies the effects on cyclycization on the conformational
fluctuations of a γ-AApeptide used for high-throughput libraries. Chapter 5 is a structural study on a
mini-fibril of spider dragline silk, in which a native-like ensemble was generated using temperature
replica exchange. Chapter 6 investigates the structural features of repetitive motifs found in spider
dragline silk when subject to both dope-like and fiber-like conditions. Chapter 7 elucidates
conformational differences between the RXRα and the RXRβ ligand-binding domains and seeks to
understand the atomic basis for different ligand binding affinities. This body of work has contributed
to the understanding of conformational fluctuations and changes that occur in protein-DNA binding
systems, drug-binding, regulation of chaperones via post-translations modifications and spider
dragline silk.

viii

FLUCTUAT NEC MERGITUR

ix

Chapter One
Introduction
Molecular simulation provides unparalleled detail into physical processes, allowing a fully
atomistic representation. In general, it consists of the evaluation of an energy function,
followed by sampling/optimization based upon that energy function. Sampling typically may
be broken into time-based sampling (i.e. molecular dynamics) and statistical sampling (i.e.
Monte Carlo). Energy functions may be classical, polarizable or quantum mechanical. First
molecular simulations were performed using 2D ideal gases in the 1950’s with hard sphere
potentials,1 while the first simulations of biomolecules occurred two decades later, in the
1970’s.2 During the last two decades, this field has experienced rapid development, creating
highly accurate force fields along with methods able to sample relevant timescales. Molecular
dynamics (MD) is a simulation technique integrating the equations of motion of a system
through time. This involves a process of discrete integration timesteps, in which the forces are
evaluated from the gradient of the potential energy (eq. 1.1) and new positions calculated using
an integration scheme.

𝐹(𝑟𝑖 ) = −

𝜕𝑉({𝑟})
𝜕𝑟𝑖

(1.1)

Where F is the force, ri the position of point i, V the potential energy, which is a function of
the set of all positions.

1

1.1

Force Fields

Force fields are a collection of parameterized mathematical expressions used to represent
various energetically important physical phenomena. Parameters of a force field, obtained by
comparison to high-level quantum mechanical simulations with corrections for experimental
observations, may be used to describe different atoms present in chemical structures. All atom
force fields are generally classified as classical or quantum mechanical. Classical force fields
may then be subdivided into polarizable and non-polarizable. Classical force fields neglect
electronic degrees of freedom, whereas quantum mechanical force fields treat electrons
explicitly. Classical simulations scale as O(N2), but using cutoffs3 and particle-mesh Ewald
techniques,4-5 these simulations scale as N log(N). Contrastingly, quantum mechanical
simulations scale much worse, restricting the size of the systems that may be treated. Because
peptides in explicit solvent are typically minimally > 10,000 atoms, making conformational
sampling using purely quantum mechanical methods prohibitively expensive.
As an example, the CHARMM force field6-9 contains terms describing molecular bonding,
angles, dihedrals, improper dihedrals, CMAP corrections10, Urey-Bradley terms, van der Waals
and Coulombic interactions (eq 1.2).8
𝑉(𝒓) = ∑ 𝐾𝑏 (𝑏𝑖 − 𝑏0 )2 + ∑ 𝐾𝜃 (𝜃𝑖 − 𝜃0 )2 + ∑ 𝐾𝑈𝐵 (𝑆𝑖 − 𝑆0 )2 +
𝑏𝑜𝑛𝑑𝑠

𝑎𝑛𝑔𝑙𝑒𝑠

𝑈𝐵
2

∑

𝐾𝜒 (1 + 𝐶𝑜𝑠(𝑛𝜒 − 𝛿)) +

𝑑𝑖ℎ𝑒𝑑𝑟𝑎𝑙𝑠

𝑛𝑜𝑛𝑏𝑜𝑛𝑑𝑒𝑑

𝐾𝜔 (𝜔𝑖 − 𝜔0 )2 +

𝑖𝑚𝑝𝑟𝑜𝑝𝑒𝑟𝑠
12

∑

∑

𝜎𝑖𝑗
{𝜖𝑖𝑗 [( )
𝑟𝑖𝑗

6

𝜎𝑖𝑗
𝑞𝑖 𝑞𝑗
−( ) ]+
}+
𝑟𝑖𝑗
4𝜋𝜖0 𝑟𝑖𝑗

2

∑
𝑟𝑒𝑠𝑖𝑑𝑢𝑒𝑠

𝑈𝐶𝑀𝐴𝑃 (𝜙, 𝜓)

(1.2)

The first sum is over all bonds, with Kb the bonding force constant, b0 the equilibrium bond
length and bi the current bond length. The second sum if over all angles, where Kθ is the angular
force constant, θ0 is the equilibrium angle and θi is the current value for the angle. The third
sum is over all Urey-Bradley terms, which is the distance between a first and third body in an
angle. KUB is the force constant, S0 is the equilibrium distance and Si is the current distance.
The fourth sum is over all dihedrals, Kχ is the dihedral angle force constant, χ is the dihedral
angle, n the multiplicity and δ an offset. The fifth sum is over all improper torsions, Kω is the
force constant, ω0 the equilibrium improper angle and ωi the current improper angle. The sixth
term is the nonbonded portion of the forcefield. The first term is the Lennard-Jones potential
and account for the van der Waals interactions. It consists of a repulsive term and a dispersive
term. Two parameters ε and σ are used in the potential. The parameter σij corresponds to the
location of the minima for the potential and εij the depth of the minima. The variable rij
corresponds to the distance between atoms i and j. The second nonbonded term is the
Coulombic potential, a simple point charge potential. As in the Lennard-Jones potential, rij
corresponds to the distance between atoms i and j, qi the charge on atom i, qj the charge on
atom j and ε0 the permittivity of free space. The final sum is a corrective sum for the φ and ψ
dihedral angles.10 Bonded parameters are obtained from the harmonic approximation. UreyBradley terms,8 improper dihedrals8 and CMAP terms10 are corrective to better match circular
dichroism results, planar geometries and Ramachandran data, respectively
Amber11-14 is another classical forcefield used for protein simulation (eq. 1.3).

3

𝑉(𝑟) = ∑ 𝐾𝑏 (𝑏𝑖 − 𝑏0 )2 + ∑ 𝐾𝜃 (𝜃𝑖 − 𝜃0 )2 +
𝑏𝑜𝑛𝑑𝑠

∑

1
∑ 𝐾𝑛 [1 + cos(𝑛𝜔 − 𝛾)] +
2

𝑑𝑖ℎ𝑒𝑑𝑟𝑎𝑙𝑠 𝑛

𝑎𝑛𝑔𝑙𝑒𝑠
12

∑
𝑛𝑜𝑛𝑏𝑜𝑛𝑑𝑒𝑑

𝜎𝑖𝑗
{𝜖𝑖𝑗 [( )
𝑟𝑖𝑗

6

𝜎𝑖𝑗
𝑞𝑖 𝑞𝑗
−( ) ]+
} (1.3)
𝑟𝑖𝑗
4𝜋𝜖0 𝑟𝑖𝑗

The AMBER forcefield14 possessed a similar functional form as the CHARMM forcefield with
several notable distinctions. The first is the lack of Urey-Bradley, improper dihedrals and
CMAP corrections. Additionally, there is an important distinction in the dihedrals. AMBER
treats dihedral as a Fourier series (often n=3), whereas CHARMM uses a squared term.

1.2

Periodic Boundary Conditions

The goal of simulation is to provide predictive capabilities and accurately model experimental
results. However, a problem of scale appears in that experimental measurements are made on
O(1023) atoms while computation models at most O(109), typically O(104)-O(106) for classical
simulations. Moreover, simulations are of finite size compared to the systems being simulated,
whereas experimental measurements are performed in bulk. Thus, boundary effects become
problematic for molecular simulations, and indeed different results will be obtained for
differently sized systems.15 To simulate a bulk system and ameliorate these finite size effects,
periodic boundary conditions may be used.16 The system may be treated as a unit cell of an
infinite crystal.17 By taking into account interactions with periodic images of the system, a
molecule at the boundary of the system sees a similar bulk environment as a molecule in the
middle of the system. This poses a new set of problems. Consider for an additive pairwise

4

potential (such as the CHARMM force field8) that our potential energy now becomes of the
form given in eq. 1.4.

𝑉(𝑟) =

1
∑ 𝑉(|𝑟𝑖𝑗 + 𝑛𝐿|)
2

(1.4)

𝑖≠𝑗,𝑛

Where L is the size of the unit cell, the ½ term accounts for the redundancy in calculating the
pair-potential for i-j and j-i, and n is the periodic image. Thus, with no further treatment, we
must sum over all periodic images to calculate the energy. Since this is not efficient (or possible
for an infinite number of images) a solution must be presented. This may be done via
nonbonded cutoff schemes.

1.3

Cutoff Schemes

Since the potentials have inverse dependence on the distance between two points, it may be
tempting to merely set a value for this distance and then subsequently assume all points beyond
this distance do not contribute significantly to the energy and exclude them from calculation.
This is inadvisable for two reasons. The first is the introduction of impulse forces, due to the
introduction of a delta function for the force at the cutoff radius.18 The Lennard-Jones and
Coulombic potential are zero only in the limit of infinite separation between two bodies. As a
result, it would be possible for a particle to have a zero interaction with another particle at time
t and then subsequently have a finite interaction at the next timestep. This results in impulse
forces at the boundary of the cutoff and can cause numerical instabilities. Additionally, while
Lennard-Jones potentials rapidly head to zero (typically, within 12 Å separation) electrostatics
decay to zero much more slowly and would require a much larger (and less efficient) cutoff for
5

most charged systems.19-20 In order to facilitate efficient and correct simulations, different
cutoff schemes may be used. Two such schemes for Lennard-Jones are the switching3, 21-22 and
the shifting potentials.18 Switching potentials modify the potential functions to force the
potential to go to zero at the cutoff. The use of the switching function perturbs the dynamics
slightly but leaves the minima intact. The second option is the shifting method, in which the
potential energy is shifted up to force the potential to go to zero at the desired cutoff. This does
not perturb the dynamics but does affect the minimum structure. Both methods are effective
and produce similar results with a sufficiently large cutoff.3
Cutoff schemes for electrostatics use an approach based on Ewald summation.23 Considering
the potential introduced in eq. 1.4, it is apparent that the potential is a poorly converging sum.
A converging sum may be obtained by considering a set of point charges as a set of smoothly
screened point charges minus the negative of the smooth screening functions. Using this
approach, the electrostatic energy may be calculated using a sum in real space and a sum in
Fourier space. First a sum of the long-range interactions in Fourier space (eq. 1.5).

𝑉𝐹𝑜𝑢𝑟𝑖𝑒𝑟 =

1
4𝜋
𝑘2
|𝜌(𝑘)|2 exp (− )
∑
2𝑉
𝑘
4𝛼

(1.5)

𝑘≠0

Where ρ(k) is defined by eq. 1.6.
𝑁

𝜌(𝑘) ≡ ∑ 𝑞𝑖 exp(𝑖𝑘 ∙ 𝑟𝑖 )

(1.6)

𝑖=1

Then, the short-range interactions in real space (eq. 1.7).
𝑁

𝑉𝑟𝑒𝑎𝑙

𝑞𝑖 𝑞𝑗 erfc(√𝛼𝑟𝑖𝑗 )
1
= ∑
2
𝑟𝑖𝑗
𝑖≠𝑗

6

(1.7)

And finally, a correction for the self-interaction (eq. 1.8).
𝑁

𝑉𝑠𝑒𝑙𝑓

𝛼
= √ ∑ 𝑞𝑖2
𝜋

(1.8)

𝑖=1

The final electrostatic energy may then be calculated from these three parts (eq. 1.9).
𝑉𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑠𝑡𝑎𝑡𝑖𝑐 = 𝑉𝑟𝑒𝑎𝑙 + 𝑉𝐹𝑜𝑢𝑟𝑖𝑒𝑟 − 𝑉𝑠𝑒𝑙𝑓

(1.9)

The Ewald method scales as O(N3/2), however, better scaling may be achieved using the
particle-mesh Ewald method.4-5 This performs a discrete fast Fourier transform by localizing
the charges to a set of lattice points. Electrostatics interactions may then be calculated and a
spline used to interpolate between points. This method scales linearly as O(N ln (N)), and is
most commonly used for contemporary treatment of electrostatics in biomolecules.

1.4

Integrators

Integrators should be time-reversible, conserve long-term energy and be accurate with
reasonably large time-steps. Verlet integrators fulfill all of these requirements. The Verlet
integrator24 is given by eq. 1.10.

𝑟(𝑡 + Δ𝑡) = 2𝑟(𝑡) − 𝑟(𝑡 − Δ𝑡) +

𝐹(𝑡) 2
Δ𝑡 + 𝑂(Δ𝑡 4 )
𝑚

(1.10)

Here, t is the current time and Δt the integration timestep. The Verlet integrator requires the
current position, the previous position and the forces to be known in order to calculate new
positions. Notably, velocity is not required, however, must be calculated in order to determine
the kinetic energy (eq. 1.11).
7

𝑣(𝑡) =

𝑟(𝑡 + Δ𝑡) − 𝑟(𝑡 − Δ𝑡)
+ 𝑂(Δ𝑡 2 )
2Δ𝑡

(1.11)

It is important to note that the error for the velocities are on the order of O(Δt2). This can pose
problems for the long-term conservation of energy. Another integrator in the Verlet family is
the Leap-frog integrator16 (eq. 1.12-1.13).
Δ𝑡
) Δ𝑡
2

(1.12)

Δ𝑡
Δ𝑡
𝐹(𝑡)
) = 𝑣 (𝑡 − ) +
Δ𝑡
2
2
𝑚

(1.13)

𝑟(𝑡 + Δ𝑡) = 𝑟(𝑡) + 𝑣 (𝑡 +

𝑣 (𝑡 +

This integrator calculates the velocities at half timesteps, using the current forces and the
previous velocity to calculate the new velocity. This algorithm has a better estimate of the
kinetic energy but has the disadvantage that the velocities and forces are always at different
integration timesteps. The velocity Verlet algorithm25 allows for a more accurate kinetic energy
estimation than the Verlet and also calculate the position and velocities at the same timestep
(eq. 1.14-1.15).

𝑟(𝑡 + Δ𝑡) = 𝑟(𝑡) + 𝑣(𝑡)Δ𝑡 +

𝑣(𝑡 + Δ𝑡) = 𝑣(𝑡) +

𝐹(𝑡) 2
Δ𝑡
2𝑚

𝐹(𝑡 + Δ𝑡) + 𝐹(𝑡)
Δ𝑡
2𝑚

(1.14)

(1.15)

This algorithm works by computing the new velocities using the current and previous forces.
An important point to note is that all Verlet algorithms are equivalent,16 and will produce
equivalent trajectories.
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1.5

Ensembles

Comparison of in silico results to experimental results produces important insights. To better
match values calculated from experiment, MD is performed in matching ensembles, typically
NPT (constant number of particles, constant pressure and constant temperature), or NVT
(constant number of particles, constant volume and constant temperature). This requires
temperature regulation (thermostat) and pressure regulation (barostat). It is pertinent to mention
that these (and all other) ensembles are equivalent in the thermodynamics limit.26 One popular
form of temperature regulation is achieved via Langevin dynamics.27 Integration if performed
stochastically using eq. 1.28.
𝐹(𝑡) = 𝐹(𝑟) − 𝛾𝑣(𝑡) + 𝑓(𝑡)

(1.28)

The first term is the force derived from the potential energy. The second term is a drag force
meant to replicate a viscous media. The third term is a temperature-dependent stochastic term,
corresponding to fictitious collisions. Langevin dynamics mimics Brownian dynamics. It is
important to note that collisions with a thermal bath result in the loss of time-correlation,
meaning that only configurational parameters may be calculated. The second thermostat is the
Nòse-Hoover thermostat.28 This thermostat is different from Langevin dynamics in that a
fictitious particle is coupled to the system (eq. 1.29).

𝐻(𝑟, 𝑝, 𝑝𝑠 , 𝑠) = ∑
𝑖

𝑝𝑖2
𝑝𝑠2
+
𝑉({𝑟})
+
+ 𝑁𝑝 𝑘𝑇𝑙𝑛(𝑠)
2𝑚𝑠 2
2𝑄

(1.29)

Here, Np is the number of momentum degrees of freedom, Q is the mass of the particle and s a
scaling parameter, coupled to the timestep. Because the momenta of the real particles are
9

coupled to the momenta of the fictitious particle, the temperature is regulated. A significant
advantage of the Nose-Hoover thermostat, is that time-averages are preserved (i.e. dynamics
are deterministic). Other thermostats are the Berendsen,29 Andersen30 and velocity scaling31
(isokinetic).
Two barostats to be discussed are the Berendsen barostat29 and a Monte Carlo barostat.32 The
Berendsen barostat adds an additional term to the equations of motion (eq. 1.30).
𝑑𝑃 𝑃0 − 𝑃
=
𝑑𝑡
𝜏𝑃

(1.30)

Where P0 is the reference pressure of the bath, P is the instantaneous pressure and τP is the time
constant coupling the system to the bath. This results in a scaling factor, which modifies the
system volume to facilitate constant pressure. The pressure may be maintained using Monte
Carlo moves as well.32 After a predetermined number of dynamics steps, a volume scaling
move may be made (corresponding to a change in pressure) and a Metropolis algorithm used
to accept or reject the move (eq. 1.31).
𝑉1
Δ10 = (𝐸1 − 𝐸0 ) + 𝑃0 (𝑉1 − 𝑉0 ) − 𝑁𝑘𝐵 𝑇0 ln ( )
𝑉0

(1.31)

Where 0 and 1 are indices for the system before and after the volume scaling move,
respectively, E is the energy of a system, V is the volume, P0 is the reference pressure, N is the
number of atoms, kB the Boltzmann constant and T0 the reference temperature.
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1.6

Sampling Efficiency

From above, it is clear that the accuracy of the integration scheme is determined by the size of
the timestep. The timestep must be as large as possible to facilitate faster sampling, but small
enough to prevent long-time energy drifts and local instabilities. The size of the timestep must
correspond to the timescale of the phenomena with the highest frequency for accurate
integration and to be physically meaningful. For proteins in which chemical bonding remains
unchanged, this is the vibration of the hydrogen bond. This results in a timestep of ~1 fs, which
may be increased to 2 fs when using constraints on the hydrogen bond lengths (such as
SHAKE33). Clearly, this results in a limitation of what physical phenomena may be observed
in simulation due to the constraints of simulation time. For example, proteins folding times
range from O(102) – O(106) μs.34 Practical simulation times range from O(100) – O(102) μs,3536

depending on hardware and system size. Because of the ruggedness of the free energy

landscape for conformation transitions,37 employing a “brute-force” MD approach precludes
the observation of many phenomena of chemical interest for these and many other systems. To
circumvent these limitations, alternative schemes may be devised to practically “speed-up” the
timescale sampled (which shall be discussed below).38-40 This results in phenomena that would
occur on longer timescales occurring on a shorter timescale. Two broad approaches may be
taken to this, biasing a reaction coordinate (e.g. umbrella sampling41) or biasing an ensemble
(e.g. replica exchange42). It is noteworthy to mention that these may also be combined.43
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1.7

Free Energy Calculations

One may simply ask why it is not possible to directly calculate thermodynamic variables from
a simulation. Considering the equation for free energy (eq. 1.32).
𝐹 = −𝑘𝐵 𝑇ln(𝑍(Γ))

(1.32)

𝑍(Γ) = ∫ exp(−βH(Γ)) dΓ

(1.33)

Where F is the free energy, kB the Boltzmann constant, T the temperature, Z the partition
function and Γ the volume of phase space. It becomes immediately obvious why this is not
feasible. Thermodynamic values (such as free energy shown above) are functions of the volume
of phase space, which is neither known nor calculable for all but the simplest systems. Clearly,
an alternative strategy is required.

1.8

Umbrella Sampling

So long as a sufficiently high barrier between two states exist, transformation between two (or
more) states may be monitored with a reaction coordinate. This can be any number of
observables in simulation, ranging from simple distances to combinations of multiple physical
parameters. Assuming that a reaction coordinate sufficiently describes a physical process, an
artificial restraint may be added to drive it a certain point via a restraining potential (eq. 1.34).41
𝐻 ′(𝑟) = 𝐻(𝑟) + 𝜋(𝑟)

(1.34)

Where Hʹ(r) is the Hamiltonian for r, which is a sum of the unperturbed Hamiltonian and the
biasing potential. This forces the simulation to sample parts of phase space considered relevant
12

to a process, instead of waiting for a “natural evolution” of the system to these regions of phase
space. By adding a biasing potential to the simulation, we effectively observe longer time-scale
phenomena on a shorter time length. This results in sampling a different probability
distribution. The statistical average for a variable, θ, may be calculated using eq. 1.35.41

< 𝜃 >0 =

𝜃
< 𝜋 >𝜋
1
< 𝜋 >𝜋

(1.35)

Remarkably, this allows for the calculation of a given variable in an unbiased ensemble from
statistical averages of the biased ensemble! Umbrella sampling is extremely useful for the
introduction of a non-Boltzmann weight. This means overlap between adjacent windows is
easier to obtain because we can use non-exponential functions (such as a harmonic restraining
potential producing a Gaussian distribution).

1.9

Weighted Histogram Analysis Method

As of now, we have assumed a single simulation in which a relevant part of phase space is
sampled via adding a restraining potential to a given reaction coordinate. However, exploration
of the full reaction coordinate by use of multiple simulations has not been discussed. The
previous argument can be simply extended by running multiple copies of a given system
(labeled windows) and restraining them to different parts of the reaction coordinate. These
windows may then be combined to produce values for various thermodynamic properties along
the given reaction coordinate. Unlike a single window, use of multiple windows must be
combined utilizing reweighting techniques. The most popular of these, the weighted histogram
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analysis method (WHAM),44 allows the statistical weights for each window to be recovered
and then used to calculate thermodynamics properties. This is achieved by constructing a set
of histograms and iterating to self-consistency using eq. 1.36 and 1.37.

𝑝0𝑒𝑠𝑡 (𝑄) =

𝑍𝑖 = ∫ 𝑑𝑄𝑒

∑𝑛𝑖=1 𝑁𝑖 (𝑄)
𝑒 −𝛽𝜔𝑖 𝑚𝑖 𝑍0
∑𝑛𝑖=1
𝑍𝑖

−𝛽𝜔𝑖

(1.36)

∑𝑛𝑗=1 𝑁𝑗 (𝑄)
𝑒
∑𝑛𝑘=1

−𝛽𝜔𝑘 𝑚

𝑍𝑘

(1.37)
𝑘

The eq. 1.36 is the estimate of the unbiased probability, where Z0 is the unbiased partition
function, Zi the biased partition function, mi the number of sample for window i, Ni the number
of samples in window i, ωi the biasing energy for window i, mk is the number of samples in
window k, Q is the value of the reaction coordinate and n the total number of windows. The
estimate for the biased partition functions is given by eq. 1.37, where the variables are the same
as those for the estimate of the unbiased probability.
Since this is an implicit equation, an iterative solution is necessary. In fact, only ratios of the
partition function may be meaningfully obtained. Therefore, one partition function is fixed at
a constant value (Z0), and the ratios for all remaining Z are solved until self-consistency. The
free energy between the bins may then be calculated as the difference between these two
partition functions (eq. 1.38).
𝑍𝑛
Δ𝐹 = −𝑘𝐵 𝑇𝑙𝑛 ( )
𝑍0

(1.38)

WHAM is a robust method that allows for the back calculation of statistical properties using
information from biased simulations. Several key points regarding this method must be made.
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First, due to the use of a histogram, results can vary by bin width. Often, this is not a problem,
as a sufficiently small bin width minimizes this error.45 Secondly, because the method is
iterative, a solution is not guaranteed, as convergence may not be achieved.

1.10

Adaptive Umbrella Sampling

A second approach to umbrella sampling is an adaptive sampling scheme,46-48 combining
WHAM and umbrella sampling. As with umbrella sampling, one or more reaction coordinates
may be subdivided into windows. These windows are then sampled during a single simulation
and statistics for the windows are monitored. From this, the free energy along visited parts of
the reaction coordinate may then be calculated. The negative of this calculated umbrella
potential is then added as a biasing potential to discourage revisiting the same bins and enhance
conformational sampling. After a set number of equilibration timesteps, statistics are then
collected again to build a new umbrella potential. By combining multiple umbrella potentials,
the system may be simulated until diffusive behavior is achieved.

1.11

Replica Exchange

Until this point, sampling has only been accelerated along several degrees of freedom.
However, several degrees of freedom can be insufficient in cases where large conformational
changes occur or where high orthogonal free energy barriers exist. In these cases, replica
exchange42, 49 may be used. The general algorithm consists of running multiple copies of the
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system under different conditions (temperature differences, Hamiltonians, restraints) followed
by periodic exchange attempts between neighboring replicas, using a Gibb’s sampler (eq. 1.39).
Δ𝑚𝑛 = 𝛽𝑚 (𝐻𝑚 (𝑟𝑛 ) − 𝐻𝑚 (𝑟𝑚 )) + 𝛽𝑛 (𝐻𝑛 (𝑟𝑚 ) − 𝐻𝑛 (𝑟𝑛 ))

(1.39)

Here, m and n are two different replicas, β is the Boltzmann factor, Δmn is the exchange
criterion, and Hm and Hn are the Hamiltonian for systems m and n, respectively. In each case,
the coordinates of m and n are reweighted in the Hamiltonians of n and m, respectively.

1.12

Temperature Replica Exchange

In its original implementation, replicas were run at different temperatures to enhance
conformational sampling.42 This is advantageous due to the fact that all momenta are biased
identically, allowing for large conformational changes without the need for a priori information
regarding reaction coordinates. Additionally, there is no need to copy the coordinates between
processors for energy evaluations in each Hamiltonian, due to the simplification of the
exchange criterion (eq. 1.40).
Δ𝑚𝑛 = (𝛽𝑚 − 𝛽𝑛 )(𝐻𝑛 (𝑟𝑛 ) − 𝐻𝑚 (𝑟𝑚 ))

(1.40)

The spacing of the replicas is extremely important to facilitate traveling through temperature
space. It has been shown that geometric temperature spacing in temperature space produces the
best exchange in the absence of a phase transition. However, a phase transition results in a
bottleneck in traveling due to the differences in the energy fluctuations. This can be solved by
changing the spacing based on the heat capacities to optimize energy overlap between the
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replicas.40 Additionally, since the fluctuations of energy scale as 1/√𝑓, where f is the number
of degrees of freedom, this method scales poorly with system size.50

1.13

Hamiltonian Replica Exchange

In lieu of running replicas at different temperatures, replicas may also be run in different
Hamiltonians at the same temperature. In this case, the full exchange criterion in eq. 1.39 must
be used. Hamiltonian replica exchange has been employed in numerous ways to enhance
conformational sampling, including scaled interactions,51-52 Tsallis dynamics,53 and reaction
coordinates.43,

54-55

An example of such a scheme is the Replica Exchange with Solute

Tempering (REST).51 REST scales the interactions of the system using the Hamiltonian given
in eq. 1.41.

𝐻𝑚 (𝑟𝑚 ) = 𝐻𝑝 (𝑟𝑚 ) + (

𝛽0
𝛽0 + 𝛽𝑚
) 𝐻𝑝𝑤 (𝑟𝑚 ) + (
) 𝐻𝑤𝑤 (𝑟𝑚 )
𝛽𝑚
2𝛽𝑚

(1.41)

Here, the Hamiltonian of the system has been decomposed into three separate components, the
protein interactions, the protein-water interactions and the water-water interactions. This
results in a modified exchange criterion (eq. 1.42).
1
1
Δ𝑚𝑛 = (𝛽𝑚 − 𝛽𝑛 ) [(𝐻𝑝 (𝑟𝑛 ) + 𝐻𝑝𝑤 (𝑟𝑛 )) − (𝐻𝑝 (𝑟𝑚 ) + 𝐻𝑝𝑤 (𝑟𝑚 ))]
2
2

(1.42)

This is highly advantageous compared to a typical exchange criterion due to the removal of
water-water interactions in the term. The removal of the largest number of degrees of freedom
results in the ability to effectively simulate much larger systems. This may further be improved
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through the inclusion of Tsallis53 dynamics, called Multiple scaling Replica Exchange with
Solute Tempering (MREST).56 In this case, the Hamiltonian takes the form of eq. 1.43.
̃ (𝑟𝑚 ; 𝑞𝑚 , 𝑇𝑚 ) =
𝐻

𝑞𝑚
ln[1 + 𝛽𝑚 (𝑞𝑚 − 1)(𝐻𝑚 (𝑟𝑚 ) − 𝜖)]
𝛽𝑚 (𝑞𝑚 − 1)

(1.43)

The energy is further flattened by the logarithm function. Calculation of the forces results in a
prefactor containing the energy in the denominator. This results in an inverse relationship
between the energy and the force, facilitating escape from low energy minima and sampling of
barriers. Additionally, use of a Tsallis ensemble53, 57-58 changes the metric of phase space,
broadening energy distributions, which facilitates better overlap. For this implementation, there
are two parameters that must be decided for the simulation, q and ε. The entropic scaling factor,
q, is system size dependent and should be chosen such that it is less than 1 + 1/f,56 where f is
the number of degrees of freedom. This prevents instabilities from arising. The parameter ε is
an offset to prevent the argument of the logarithm from being zero. Thus, we may determine
the value by setting the argument of the logarithm to be greater than zero (eq. 1.44) and solving
for ε (eq. 1.45).
1 + 𝛽𝑚 (𝑞𝑚 − 1)(𝐻𝑚 (𝑟𝑚 ) − 𝜖) > 0

𝜖>

1
𝛽𝑚 (𝑞𝑚 − 1)

+ 𝐻𝑚 (𝑟𝑚 )

(1.44)

(1.45)

The value for Hm(rm) can be obtained from short test simulations and set equal to the minimum
potential energy obtained.
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1.14

Molecular Docking

Simulation of drug-protein interactions is of extreme interest for the development of novel
therapeutic compounds. However, it is a uniquely challenging problem due to the large number
of degrees of freedom involved in the binding process. Molecular docking is a widely used
approach for the discovery of novel drug compounds and the estimation of binding free
energy.59-62 Autodock63 is a popular tool for molecular docking and shall be discussed here.
One approach is to estimate the binding free energy using a semi-empirical free energy
function64 (eq. 1.46).
𝐿−𝐿
𝐿−𝐿
𝑃−𝑃
𝑃−𝑃
) + (𝑉𝑏𝑜𝑢𝑛𝑑
)
Δ𝐺𝑏𝑖𝑛𝑑𝑖𝑛𝑔 = (𝑉𝑏𝑜𝑢𝑛𝑑
− 𝑉𝑢𝑛𝑏𝑜𝑢𝑛𝑑
− 𝑉𝑢𝑛𝑏𝑜𝑢𝑛𝑑
𝑃−𝐿
𝑃−𝐿
+(𝑉𝑏𝑜𝑢𝑛𝑑 − 𝑉𝑢𝑛𝑏𝑜𝑢𝑛𝑑 ) + Δ𝑆𝑐𝑜𝑛𝑓

(1.46)

Where the first term indicates the potential energy difference between the bound and unbound
ligand, the second term indicates the difference between the bound and unbound protein, the
third term indicates the difference between the bound and unbound protein-ligand interactions
and the final term in the conformational entropy lost upon binding. Each potential term takes
the following form64 (eq. 1.47).
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𝜎𝑖𝑗𝑣𝑑𝑤
𝑉 = 𝑊𝑣𝑑𝑤 ∑ {𝜖𝑖𝑗 [(
)
𝑟𝑖𝑗
𝑖,𝑗
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𝜎𝑖𝑗ℎ𝑏𝑜𝑛𝑑
𝑊ℎ𝑏𝑜𝑛𝑑 ∑ {𝐸(𝑡) [(
)
𝑟𝑖𝑗
𝑖,𝑗

6

𝜎𝑖𝑗𝑣𝑑𝑤
−(
) ]} +
𝑟𝑖𝑗
10

𝜎𝑖𝑗ℎ𝑏𝑜𝑛𝑑
−(
)
𝑟𝑖𝑗

]} +

𝑟𝑖𝑗2
𝑊𝑒𝑙𝑒𝑐 ∑
𝑊𝑠𝑜𝑙𝑣 ∑(𝑆𝑖 𝑉𝑗 + 𝑆𝑗 𝑉𝑖 ) exp (− 2 )
2𝜎
𝑒(𝑟𝑖𝑗 )𝑟𝑖𝑗
𝑞𝑖 𝑞𝑗

𝑖,𝑗

(1.47)

𝑖,𝑗

In all cases, the W term corresponds to a weight. The first term is the typical Lennard-Jones
potential. The second term is a directional 12-10 potential used for hydrogen bonding, the third
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term is a typical Coulombic potential, and the final term is composed of a desolvation parameter
(S) dependent on the volume surrounding a given atom (V). Select degrees of freedom may
then be modified in order to generate different ligand binding poses within the protein binding
region. Often, important ligand torsional degrees of freedom are chosen, which bonds and
angles fixed. Additionally, residues believed important to protein-ligand interactions may also
be optimized. Optimization of the binding poses can be performed using a number of potential
algorithms. Here a genetic algorithm will be used.65 Using the language of genetics, a set of
state variables describing the orientation of the ligand with respect to the protein may be
thought of as genes. All genes are taken together to compose a genotype. The phenotype is then
the atomic coordinates, and the fitness of these atomic coordinates are assessed using the
energy function. Crossover and random mutation are used to generate new genotypes. A
population may then be generated that maximizes fitness functions and used as the beginning
population for the next search.

1.15

Site-Identification by Ligand Competitive Saturation

Identification of favorable drug-protein binding interactions allows for the design of novel
compounds in silico. One such method to achieve this is the Site-Identification by Ligand
Competitive Saturation (SILCS) method,66 a version of molecular flooding.67 SILCS runs
multiple simulations of an apo state protein using different solvent, which mimic different
protein-drug interactions. Three broad classes of interactions used are hydrophilic (hydrogen
bond donor or acceptor), hydrophobic and aromatic. These may be investigated by running in
water, 1 M propane and 1M benzene respectively. Typically, propane and benzene would
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aggregate during a simulation in water, however, a propane-propane or benzene-benzene
repulsive Lennard-Jones potential (ε = -0.01 kcal/mol; σ = 12.0 Å) is added to prevent
aggregation and facilitate exploration of protein-solvent interactions. Using these simulations,
the simulation space may be binned and the occupancy of the solvent molecules calculated to
construct a Fragmentation Map (FragMap). This may be related to a Grid Free Energy (GFE),
which is the free energy associated with the occupancy of the solvent molecule in the grid
space) via eq. 1.48.
𝐺𝐹𝐸 = min [−𝑅𝑇𝑙𝑛 [

𝜌𝑖
𝜌𝑏𝑢𝑙𝑘

] , 0]

(1.48)

Where ρi is the occupancy at bin i and ρbulk is the bulk occupancy. This allows for the
identification of important interactions and the relative energetic contribution to binding free
energy.

1.16

Simulations of Biomolecules

Protein structure determines its function, which is critical to cellular processes and all of life.
Proteins, however, are not static structures, relying on conformational fluctuations to provide
regulation and facilitate biological processes. Conformational transitions and structural
rearrangements facilitate numerous processes,68 including ligand-binding,69 protein-DNA
complex formation,70 and many more.71-72 Employing molecular dynamics (MD) allows for
these systems to be studied at fully atomic resolution,68 which is ideal for understanding the
driving forces for conformational changes. With the advent of the GPU revolution,73
microsecond simulations for reasonably sized systems (<50,000 atoms) using classical force
21

fields have now become feasible on widely accessible hardware.35-36, 74 Because many of these
local structural changes occur on the 10 – 1000 ns scale, MD is an ideal technique to study
these phenomena. Biomolecules represent a unique simulation challenge due to the ruggedness
of the free energy landscape they sample. This can result in prohibitively long simulations. As
a result, many of the enhanced sampling techniques discussed previously may be used to
accelerate conformational sampling of biomolecular systems.40 Use of these techniques,
however, results in broken time correlation. This means that thermodynamic properties are
conserved, but kinetic properties are not, requiring postprocessing techniques for the
calculation of kinetic properties.75-77 My work has primarily focused on the conformation
fluctuations and structural changes that occur in biomolecular and biologically inspired
systems.
In chapter 2, molecular dynamics was used to investigate the effects of mutation of the type 6
E2 protein of human papillomavirus (HPV) when binding DNA.78 Wild type (WT) type 6 E2
protein DNA binding affinity is heavily determined by a four base linker sequence separating
the cognate binding sequence. Mutation by removal of two terminal Leu on both monomers of
the DNA-binding dimer results in an increase in the binding affinity for the cognate sequence
and a larger increase in the binding affinity for the noncognate sequence.79 Molecular dynamics
simulations identified motions of a β2-β3 loop that occur when the WT protein is bound to its
cognate sequence, but not when bound to its noncognate sequence. These motions were also
identified in the ΔLL protein when bound to both sequences. Quasiharmonic analysis revealed
that twisting of the β-barrel core occurred allowing the hinge-like motion of the loop.
Chapter 3 investigates the effects of phosphorylation on the fluctuations of the C-terminal
domain of Cdc37.80 Cdc37 is the cochaperone of HSP90, helping to recruit client kinases to
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facilitate proper folding. This cycle is heavily regulated by various post-translational
modifications.81-83 Here, the structural effects of phosphorylation on Y298 of the C-terminus
of CdC37 were investigated using molecular dynamics, along with a phosphomimetic mutant.
Comparison between the phosphorylated and unphosphorylated systems revealed loss of native
contacts between the phosphorylated Y298 and several other residues. These contacts were
maintained in the unphosphorylated system.
Chapter 4 investigates the effects on the cyclicization on the conformational sampling of γAApeptides.84 Cyclicization represents a strategy to improve binding-affinity for compounds.
It is though that by restricting the conformational space of sampling, the compounds sample
lower energy conformations, which are conducive to binding. Here, a linear γ-AApeptide and
its cyclical analogue were parameterized and simulated. Analysis revealed higher
conformational fluctuations for the linear than for the cyclical. Clustering showed a higher
number of clusters for the linear, and free energy analysis showed that higher cluster were less
accessible for the cyclic compound than the linear. Finally, quasiharmonic analysis was used
to calculate the vibrational entropy for each cluster, revealing a lower entropy for the cyclic
compounds. Taken together, this indicates that the cyclic compound is more restricted in
conformational space, both between clusters and within clusters.
Chapter 5 uses temperature replica exchange to investigate the conformations of a native-like
ensemble of mini-fibrils of spider dragline silk.85 Dragline silk is desirable for its high strength
and elasticity and is structurally composed of crystalline β-sheets embedded in an amorphous
matrix. Atomic level structural information about it is sparse. Two systems were built, each
with different models of the β-sheet regions, separated by an amorphous linker. Temperature
replica exchange was then performed to generate a native-like ensemble. Ramachandran plots
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revealed a highly symmetric (φ,ψ) distribution due to the high Gly-content. Analysis of
secondary structure revealed high stability of the β-sheet regions. The amorphous regions
contained small populations of β-sheets, α-helices and 310-helices. The formation of
polyproline II (PPII) helices, which is indicated by NMR studies, were not observed.
Chapter 6 further investigates the amorphous region of spider dragline silk using five model
peptide sequences from N. clavipes. MREST is used to sample monomeric systems in water
(simulating the aqueous dope), octanol (simulating fiber conditions) and a trimer in water. A
higher protein concentration closer to those found in the dope was simulated using molecular
dynamics. Additionally, pulling experiments were performed on monomer and trimer systems
in water to investigate the effects of a model spinning process. PPII helices were found to form
in higher amount in octanol and during pulling. Thus, the formation of this secondary structure
is facilitated during the spinning process.
Chapter 7 investigates the ligand binding of bexarotene and bexarotene derivatives to the
retinoid X-receptor (RXR) type α and β.67 Top poses taken from previous docking studies are
used as the starting point for molecular dynamics studies.86 Additionally, SILCS simulations66
are performed and compared to the binding conformations from MD. SILCS simulations found
that the RXRα was more hydrophilic and the RXRβ more hydrophobic. Additionally, a
hydrophobic pocket surrounding part of the ligand binding region revealed additional room for
ligand modifications. A second hydrophobic pocket was identified in RXRβ, indicating
interactions that may be used for specificity.
These projects are connected by the investigation of the effects of conformational fluctuations
on the structural properties of biomolecules and biomolecular-inspired systems. These
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fluctuations have been investigated using both molecular dynamics and enhanced sampling
techniques to facilitate atomic-level resolution of conformational fluctuations.
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Chapter Two
Importance of β2−β3 Loop Motion for the Increased Binding and Decreased Selectivity of
the ΔLL Mutant of the Human Papillomavirus Type 6 E2 Protein

Note to Reader: This chapter is reprinted and adapted with permission from Geoffrey M. Gray
and Arjan van der Vaart from Biochemistry, see Appendix A.

2.1

ABSTRACT

The binding affinity of the human papillomavirus type 6 E2 protein is strongly mediated by the
sequence of the DNA linker region, with high affinity for the AATT linker and low affinity for
the CCGG linker. When two terminal leucine residues are removed from the protein, the level
of binding to both strands increases, but unequally, resulting in a significant decrease in
selectivity for the AATT linker strand. To rationalize this behavior, we performed molecular
dynamics simulations of the wild-type and mutant protein in the apo state and bound to DNA
with high-affinity AATT and lowaffinity CCGG linker strands. While no stable contacts were
made between the β2−β3 loop and DNA in the wild type, this loop was repositioned in the
mutant complexes and formed electrostatic contacts with the DNA backbone. More contacts
were formed when the mutant was bound to the CCGG linker strand than to the AATT linker
strand, resulting in a more favorable change in interaction energy for the CCGG strand. In
addition, significant differences in correlated motions were found, which further explained the
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differences in binding. The simulations suggest that β2−β3 loop motions are responsible for
the increased affinity and decreased selectivity of the mutant protein.

2.2

Introduction

Papillomaviruses are double-stranded DNA viruses that infect mammals, and more than 100
human papillomaviruses (HPV) have been identified.87 Some of these viruses like HPV-6 and
HPV-11 cause benign warts, while others like HPV16, HPV-18, and HPV-31 are associated
with cancer and in particular cervical carcinomas.88-89 A key regulator of the papillomavirus
life cycle is the E2 protein, which controls the initiation of transcription of nearly all viral
promoters and is required for viral DNA replication.90 E2 is a homodimer, and each chain
consists of three domains: an N-terminal transactivation domain, a hinge region, and a Cterminal DNAbinding domain (DBD). The DBD dimer consists of an eight stranded
antiparallel β-barrel, which binds the major groove of the 5′-ACCgNNNNcGGT-3′ consensus
sequence by two αhelices, where the lowercase letters indicate preferred nucleotides and
NNNN is the variable spacer sequence.90-91
DNA is bent in all E2−DNA complexes, and the minor groove of the spacer is compressed.9091

The amount of bending depends on the viral species because of differences in the electrostatic

surfaces and the separations between the recognition helices among the various E2 proteins. 92
In HPV E2, no contacts are made between E2 and the spacer; however, binding affinities are
strongly modulated by the spacer sequence, with high affinities for A:T rich sequences and low
affinities for G:C rich sequences.93-94 This difference in binding is thought to be due to the ease
by which the DNA forms prebent structures that resemble the conformation in the complex.91,
94

The high-affinity AATT spacer sequence spontaneously forms a bent structure with a
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compressed minor groove; the medium affinity TTAA sequence is bent and prefers a widened
minor groove, and the low-affinity ACGT sequence is unbent and prefers a widened minor
groove.95-96 G:C sequences are less flexible than A:T sequences and do not form prebent
structures.94 For certain sequences, salts affect the stability of the prebent structure,97-98 while
very floppy spacers, like nicked DNA constructs, have weakened affinities because of entropic
penalties.94-95
Of all characterized E2 proteins, HPV-6 E2 is the most selective for the spacer sequence. For
example, HPV-6 E2 prefers AATT 1000-fold over CCGG, while for HPV-16 E2, this
preference is only 10-fold.99 This selectivity is thought to stem from differences in molecular
adaptability.93 While HPV-16 E2 shows substantial rearrangements upon DNA binding, such
as a shift in the position of the recognition helices and the ordering of the β2−β3 loop, binding
of HPV-6 E2 to high affinity DNA is accompanied by minimal protein deformation. There is
no reorientation of the recognition helices and no rearrangement of the β2−β3 loop (Figure
1A).93 In addition, the C-terminal Leu 367 and Leu 368 residues have been shown to be
important for the selectivity of HPV-6 E2.79 These two residues are positioned in the core of
the β-barrel (Figure 2.1) and are absent in most other E2 proteins.79, 100
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Figure 2.1. Structure of HPV-6 E2 protein. The apoprotein is colored blue, the AATT complex
orange, and the CCGG complex yellow. The position of the linker is indicated by stars, and
Lys 323 is shown by spheres. All structures were overlaid with respect to the X-ray structure
of the wild-type−AATT complex; both front and side views are shown. (A) X-ray crystal
structures of the wild-type protein (Protein Data Bank entries 1R8H99 and 2AYB93). Leu 367
and Leu 368 of the AATT complex are colored red. (B) Averaged simulation structure of the
wild-type protein. (C) Averaged simulation structure of the ΔLL mutant.

A study of the HPV-6 ΔLL DBD, a mutant in which Leu 367 and Leu 368 were removed,
showed that sequence selectivity was significantly diminished in the mutant.79 The level of
binding to both the high-affinity AATT spacer sequence and the nonspecific CCGG spacer was
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increased for the ΔLL mutant, but because the level of binding to the nonspecific spacer was
increased by a larger factor, the specificity for the high-affinity sequence decreased 6-fold. In
addition, there was a significant increase in the rate of the first step of complex formation for
the ΔLL mutant.79
While no high-resolution structures are available for the ΔLL mutant in the apo or DNA-bound
states, it was hypothesized that the behavior of the ΔLL mutant is due to a change in protein
motion.79 Nuclear magnetic resonance (NMR) relaxation and hydrogen exchange studies of the
apo state showed a small increase in the flexibility of the hydrophobic core and in the loop
regions connecting the recognition helices. This was thought to improve protein adaptability,79
but because no NMR data are available for the ΔLL−DNA complex, information about the
motion, flexibility, and specific structural changes of the mutant complex is lacking.
To further rationalize the behavior of the HPV-6 E2 ΔLL mutant, we performed molecular
dynamics (MD) simulations of the wild type (WT) and ΔLL mutant in the apo states, and in
complex with DNA with high-affinity AATT and low-affinity CCGG spacers. Our simulations
indicate that the increase in binding affinities and decrease in selectivity stem from the
rearrangement of the β2−β3 loop, which forms transient contacts with DNA in the mutant
complexes.

2.3

Methods

Initial structures for the wild-type apoprotein and high-affinity DNA-bound complex were
taken from the Protein Data Bank (entries 1R8H99 and 2AYB,93 respectively). To prevent
excessive fraying, DNA in the complex was extended by an extra G:C base pair on each end,
resulting in the 5′GCAACCGAATTCGGTTGC-3′ sequence (Figure 2.2).
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Figure 2.2. Simulated DNA sequence. The sequence of the NNNN spacer region is 5′-AATT3′ for the high-affinity linker and 5′-CCGG3′ for the low-affinity linker.

In this sequence, the high-affinity AATT linker is underlined; we will refer to this DNA strand
as “AATT”. Because no experimental structure was available, modeling was used to construct
the initial structure of the low-affinity CCGG linker complex. Only the linker base pairs were
modified; coordinates of the protein, DNA backbone, and all other base pairs were taken from
the 2AYB crystal structure. The CCGG base pairs were built with 3DNA,101 keeping all step
parameters identical to the step parameters observed for the corresponding AATT base pairs in
the crystal structure. Because step parameters describe the overall orientation of two adjacent
bases in terms of rigid body rotations and translations,102 this procedure produced an initial
configuration of the CCGG linker that was similar to the configuration of the AATT linker in
the 2AYB crystal structure. In the following, we will refer to the CCGG linker DNA strand as
“CCGG”. Initial structures of the apo and complex states of the ΔLL mutant were obtained by
deleting the terminal Leu residues. Starting structures of bare DNA were built in the unbent Bform using 3DNA.101 Using Ambertools13,103 systems were solvated in a TIP3P octahedral
waterbox,104 with a KCl concentration of 150 mM. After energy minimizations, the NPT
ensemble was simulated using Langevin dynamics with a collision frequency of 5 ps −1 for
temperature control27 and weak coupling with isotropic scaling and a relaxation time of 5 ps
for pressure control.29 To avoid synchronization artifacts, the Langevin bath was initialized
with a different random seed at each restart.105-106 Bonds involving hydrogen atoms were
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constrained using the SHAKE algorithm,33 allowing for a 2 fs time step, and the particle mesh
Ewald was used to calculate long-range electrostatics.4 Systems were heated from 120 to 300
K over 1 ns with 1 kcal mol−1 Å−2 restraint on all protein and DNA heavy atoms, followed by
restrained equilibrations over 2 ns, in which the force constant was gradually reduced from 1.0
to 0.5 to 0.25 to 0.1 kcal mol−1 Å−2. Systems were subsequently equilibrated for 31 ns without
restraints, followed by MD production runs of 190 ns; reported properties were calculated from
the production runs. All MD simulations were performed using the Amber force field11-13 and
the Amber12 GPU code.36 Coordinates were written every 10 ps; Stride107 was used to calculate
protein secondary structure, and DNA geometry was calculated using 3DNA108 and
MADBEND.109 Visual analyses were performed with VMD110 and Chimera.111 NMR order
parameters were calculated using the IRED approach112 as implemented in CPPTRAJ.113 All
other analyses were also performed with CPPTRAJ. Hydrogen bonds were calculated using a
distance cutoff between heavy atoms of 3.0 Å and an angular cutoff of 45°. Contact analysis
was performed between the DNA heavy atoms and protein heavy side chain atoms using a
cutoff of 6.0 Å. The mass-weighted Pearson correlation matrices and quasiharmonic modes
were calculated using standard methods.114-115The free energy cost of DNA bending was
estimated using Olson’s empirical model, which describes the DNA deformation energy in
terms of step parameters.116 In this model, the energy of each dimer step is given by E
j,

where the i and j indices represent the six step parameters (roll, twist, tilt,

shift, slide, and rise), Δθi is the deviation of step parameter i from its equilibrium value, and fij
terms are force constants; the energies of all dimer steps are summed to give the total DNA
deformation energy. The equilibrium values of the step parameters and the force constants were
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obtained from statistical analyses of X-ray structures; we used the standard, published values
of these parameters for our analysis.116

2.4

Results

NMR order parameters (S2) were calculated from the apo state trajectories (Figure 2.3) and
compared to experimental values where available (Figure 3A).79 In the NMR experiments, not
all order parameters were obtained; for example, S2 values for a large portion of the β2−β3 loop
were unresolved, and others were missing, as well.79 Trends were generally well reproduced in
the simulations, with high S2 values (>0.85), indicating high rigidity, for most of the protein,
and low S2 values, indicating flexibility, for the termini and the β2−β3 loop region. The
simulation overestimated the rigidity of the N-terminus by ∼0.2 and underestimated the rigidity
of the C-terminus by ∼0.2; this corresponded to a root-mean-square deviation of ∼0.5 Å. The
flexibility of Gly 291 at the end of β1 was underestimated by ∼0.2 for the mutant protein. Other
discrepancies were the flexibility of Ala 320 that was underestimated by ∼0.1 in the wild type,
the flexibility of His 326 that was overestimated by ∼0.2 in the mutant, and the flexibility of
β3 that was underestimated by <0.1 in the mutant. In the mutant, the flexibilities of Arg 355
and His 356 were overestimated by ∼0.1, and the flexibility of β4 was overestimated for some
residues and underestimated for others by <0.05. Despite these small differences, the overall
dynamics of the apo states were captured well by MD. Panels C and D of Figure 2.3 show the
order parameters for the DNA-bound complexes calculated from the MD trajectories; these
have not been measured experimentally. While the S2 parameters for the apo and complex states
were similar for most regions, large differences in order parameters were observed for the β2−β3
loop and the termini. Compared to the apo states (Figure 2.3B), the β2−β3 loop was significantly
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more flexible in the wild-type and mutant complexes with high affinity DNA (Figure 2.3C)
and significantly more flexible in the mutant−CCGG complex (Figure 2.3D). The flexibility of
the β2−β3 loop in the wild-type−CCGG complex was similar to that of the wild-type apo state,
except for the motion of Lys 323, which was more flexible in the CCGG complex. The Nterminus was more flexible in the complex simulations than in the apo simulations, while the
C-terminus of the mutant complexes showed increased flexibility adjacent to the deletion site
(Met 365 and His 366).

Figure 2.3. Protein S2 order parameters. Values are averaged over both chains, with data for
the wild type (●) and ΔLL mutant (□). (A) Apo state, experimental values.79 (B) Apo state,
simulation values. (C) AATT complex, simulation values. (D) CCGG complex, simulation
value. Root-mean-square deviations (rmsds) for the DNA phosphorus atoms are listed in Table
2.1 for all systems. These rmsd values were calculated with respect to four reference states: the
averaged structure of the simulated system, the averaged simulation structure of the wild-
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type−AATT complex, the X-ray wild-type−AATT complex structure,7 and the averaged
structure of bare DNA or apo state protein as obtained from separate simulations. The DNA
rmsd values with respect to the averaged structure, the simulated wild-type− AATT complex
structure, and the crystal structure are nearly identical for all systems, indicating that the
structure and dynamical behavior of DNA were similar in all complexes. The rmsds with
respect to bare DNA were similar for the wildtype− and mutant−AATT complexes and similar
for the CCGG complexes. However, these rmsd values were higher in the CCGG than in the
AATT complexes. This difference indicates that CCGG DNA undergoes larger structural
changes than AATT DNA upon binding. Structural analyses showed the structural differences
were mainly due to global tilt,109 which was more similar to the protein−DNA complex values
for bare AATT than for bare CCGG. Because DNA deformations are costly in terms of
energy,70, 116 less energy will be spent to bend DNA in the AATT complex than in the CCGG
complex. In fact, using Olson’s model to estimate the energy cost of DNA bending,116 relative
to the wild-type−AATT complex, DNA was deformed by 1.2 kcal/mol in the mutant−AATT
complex, by 7.6 kcal/mol in the wild-type−CCGG complex, and by 9.8 kcal/mol in the
mutant−CCGG complex. This observation is in agreement with the hypothesis that AATT
DNA can form prebent structures that resemble the conformation in the complex, while CCGG
DNA cannot,91, 94 and helps explain the difference in affinity for the AATT and CCGG linkers.
Backbone rmsd values for the protein are also listed in Table 2.1. The rmsd is shown with
respect to the same four reference states, except that the last reference now refers to the
averaged structure of the apo state as obtained in separate simulations. The rmsd values with
respect to the averaged structures were low for all systems (≤1.1 Å), which indicates that the
proteins are fairly rigid after equilibration. The largest rmsd values with respect to the crystal
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and wild-type−AATT complex simulation were observed in the mutant protein, with the rmsd
in the CCGG complex being larger than the rmsd in the AATT complex. This indicates that
the mutant protein had more significant structural changes than the wild type upon binding
DNA, especially for the mutant−CCGG complex. The smallest rmsd with respect to the
averaged simulation structure and the crystal structure was observed for the wild-type−CCGG
complex, indicating that this complex had the fewest structural changes.

Table 2.1. Rmsd Values (Angstroms) of the Protein Backbone and DNA Phosphorus Atoms
with Respect to the Averaged Simulation Structure, the Averaged Simulation Structure of the
Wild-Type−AATT Complex, the X-ray Wild-Type−AATT Complex Structure,[*] and the
Averaged Structure of Bare DNA or Apo State Protein (unbound) Simulations.

DNA

reference

WT−AATT

WT−CCGG

mutant−AATT mutant−CCGG

averaged sim.

1.04 ± 0.16

1.03 ± 0.16

0.96 ± 0.16

1.02 ± 0.20

WT−AATT sim.

1.04 ± 0.16

1.20 ± 0.17

1.01 ± 0.14

1.21 ± 0.18

X-ray WT−AATT 1.29 ± 0.15

1.39 ± 0.16

1.31 ± 0.16

1.45 ± 0.17

average

7.87 ± 0.19

5.17 ± 0.15

7.89 ± 0.18

unbound 5.11 ± 0.16

sim.
protein

averaged sim.

1.07 ± 0.14

0.74 ± 0.10

0.94 ± 0.21

0.95 ± 0.22

WT−AATT sim.

1.07 ± 0.14

1.16 ± 0.08

1.72 ± 0.16

1.88 ± 0.23

X-ray WT−AATT 1.57 ± 0.31

1.06 ± 0.10

1.83 ± 0.24

2.01 ± 0.23

average

0.94 ± 0.09

1.40 ± 0.23

1.87 ± 0.21

unbound 1.43 ± 0.34

sim.
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Figure 2.1 shows overlays of the averaged simulation structures and wild-type apo99 and wildtype−AATT complex93 crystal structures. Consistent with the low rmsds, no significant
structural differences existed between the DNA of the systems. The protein structure was also
very similar in all systems, except for the conformation of the β2−β3 loops. In the crystal
structures of the wild-type apo and AATT complex, the β2−β3 loops are ordered and point
toward the β-barrel, away from the DNA. In these structures, the side chain of Lys 323 points
toward the α1−β2 loop, away from the DNA. While these conformations of Lys 323 and the
β2−β3 loops were largely retained in the averaged wild-type complexes and wild-type and
mutant apo proteins, the β2−β3 loop changed position in the mutant complexes and moved
toward the DNA. Lys 323 of the loop changed its relative orientation, pointing toward the DNA
and making transient contacts with the phosphates of Gua 31 and Gua 32. The loop motion and
transient contacts were observed for only chain A of the mutant protein; in chain B, the β2−β3
loop was also displaced, but to a lesser extent (Figure 2.1C).

Hydrogen bonds between the protein and DNA are listed in Table 2.2 These are split up into
specific hydrogen bonds, which are between a base and protein, and nonspecific hydrogen
bonds between a phosphate and the protein. All specific and nonspecific hydrogen bonds
present in the wild-type−AATT crystal structure were also prevalent in the simulation
structures, with the exception of a specific contact involving Asn 294. In the wild-type−AATT
crystal structure, this residue hydrogen bonds with the Cyt 5/Cyt 23 base. While the Cα and Cβ
positions were very similar to those observed in the crystal structure, in the simulations the
amide group was rotated and formed a persistent contact with neighboring base Ade 4/Ade 22
instead. Like Cyt 5/Cyt 23, these bases are part of the cognate sequence. With a few exceptions,
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the hydrogen bonds that were present in the crystal and in the simulations had similar
occurrences in all simulations.
Table 2.2. Hydrogen Bonding between Protein and DNA as a Fraction of the Simulation Time,
Divided into Specific Contacts with DNA Bases and Nonspecific Contacts with the Phosphate
Backbonea
DNA

Protein

Ade 3
Ade 4
Gua 13
Gua 14
Ade 21
Ade 22
Gua 31

Arg 302B
Asn 294B
Lys 297A
Lys 297A
Arg 302A
Asn 294A
Lys 297B

Cyt 2
Ade 3
Ade 4
Cyt 5
Gua/Thy 11
Cyt 12
Gua 13
Gua 14
Cyt 20
Ade 21
Ade 22
Cyt 23
Gua/Thy 29
Cyt 30
Gua 31
Gua 32

Arg 302B
Lys 349B
Arg 302B
Thr 353B
Asn 294B
Asn 294B
Ser 293A
His 318A
Lys 327A
Arg 300A
Thr 316A
Arg 300A
Tyr 301A
Arg 302A
Lys 349A
Arg 302A
Thr 353A
Asn 294A
Asn 294A
Ser 293B
Arg 300B
Thr 316B
Arg 300B
Lys 323A

Wild-type
Wild-type
AATT
CCGG
Specific
−
0.07
0.35
0.36
0.61
0.70
−
0.18
0.11
0.28
0.39
0.41
0.57
0.66
Nonspecific
1.00
1.00
0.26
0.17
0.23
0.37
0.97
1.0
0.06
0.06
0.78
0.77
0.91
0.85
−
0.07
−
−
0.58
1.00
0.92
0.85
1.00
1.00
−
0.12
0.87
0.92
−
−
−
0.52
0.96
1.00
−
0.11
0.73
0.80
0.94
0.83
0.63
0.66
0.92
0.85
1.00
1.00
−
−
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Mutant AATT

Mutant
CCGG

0.28
0.40
0.64
−
0.08
0.35
0.67

−
0.33
0.65
−
0.26
0.34
0.68

0.93
−
0.17
0.99
0.08
0.77
0.92
−
0.12
0.53
0.93
1.00
−
1.00
0.19
0.35
0.95
−
0.77
0.91
0.57
0.93
1.00
0.43

1.00
0.21
−
1.00
−
0.79
0.76
0.07
−
0.55
0.91
1.00
−
0.87
−
0.21
0.88
−
0.77
0.81
0.65
0.86
1.00
0.30

Transient hydrogen bonds not present in the wild-type− AATT crystal structure were observed,
as well. The most prominent of these were nonspecific hydrogen bonds between the β2−β3 loop
and the DNA, which were observed only in the mutant (Figure 2.4). Lys 323A formed a
nonspecific hydrogen bond with Gua 32. This hydrogen bond was observed 43% of the time
in the mutant−AATT complex and 30% of the time in the mutant−CCGG complex. In addition,
Lys 327A formed a nonspecific hydrogen bond in the mutant−AATT complex 12% of the time.
Other transient hydrogen bonds involved Lys 349 of the α2−β4 loop, which formed a
nonspecific hydrogen bond to Thy 11 for 12% of the time in the mutant−AATT complex and
a nonspecific hydrogen bond to Cyt 2 for 17−26% of the

Figure 2.4. Hydrogen bonds among Lys 323, Lys 327, and DNA for the mutant−AATT
complex. Stars indicate the position of the linker. Hydrogen bonds are shown as dashed lines.

time in all other complexes; His 318A of β2, which formed a nonspecific hydrogen bond 7%
of the time in the wild-type− AATT and mutant−CCGG complexes; and Tyr 301A of α1, which
formed a nonspecific hydrogen bond 12% of the time in the wild-type−AATT complex.
A few transient heavy atom contacts between DNA and β2 and the β2−β3 loop were formed in
the wild-type−AATT complex. These were between protein residues 315−322 of both chains
and base pairs 10−14 and 28−32. The stable hydrogen bonds between Thr 316 and Cyt 30
observed in the crystal93 were present, as well (Table 2.2). Sporadic transient contacts between
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residue Lys 323B and base pairs 13 and 14 also occurred, and residues His 326B, Lys 327B,
and Ala 329B formed transient contacts with Thy 29. Lys 327A formed sporadic transient
contacts with Thy 10, Thy 11, Gua 31, and Cyt 12, while Lys 327B formed infrequent transient
contacts with Thy 28 and Thy 29. None of these transient contacts were hydrogen bonds (Table
2.2). Contacts in the wild-type−CCGG complex were formed between residues 315B−322B of
β2 and base pairs 10−14 and 28−32, including the Thr 316 hydrogen bonds observed in the
wild-type−AATT crystal7 (Table 2.2). The β2−β3 loop remained rigid, and no contacts between
DNA and this loop were made. Formation of transient contacts with chain A occurred much
less frequently in this complex.
Heavy atom contacts between DNA and the β2−β3 loop of the mutant are shown in Figure 2.5
as a function of time; DNA contacts with β2 and β3 residues near the loop are shown, as well.
For the sake of clarity, contacts that persisted over the entire length of both simulations are
omitted from the figure. In addition to these, several other persistent contacts were observed
(Figure 2.5). Of particular interest is Lys 323A, which formed prominent hydrogen bonds with
the DNA backbone in the mutant simulations (Table 2.2 and Figure 2.4). In the mutant−
AATT complex, Lys 323A formed contacts with Cyt 30, Gua 31, and Gua 32 (and transiently
with Thy 10), while in the mutant−CCGG complex, it formed contacts with Gua 31 and Gua
32. These contacts were persistent throughout most of the simulations, even in the absence of
hydrogen bonding. The β2−β3 loop of chain B generally formed contacts with the linker region,
whereas chain A formed contacts with the minor groove of the recognition motif adjacent to
the linker. Figure 2.5 shows significant differences in the number of contacts and the contact
frequency between the two mutant complexes. The mutant−CCGG complex formed a larger
number of different contacts that involved more residues. This complex also formed more
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transient contacts. The mutant−CCGG complex had an approximately 1:1 ratio of contacts
formed by chain A and chain B, while the mutant−AATT complex had a 2:1 ratio.

Figure 2.5. Heavy atom contacts between the β2−β3 loops and DNA for the (A) mutant−AATT
and (B) mutant−CCGG complex. Contacts maintained throughout the entire simulation in both
complexes have been omitted for the sake of clarity. These are between Gua 31 and Pro 322A,
Cyt 12 and Val 331A, Cyt 12 and His 318B, Cyt 12 and Ala 320B, Thy 29 and Ser 315B, Thy
29 and Thr 316B, Thy 29 and His 318B, Thy 29 and Ala 329B, Thy 28 and His 318B, Gua 31
and Ser 315B, Gua 31 and Thr 316B, Thy 11 and Ala 329A, Cyt 30 and Ala 320A, Cyt 30 and
Ser 315B, Cyt 30 and Thr 316B, Cyt 30 and Val 331B, and Gua 13 and Ala 320B.

The formation of additional protein−DNA contacts led to more favorable protein−DNA
interaction energies in the mutant complexes (Table 2.3). While these are not free energies, the
interaction energies show the same trend as the experimental binding affinities, with
protein−DNA interactions being stronger for AATT than for CCGG, and stronger interactions
for the mutant than for the wild type. Moreover, while standard deviations are large, compared
to the wild types a larger increase in the total number of interactions was observed in the
mutant−CCGG complex (−57.5 kcal/mol) than in the mutant−AATT complex (−56.5
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kcal/mol), indicating a loss of specificity as observed in the experiments. A large portion of
this change in interactions was due to β2−β3 loop−DNA interactions (Table 3), which were
stronger for the mutant than for the wild type. Moreover, compared to the wildtype values, a
larger increase in the total number of loop interactions was observed for the mutant−CCGG
complex (−89.9 kcal/mol) than for the mutant−AATT complex (−63.0 kcal/mol). Further
decomposing the total interaction energy at the residue level, and comparing the differences
between wildtype and mutant complexes, showed that the mutant−AATT complex primarily
had increases in the number of interactions between DNA and the β2−β3 loop of chain A,
between the α2−β4 loop of chain A and base pairs 2 and 3, and, to a lesser extent, between α1 of
chain A and base pairs 20−22. There was also a notable loss of interaction between the α2−β4
loop of chain B and base pairs 2 and 3. The mutant−CCGG system had increases in the number
of interactions between DNA and the β2−β3 loops of both chains, α1 of chain A with base pairs
20−22, and the α2−β4 loop of chain B with base pairs 2 and 3, while it had a loss of interactions
between α1 of chain B and base pairs 3 and 4. Overall, the mutant had a larger number of total
increases in interactions when bound to the CCGG than to AATT. This accounted for the
decrease in interaction energy upon mutation that was greater for the CCGG complex than for
the AATT complex.
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Table 2.3. Protein−DNA Interaction Energies (kilocalories per mole). Interactions for the entire
protein and the DNA are shown, along with each individual β2−β3 loop (on chain A and B) and
the DNA.
System
wild-type AATT
wild-type CCGG
mutant AATT
mutant CCGG

β2–β3 chain A-DNA
-33.6 ± 22.2
-3.0 ± 7.4
-121.1 ± 65.7
-63.8 ± 35.2

Protein-DNA
-1147.8 ± 66.3
-1083.4 ± 65.7
-1204.3 ± 76.4
-1140.9 ± 70.2

β2–β3 chain B-DNA
-35.0 ± 44.0
-4.9 ± 10.3
-10.5 ± 7.0
-33.9 ± 19.9

Normalized variance−covariance matrices of protein fluctuations are shown in Figure 2.6.
Positive values indicate in-phase correlated motions; negative values indicate anticorrelated or
out-of-phase correlated motions, and zero values indicate uncorrelated or orthogonal motions.
Between the apo states, differences in correlated motions were minimal, with no differences in
sign. For both apo state systems, elements of the β-barrel on the same chain were positively
correlated. This positive correlation was also present in the DNA-bound complexes. In the
AATT complexes, a change in the sign of the correlation occurred in which the β2−β3 loops of
both chains for the wild type (but especially chain B) and chain A of the mutant complex
became negatively correlated with β-barrel elements of either chain (Figure 2.6, encircled). For
the CCGG− mutant complex, the sign change was observed between the β2−β3 loop on chain
A and β-barrel elements. This negative correlation did not occur in chain B of the mutant
complexes, which did not have the motion of the β2−β3 loop. No change in the sign of
correlation between the β2−β3 loops and the βbarrel occurred for the CCGG−wild-type
complex. Overall, the variance−covariance analysis showed correlations between the motion
of the β2−β3 loop and the β-barrel. These correlations were positive in the apo states. Upon
binding, certain correlations between the β2−β3 loop and β-barrel became negative for all wellbound systems (the wild-type−AATT and the mutant−AATT and −CCGG complexes, with
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binding constants of 41, 22, and 110 nM, respectively79), while it remained positive for the
poorly bound system (the wild-type− CCGG complex with a binding constant of 1203 nM79).

Figure 2.6. Normalized variance−covariance matrices. Correlations in the wild type are given
in the upper triangular parts, while correlations for the mutant are given in the lower triangular
parts of the matrices. Secondary structure elements for chain A are colored red and those for
chain B blue. Correlations of the β2−β3 loop are shown as black ovals, which are continuous
for chain A and dotted for chain B.

Quasiharmonic analyses showed that the β2−β3 loops of the apo state proteins were effectively
rigid and did not move in the lowest-frequency modes (Figure 2.7). This is in contrast to the
DNA-bound complexes, which showed significant motions of the β2−β3 loop in the lowestfrequency modes. Motions of this loop were significantly reduced in the wild-type−CCGG
complex, however. In the quasiharmonic modes of the mutant complexes, the β2−β3 loop
moved away from the protein and bent toward the DNA, making contacts. In contrast, in the
quasiharmonic modes of the wild-type−AATT complex, the β2−β3 loop moved away from the
rest of the protein but failed to move toward the DNA. In the mutant−AATT complex, the
β2−β3 loops moved in an anticorrelated fashion, with one loop moving toward the DNA and the
44

other toward the protein. In the mutant−CCGG complex, the motion between the loops was
correlated, with both moving toward the DNA at the same time. While we observed DNA
contacts with only β2−β3 of chain A of the mutant complexes, the quasiharmonic modes suggest
that chain B could form contacts, as well. Moreover, the modes imply that in the mutant−AATT
complex, only one β2−β3 loop will make DNA contacts at a time, while in the mutant−CCGG
complex, one or both loops can contact DNA at a time. This might further explain the loss of
selectivity upon mutation, that is, the reason why the mutant had a larger increase in binding
affinity for CCGG than for AATT.79
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Figure 2.7. Lowest vibrational quasiharmonic mode for the (A) wildtype−AATT, (B) wildtype−CCGG, (C) mutant−AATT, and (D) mutant−CCGG complexes. Arrows indicate the
direction of motion, with the length of the arrows corresponding to the magnitude of motion.

2.5

Discussion

MD simulations were performed to rationalize the increased binding affinity of the ΔLL mutant
of the HPV-6 E2 protein for both high-affinity AATT and low-affinity CCGG linkers and the
associated loss of selectivity for the high-affinity linker. The simulations showed that the DNA
conformation was nearly identical in the mutant− and wild-type−AATT and −CCGG
complexes. The simulations also indicated that there is greater structural similarity between the
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bound and unbound AATT strand than between the bound and unbound CCGG strand. This
observation supports the hypothesis that AATT is prebent in solution, resulting in greater
affinity of AATT than of CCGG. This greater affinity is also due to more favorable
complementary contacts between the wild type and AATT, resulting in a more favorable
protein−DNA interaction energy (Table 2.3). Moreover, the simulations showed significant
differences in the conformation of the β2−β3 loop. This loop was rearranged in the mutant
complexes, forming new contacts with the DNA, including a nonspecific hydrogen bond. The
number of new contacts was larger in the mutant−CCGG complex than in the mutant−AATT
complex, and the associated change in interaction energy was also more favorable in the CCGG
complex. These observations suggest that the increased affinities and decreased selectivity of
the ΔLL mutant stem from β2−β3 loop motion.
Detailed analyses showed that the β2−β3 loop motion is hindered in the apo states and also in
the wild-type−CCGG complex. Quasiharmonic modes showed limited motion of the β2−β3
loop in the wild-type−AATT complex, and in the simulation, a few transient contacts were
sporadically formed between the loop and DNA. Nevertheless, these contacts would be an
additional contributing factor to the selectivity of the wild type for AATT. The β2−β3 loop fully
moved toward the DNA in the mutant complexes, forming stable contacts with the DNA. While
in the simulations these contacts were formed by only one protein chain, quasiharmonic modes
suggested that the other chain could form contacts, as well. Because the motion of the β2−β3
loops was anticorrelated in the mutant− AATT complex, it is likely that only one chain forms
contacts at a time in the mutant−AATT complex. In contrast, in the mutant−CCGG complex,
the motion between the β2−β3 loops was correlated, and both chains could make contact at one
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time. This difference in motion would further decrease the selectivity of the mutant for the
AATT complex.
The site of the ΔLL mutation is near the β-barrel, and in experiments, subtle changes in β-barrel
dynamics were measured.14 Our simulations elucidated an important connection between
motions of the β-barrel and motions of the β2−β3 loops. In the apo state, motions between the
β2−β3 loop and the β-barrel were positively correlated. The correlation was also positive in the
wild-type−CCGG complex (which binds poorly), but negative for many elements in the wildtype− AATT and mutant−AATT and −CCGG complexes (which bind well). The out-of-phase
motions between the β-barrel and the β2−β3 loops allowed the loop to move away from the
βbarrel in the systems that bind well. These observations suggest that correlated motions
between the β-barrel and β2−β3 loops are important for selectivity and binding.
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Chapter Three

Phosphorylation induced cochaperone unfolding promotes kinase recruitment and client
class specific Hsp90 phosphorylation

Note to Reader: This work was performed in collaboration with the Gelis Group (Department
of Chemistry, University of South Florida) and the Neckers Group (National Institute of
Health). My contribution to this project was all molecular dynamics simulations. This chapter
is reprinted and adapted with permission from the above authors and Geoffrey M. Gray and
Arjan van der Vaart from Nature Communications, see Appendix B.

3.1

Abstract

During the Hsp90-mediated chaperoning of protein kinases, the core components of the
machinery, Hsp90 and the cochaperone Cdc37, recycle between different phosphorylation
states that regulate progression of the chaperone cycle. We show that Cdc37 phosphorylation
at Y298 results in partial unfolding of the C-terminal domain and the population of folding
intermediates. Unfolding facilitates Hsp90 phosphorylation at Y197 by unmasking a
phosphopeptide sequence, which serves as a docking site to recruit non-receptor tyrosine
kinases to the chaperone complex via their SH2 domains. In turn, Hsp90 phosphorylation at
Y197 specifically regulates its interaction with Cdc37 and thus affects the chaperoning of only
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protein kinase clients. In summary, we find that by providing client class specificity, Hsp90
cochaperones such as Cdc37 do not merely assist in client recruitment but also shape the posttranslational modification landscape of Hsp90 in a client class-specific manner.
3.2

Introduction

Heat shock protein 90 (Hsp90) is the core component of a machinery involved in the
conformational maturation of a large set of proteins of near-native conformation. It acts upon
substrates in the context of a multistep chaperone cycle, which is subject to multiple layers of
regulation117-118. At the level of the chaperone, the nature of the nucleotide-liganded state
controls the population shift between conformations that differ in their local or global
molecular architecture119-122 as well as in the residence time in each conformation123. At the
level of the machinery, a large cohort of cochaperones tunes the Hsp90 chaperone cycle124.
Recruiting cochaperones, such as p60Hop (Sti1) and Cdc37 (p50), act on both the client and the
chaperone to stabilize the open Hsp90 conformation, slow down its ATPase activity, and
promote efficient client transfer to Hsp90125-129. In contrast to Hop, Cdc37 does not function
strictly as an adaptor protein. Its selective unfoldase activity on the client over nonclient kinases
allows for substrate sorting and efficient transfer to Hsp90 by imposing an open kinase
conformation130 competent for stable chaperone association131-132.
As another layer of regulation in eukaryotes, Hsp90 undergoes a plethora of post-translational
modifications (PTMs) that include phosphorylation, acetylation, S-nitrosylation, oxidation,
SUMOylation, methylation, and ubiquitination81-83. Hsp90 PTMs occur as molecular events
that assist in the timely progression through the chaperone cycle133 or as a response to stimuli
such as DNA damage134-135 and nitric oxide levels136. They have diverse functional
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consequences that range from altered interaction profiles with clients137, cochaperones133, 138,
nucleotides, or small-molecule inhibitors138, to translocation139-140, secretion141, and
conformational changes142-144. Cochaperones are also subject to PTMs, adding yet another layer
of regulation. Phosphorylation of cochaperones modulates their interaction with upstream
folding machineries, clients, and Hsp90132-133, 145-147.
During the kinase chaperone cycle, both Hsp90 and the kinase specific cochaperone Cdc37
undergo multiple phosphorylation events. The cycle begins with Cdc37 phosphorylated at S13
by CK2, a constitutive modification required for kinase maturation148-149. Subsequently, a
series of tyrosine phosphorylations on Cdc37 and Hsp90 allow for the disassembly of the
substrate recruitment complex and progression of the cycle132. Phosphorylation of Cdc37 at Y4
and Y298 by the non-receptor tyrosine kinase (nRTK) Yes compromises its ability to form
complexes with a set of client kinases132. Hsp90 phosphorylation at Y197 by Yes or alternative
nRTKs results in Cdc37 dissociation and promotes Y313 phosphorylation, which assists in
engaging Aha1 into the chaperone complex. The cycle ends with the phosphorylation of Y627,
which favors the release of clients and cochaperones132. Dephosphorylation is equally
important for kinase maturation and the cochaperone phosphatase PP5 was found to act on
pS13147,

150

. Finally, Cdc37 phosphorylation at S339 by Ulk1 compromises its ability to

associate with protein kinases151, while an isoform-specific phosphorylation on Hsp90β by
CK2 (S365) compromises its ability to interact with Cdc37152.
At a molecular level, the mechanism by which multiple phosphorylation events impact the
Hsp90 chaperone cycle remains unexplored. We show that the kinase-specific cochaperone
Cdc37 promotes tyrosine phosphorylation of Hsp90 in a client class-specific manner. Our data
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reveal a mechanism by which specific Hsp90 modification patterns may occur through
cochaperone-mediated recruitment of the corresponding modifying enzymes.

3.3

Methods

Full-length human Cdc37 (Cdc37) and C-Cdc37 (a.a. 288–378) were cloned in a
pDB.His.MBP vector and the catalytic domain of bRaf was cloned in a pDB.His.GST vector130,
153

. The plasmid encoding for residues 86–543 of human HOP was obtained from DNASU

(#HsCD00530871). The SH2 domains of Yes, Src, Hck, and Lyn cloned in a pGEX vector that
encodes for an N-terminal, GST tag, and a PreScission cleavage site were a gift from Bruce
Mayer (Addgene plasmid # 46532, 46510, 46445, and 46452). The DNA encoding for the SH3
domain of Yes (amino acids 91–152) was synthesized for an E. coli-optimized codon usage
(GeneArt) and cloned into a pDB. His. GST vector to produce a fusion protein with an Nterminal, His6-GST purification tag, and a TEV cleavage site, using the set of primers listed in
Table 3.1. The DNA encoding for full-length Hsp90αα1 and full-length Hsp90αβ1 cloned in a
pET28 plasmid encoding for a His tag was a gift from the laboratories of Chad Dickey (USF
Health) and Ernst Schonbrunn (Moffitt Cancer Center). Cdc37 and Hsp90 point mutants were
generated using the QuikChange II XL Site-Directed Mutagenesis Kit (Agilent) and the set of
primers listed in Table 3.1.
Hsp90, Hop, Aha1, SH2, and SH3 constructs were transformed into BL21(DE3) (NEB). For
the expression of Hsp90, Hop, and Aha1 constructs, cells were incubated at 37 °C until OD600
~0.6 and then chilled for 10 min in a water/ice bath. Protein overexpression was induced by
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the addition of IPTG at a final concentration of 0.5 mM for 20 h at 18 oC. For the expression
of the SH2 and SH3 constructs, cells were incubated at 37 °C until OD600 ~0.6 and
overexpression was induced by the addition of IPTG at a final concentration of 0.5 mM, for 5
h at 20 oC. Protein labeling was performed using the same expression scheme.

13

C/15N

uniformly labeled proteins were produced in minimal media supplemented with 15NH4Cl and
U-13C6 glucose. Methyl-group site-specific labeling of Val, Leu, Ileδ, Met, and Ala residues
was performed in a perdeuterated background with the addition of 50 mg/L α-ketobutyric acid,
100 mg/L α-ketoisovaleric acid, 125 mg/L Met-[2H/13CH3], and 50 mg/L Ala-[2H/13CH3] to the
media 40 min before induction154-155.
Cdc37 constructs, bRaf, Hop, and Aha1 were purified by two steps of Ni2+ -affinity and sizeexclusion chromatography130, 153. Cdc37 was further purified over an anion exchange column.
Cells overexpressing Hsp90 were resuspended in 20 mM Tris, pH = 8.0, 500 mM NaCl, 10
mM imidazole, 3 mM DTT, 1 mM PMSF, protease inhibitor cocktail, and 0.1 mg/ml lysozyme.
Cells were disrupted by sonication and the lysate was clarified by centrifugation before loading
to a Ni2 +-affinity column. After extensive washing with lysis buffer, the Hsp90 was eluted in
the same buffer containing 400 mM imidazole and loaded to a Superdex 200 26/ 600 in 50 mM
Tris, pH = 8.0, 1 M NaCl, 0.5 mM EDTA, and 3 mM DTT. Finally, it was further purified
through a 10-ml HiTrap Q Sepharose FF run with a 50 mM–1 M NaCl gradient in 25 mM Tris,
pH = 7.5, 4 mM EDTA, and 3 mM DTT. Cells overexpressing the SH2 constructs were
resuspended in 20 mM Tris, pH = 8.0, 150 mM NaCl, 0.5 mM EDTA and 5 mM bmercaptoethanol, 1 mM PMSF, and 0.1 mg/ml lysozyme and lysed by sonication. The lysate
was loaded on a GST fast-flow column and after extensive washing with lysis buffer, proteins
were eluted with 40 mM glutathione. The fusion protein was cleaved with PreScission protease
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overnight at 4 °C and the GST tag was removed by running a second GST column. Finally,
proteins were purified through a Superdex 75 column in 20 mM Tris, pH = 7.5, 100 mM NaCl,
0.5 mM EDTA, and 2 mM DTT. Cells overexpressing the SH3 construct of Yes were
resuspended in 50 mM KPi, pH = 6.5, 150 mM NaCl, and 2 mM DTT and lysed by sonication.
The same buffer was used throughout all purification steps. After centrifugation, the lysate was
loaded on a GST column and the protein was eluted by 40 mM glutathione. The fusion protein
was cleaved using TEV protease at 4 °C (overnight) and the SH3 domain was separated through
a Ni2 + sepharose column (in the presence of 20 mM imidazole) and subsequently further
purified through a Superdex 75.
The phosphotyrosine-modified decapeptide EVpYESLPEEL corresponding to the residues
296–305 of Cdc37 was synthesized by GL Biochem.

All NMR spectra were acquired with Varian direct drive 600and 800-MHz spectrometers
equipped with a cryoprobe, processed using NMRpipe, and analyzed using Sparky (T. D.
Goddard and D. G. Kneller, SPARKY 3, University of California, San Francisco, CS, USA).
The methyl-group and backbone chemical shift assignment for wild-type C-Cdc37 was
described previously130, 153. Sequential 1H, 13C, and

15

N backbone chemical shift assignment

for C-Cdc37Y298F, C-Cdc37Y298E, and C-Cdc37 in the presence of 9 M urea, YesSH2, and YesSH3
was obtained by standard 3D triple-resonance experiments, acquired at 30 °C for C-Cdc37 and
YesSH3 constructs, and at 25 °C for YesSH2. The backbone assignment of YesSH3 at 30 °C was
transferred to 5 °C by acquiring a set of five spectra at intermediate temperatures. The backbone
assignment of C-Cdc37Y298E was further facilitated by the use of selective amino acid labeling
with 15N-Ala, -Gln, and -His, as well as tracing signals during the urea-unfolding transition of
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wild-type C-Cdc37. Methyl-group assignment of Cdc37Y298E was obtained by tracing signals
during the unfolding transition of wild-type C-Cdc37 together with a set of four valine mutants
for M1, M316, M324, M337, and A329. The 3D HMQC–NOESY–HMQC spectrum of CCdc37Y298E was acquired with a mixing time of 0.4 s at 30 oC. The urea-unfolding transition of
wild-type C-Cdc37 was performed by titrating two samples of equal concentration (0.4 mM)
prepared in the absence or presence of 9 M urea into each other to obtain a series of urea
concentrations in 0.5 M steps.
Protein dynamics for wild-type C-Cdc37 were described previously153. For CCdc37Y298F, ps–
ns timescale motions were characterized by measuring [1H]–15N heteronuclear NOEs156, at 800
MHz, in the presence or absence of a 3 s presaturation period prior to the 15N excitation pulse
and using recycle delays of 2 and 5 s, respectively, at 30 oC. The data with and without NOE
were acquired in a fid-interleaved fashion. R1 and R2 15N relaxation rates were measured at 800
MHz, using standard pulse sequences157 with a recycle delay of 3 s, at 30 oC. The delay periods
in the series for R1 and R2 were set to 20 ( × 2), 50, 100 ( × 2), 200, 300, 400, 600, 800, 1000,
1200, 1500, and 2000 ms and to 10 (×2), 30, 50 ( × 2), 70 ( × 2), 90, 110, 130, 210, and 330
ms, respectively. Relaxation rate constants were determined by fitting Sparky-extracted peak
heights to mono-exponential functions using relax158. Errors were determined by recording
duplicate experiments for selected delay periods, noted by (×2) above. N–H vector motions
were analyzed by the reduced spectral density-mapping approach and using scripts in relax.
The YesSH2-phosphopeptide titration was performed at 25 °C by the addition of 1.2-molar
equivalents of phosphopeptide at a concentration of 250 μM. Addition of higher excess of
phosphopeptide did not cause any further changes in the 15NHSQC spectrum of YesSH2. The
YesSH3 titration was performed at 5 oC, by the addition of 6.0 molar equivalents of unlabeled
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full-length Cdc37 to 15N-labeled YesSH3, at 1.2 mM and 200 μM. Chemical shift perturbations
are reported as H–NH-combined chemical shift changes, Δδ, determined according to equation
3.1:

Δ𝛿 = √Δ𝛿𝐻2 + (

𝛿𝑁 2
)
5

(3.1)

NMR spectra were acquired in 20 mM Tris, pH = 7.5, 100 mM NaCl, 0.5 mM EDTA, and 2
mM DTT prepared in either H2O or D2O (with Tris-d6), except for YesSH3 that were acquired
in 50 mM KPi, pH = 6.5, 150 mM NaCl, and 2 mM DTT.
The spectrum of phosphorylated Ile-labeled (2H/13C-CH3δ) Cdc37 was acquired by mixing 320
μL of Cdc37 at 25 μM, in 20 mM Tris-d6, pH = 7.5, 50 mM NaCl, 10 mM MgCl2, 0.2 mM
EDTA, 3 mM DTT, 2.5 mM ATP and 1 ×phosphatase inhibitors (Halt), and 7.5% D2O, with
15 μg of active human Yes kinase (EMD). The mixture was run through a desalting column
(Zeba) equilibrated in the same buffer to remove residual glycerol coming from Yes stock,
concentrated back to 320 μL, and put in a shigemi tube. The 13C-HMQC spectrum was acquired
at 30 °C after incubation for 3 h at the same temperature. A reference spectrum of unmodified
Cdc37 was acquired at the same temperature and the same buffer.
Size-exclusion chromatography was performed at 4 °C using a Biorad Enrich SEC 650
analytical column in 20 mM Tris, pH = 7.5, 100 mM NaCl, 0.5 mM EDTA, and 2 mM DTT.
Analysis of ternary complexes was performed by mixing Hsp90 variants, Cdc37 variants, and
bRaf at stoichiometric ratios of 2:1:1, while analysis of binary complexes by mixing Cdc37
variants and bRaf at stoichiometric ratios of 1:1. In both cases, the total volume was 200 μL
and the mixtures were incubated for 15 min at 4 oC. Protein molar concentrations (μM) ranged
from 40:20:20 to 12:6:6 and 30:30 to 8:8 for ternary and binary complexes, respectively.
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Wild-type and mutant constructs of Hsp90 and Cdc37 have been previously described133.
Briefly, to construct FLAG-tagged Hsp90α, BamHI and XhoI sites were engineered by PCR
of the human Hsp90α cDNA (a kind gift from W. Houry, University of Toronto, Toronto, ON,
Canada). The PCR product was subcloned into the BamHI/XhoI sites of the pcDNA3-FLAG
vector (Invitrogen). FLAG-tagged wild-type Cdc37 in pcDNA3 vector was a kind gift from
Dr. Y. Minami (University of Tokyo). To obtain HA-tagged Cdc37, we subcloned Cdc37 into
HA-pcDNA3 plasmid following the manufacturer’s instructions (Invitrogen). Point mutations
in both Hsp90 and Cdc37 were made using the QuikChange site-directed mutagenesis method
following the manufacturer’s instructions (Stratagene). FLAG-tagged bRaf plasmid was
purchased from Biomyx (pMEV-HA 2×). Glucocorticoid receptor plasmid (untagged) was
kindly provided by Dr. M. Cox (University of Texas at El Paso). GFP-tagged androgen receptor
(AR) plasmid was a kind gift of Dr. Lisa Butler (University of Adelaide). All antibodies and
other reagents were commercially obtained. HEK-293 cells were purchased from ATCC, and
were maintained in culture and transfected as previously described133. Briefly, cells were grown
in DMEM tissue culture medium containing 10% fetal bovine serum, and cells were transfected
with Lipofectamine 2000 following the manufacturer’s instructions. Proteins were
immunoprecipitated and subjected to SDS-PAGE and western blotting as described in figure
legends. Briefly, 24 h after transfection, cells were washed with PBS and lysed in a Hepes
buffer containing 10 mM Na2MoO4, 30 mM NaF, 2 mM β-glycerol phosphate, 2 mM sodium
vanadate, 100 µM bpv(phen), and complete protease inhibitors (Roche Applied Science,
Indianapolis, IN). After immunoprecipitation (see individual figure legends for antibodies used
for immunoprecipitation), proteins were boiled in sample-loading buffer, resolved by SDSPAGE, and transferred onto PVDF membrane. Membranes were probed with indicated
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antibodies (see figure legends). Antibody sources/clone #’s are as follows: GR (glucocorticoid
receptor) monoclonal antibody is from Santa Cruz Biotechnology (cat # sc-393232, 1:5000);
GFP monoclonal antibody is from Cell Signaling (cat #2956, 1:1000); GFPtrap beads are from
Chromotek (GFP-Trap A, cat # gta-20); anti-FLAG monoclonal antibody (clone M2) is from
Sigma (cat # F3165, 1:2000); anti-FLAG resin is from Sigma (M2 anti-FLAG antibody-linked
resin); Hsc/Hsp70 antibodies are from Santa Cruz (cat # sc-1059, 1:1000, sc-1060, 1:1000);
Aha1 antibody is from Rockland (cat # 600-401-974); p23 antibody is from Assay Designs
(ADI-SPA-610, 1:1000); HOP antibody is from Cell Signaling (cat # 4464, 1:1000); FKBP59
antibody is from StressMarq (SMC-139, 1:1000); Cdk4 antibody is from Santa Cruz (sc-601,
1:1000); HA antibody is from Roche diagnostics (rat anti-HA, clone 3F10, 1:1000); anti-c-Myc
Agarose Affinity Gel antibody from Sigma (cat # A7470); and penta·His Antibody, BSA-free,
is from Qiagen (cat # 34660, 1:5000). Uncropped scans of the blots and gels are provided in
Figure 3.12.
Trp fluorescence for wild-type, Y298F, and Y298E CCdc37 as a function of urea concentration
was carried out on a ISS PC1 single photon-counting fluorimeter at protein concentrations of
5 μM. Spectra were acquired with a 1-nm step interval between 310 and 450 nm and with an
excitation wavelength of 395 nm. Signal intensity at each interval is an average of eight
iterations.

Titrations were carried out on a PEAQ-ITC calorimeter (Malvern Scientific) at 20 °C for
titrations of bRaf into Cdc37 variants and at 25 °C for phosphopeptide titrations into SH2
domains. Titrations of cochaperones to Hsp90β and Hsp90α constructs were performed at 25
and 36 oC, respectively. Proteins were buffer exchanged into 20 mM Tris, 100 mM NaCl, 0.5
mM EDTA, and 1 mM tris(2-carboxyethyl)phosphine and degassed. For Cdc37bRaf titrations,
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the 200-μL sample cell was filled with Cdc37 at a concentration of ~3–8 μM protein and the
40-μl injection syringe was filled with bRaf at 35–90 μM. For Hsp90-cochaperone titrations,
the cell was filled with Hsp90 at a concentration of ~20–30 μM and the syringe with the
cochaperone at a concentration of ~300–400 μM. For the SH2-phosphopeptide titrations, the
cell was filled with the SH2 domain at a concentration of 50–60 μM and the injection syringe
was filled with phosphopeptide at a concentration of 600–750 μM. All titrations included an
initial 0.2-μL injection and were carried out by 10–12 injections, with a 4-min time interval
between each injection. The data were processed with Origin 7.0 (OriginLab Corporation) with
the point of the initial injection excluded. For all experiments, the reported error bars in the Kd
values correspond to the errors resulted in fitting of the data into a single binding site model.

Thermal denaturation of wild-type, Y298F, and Y298E C-Cdc37 for the extraction-melting
temperatures (Tm) was performed by monitoring molar ellipticity at 222 nm, using an AVIV
(215) Circular Dichroism Spectrometer. Full spectra between 195 and 250 nm were acquired
at 15, 22, and 30 oC. Protein samples were at 5 μM in 20 mM Tris, pH = 7.5, 100 mM NaCl,
0.5 mM EDTA, and 2 mM DTT. Signal intensity at each wavelength is reported as an average
of triplicate measurements, each of which was obtained using a signal-averaging time of 1 s.
The RMSDs ranged between 0.1 and 5.0 across the full spectrum.

Proteins were exchanged in 20 mM Tris, pH = 7.5, 50 mM NaCl, 0.2 mM EDTA, and 2.5 mM
DTT and mixed to achieve final protein molar concentrations (μM) of 24:12:12 and 12:12 for
ternary Hsp90Cdc37-bRaf and binary Cdc37-bRaf complexes, respectively, at a final volume
of 12 μL. The same concentrations were used for free, Hsp90, and Cdc37 variants. Mixtures
were incubated at 4 °C for 15 min and the reactions were initiated by the addition of
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phosphatase inhibitor cocktail, 0.91 μg of recombinant full-length Yes (EMD), and ATP (0.5
mM final concentration), at 22 oC. Phosphorylation was tested after 2 or 8 h, but final analysis
is provided only for the 2-h interval, as the levels either decrease or remain constant at longer
incubation times for different tyrosine residues. For analysis by mass spectrometry, 6 μl of each
reaction was run on SDS-PAGE. Coomassie-stained gel pieces corresponding to Hsp90 and
Cdc37 were excised from the gel, minced and destained before being reduced with
dithiothreitol (DTT) and alkylated with iodoacetamide (IAA), and finally digested with
trypsin/Lys-C overnight at 37 ˚C. Peptides were extracted using 50/ 50 acetonitrile
(ACN)/H2O/0.1% formic acid, and dried in a vacuum concentrator (Labconco). Peptides were
resuspended in 98% H2O/2% ACN/0.1% formic acid for LC–MS/MS analysis and separated
using a 75 µm x 50 cm C18 reversed-phase-HPLC column (Thermo Fisher Scientific) on an
Ultimate 3000 UHPLC (Thermo Fisher Scientific) with a 60-min gradient (4–40% ACN with
0.1% formic acid). Analysis was performed on a hybrid quadrupole-Orbitrap instrument (Q
Exactive Plus, Thermo Fisher Scientific). Full MS survey scans were acquired at 70,000
resolution. The top 10 most abundant ions were selected for MS/MS analysis. Raw data files
were processed in MaxQuant (v.1.5.8.3 www. maxquant.org). Spectra were identified using
Andromeda, the MaxQuant peptide identification algorithm, and searched against the
UniprotKB human protein sequence database, with constant modification of cysteine by
carbamidomethylation

and

the

variable

modification,

methionine

oxidation,

and

phosphorylation of serine, threonine, and tyrosine. Trypsin was specified as the protease, with
a maximum of two possible missed cleavages. Additionally, the database search specified mass
tolerance of 20 ppm (first search) and 4.5 ppm (recalibrated, second search) for precursor ions,
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and 20 ppm for fragment ions. Proteins were identified using the filtering criteria of 1% protein
and peptide false-discovery rate.
In total, two phosphorylation sites were detected for Cdc37 (Y298 and Y331) and nine
phosphorylation sites were detected for Hsp90 (Y61, Y160, Y197, Y284, Y309, Y438, Y492,
Y604, and Y667). The results are displayed as normalized ratios of phosphorylated over nonphosphorylated peptides and errors were calculated by quantifying phosphorylation in a set of
two different reactions. Ratios are provided only for those sites that the corresponding peptide
was identified in both reactions (Y197, Y61, Y160, Y438, Y492, and Y604). For analysis by
ProQ-Diamond staining, the fraction of the in vitro phosphorylation reaction that was run on
SDS-PAGE contained ~3.0 μg of Hsp90. Staining and destaining were performed by standard
protocols.
Initial structures of the helical core (residues 290–343) of the C-terminal domain of Cdc37
were taken from the protein data bank (PDB ID 2N5X). Systems were built using CHARMM17,
but run with OpenMM74 using the CHARMM force field159. Three different systems were
modeled, the unphosphorylated and Y298 phosphorylated wild types, and the Y298E mutant.
Systems were solvated in TIP3P104 water boxes, with at least 20 Å of solvent beyond the protein
in all directions. A nonbonded cutoff of 12.0 Å was used. Long-range electrostatic interactions
were handled using the particle mesh Ewald method5. Heating occurred with restraints of 5
kcal/(mol Å) on the backbone atoms from 150 K to either 300 K or 310 K, in intervals of 10 K
and 20 ps. Backbone restraints were then gradually released to 2.5, 1.0, 0.5, and 0.1 kcal/(mol
Å) over 10 ns of further simulation, followed by production runs. The NPT ensemble was used
with Langevin Dynamics and a Monte Carlo Barostat32. Visualization was performed with
VMD110, and AmberTools was used for the other analyses160.
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3.4

Results

Y298 hydrogen bonding regulates the conformation of CCdc37. To elucidate the functional
role of Y298 phosphorylation in kinase processing, we first investigated the impact of the Y298
hydrogen-bond network on the conformational properties of the C-terminal domain of Cdc37
(C-Cdc37), by introducing the Y298F mutation. In the NMR structure of C-Cdc37153, the –OH
group of Y298 lies within hydrogen bond distance to the carboxylate group of D310 and the
carbonyl group of Q306 (Figure 3.1a). We noted that in higher eukaryotes, where
phosphorylation regulates activity132, Y298 and D310 show a very strong evolutionary
covariation, which implies a significant functional coupling between these positions (Figure
3.8a, b). Comparison of the 15N-HSQC spectrum of C-Cdc37Y298F to that of C-Cdc37 reveals
that most signals from the folded core of the domain (a.a. 288–343) exhibit significant chemical
shift perturbation (CSP), while signals from the flexible C-terminal tail remain unaffected
(Figure 3.1b, c). The most prominent CSPs are observed for residues in helix α2, which
encompasses both D310 and Q306, as well as for residues from helix α3, which packs against
helix α2. Notably, irrespective of the magnitude of CSP, all signals appear to shift toward the
center of the spectrum, indicating that, as compared to the wild-type domain, there is a
relatively small but measurable population shift to an unfolded conformation. This is reflected
on both the thermal stability of CCdc37Y298F, where a 5 °C drop in the Tm is observed, and on
the intrinsic tryptophan fluorescence, where a 7-nm redshift of the wavelength of maximum
emission is observed, indicating a greater exposure (Figure 3.8c, d). Nevertheless, analysis of
the backbone secondary chemical shifts for Cdc37Y298F shows shortening of helices α1 and α2
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by only one and two residues, respectively (Figure 3.8d), which is in agreement with the
marginal difference in the CD spectrum of the two proteins (Figure 3.8e).

To further characterize the impact of the Y298 hydrogen bond network on the conformational
properties of C-Cdc37, we studied the backbone dynamics of C-Cdc37Y298F by measuring 15N
relaxation rates (Figure 3.8f), and adopted the reduced spectral density approach for the
analysis161 (Figure 3.8e). The low frequency spectral density, J(0), is sensitive to both slow
(μs–ms) and fast (ps–ns) timescale internal motions. Enhanced μs–ms internal motion is
manifested as J(0) values higher than one standard deviation from the mean, while enhanced
ps–ns internal motion as J(0) values lower than one standard deviation from the mean. As
compared to C-Cdc37, the folded region of CCdc37Y298F exhibits higher J(0) values, which is
reflected by an increase of the mean value from ~2.2 to ~4.0 ns/rad (Figure 3.1e). Residues for
which significantly large J(0) values are observed and thus experience enhanced μs–ms internal
motions are E296 and E299 from helix α1, E303, L305, C308, and F309 from helix α2, K312,
V314, and A329 from loop1, and helices α3 and α4, respectively, as well as residues S339 and
W342, at the end of the structured region. Importantly, a similar trend is observed for wildtype C-Cdc37, for which the same set of residues is characterized by large J(0) values, albeit
of significantly smaller values as compared to C-Cdc37Y298F. Hence, although disruption of
Y298 hydrogen bond network causes only minimal perturbation in the secondary structure of
the folded core, it partially destabilizes its tertiary structure and enhances the μs–ms dynamics
at the interface of helices α1 and α2.
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Figure 3.1. Conformational properties of C-Cdc37Y298F. a The hydrogen-bond network of
Y298 involving Q306 and D310 is shown as black dashed lines on the solution structure of CCdc37. C-Cdc37 is colored with a gray-to-red gradient, according to the observed chemical
shift perturbation between the wild-type and Y298F C-Cdc37. b Overlay of the 15N-HSQC of
Y298F (orange) and wild-type C-Cdc37 (black) with the tryptophan indole region omitted. c
Magnitude of CSP between wild-type and C-Cdc37Y298F. Prolines are shown as green bars and
unassigned residues as blue bars. CSPs higher than the mean or one standard deviation above
the mean are marked with solid and dashed lines, respectively. d Chemical shift-derived
secondary structure for wild-type (black), Y298F (orange), and Y298E (green) C-Cdc37. e
Reduced spectral density functions J(0) (top), J(ωN) (middle), and J(0.87ωH) (bottom) of
Y298F (orange) and wild-type Cdc37 (black). Solid and dashed lines mark the mean and the
mean ± one standard deviation of the spectral density functions across the C-Cdc37 sequence.
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Y298 phosphorylation results in partial unfolding of C-Cdc37. We next sought to investigate
the effect of phosphoryl group addition to the side chain of Y298 on the conformational
properties of C-Cdc37, by introducing the phosphomimetic mutation Y298E. In contrast to the
15

N-HSQC spectrum of C-Cdc37Y298F, which shows only small changes in signal dispersion

and linewidths as compared to C-Cdc37, the fingerprint spectrum of C-Cdc37Y298E exhibits
poor signal dispersion suggesting that the introduction of a negative charge on the side chain
of Y298 has a global effect on the folded region of C-Cdc37 and brings a significant loss of the
native structure (Figure 3.2a). This observation is further supported by a 13-nm redshift in the
wavelength of maximum tryptophan emission, to a position between the emission maxima of
C-Cdc37Y298F and that of C-Cdc37 acquired in the presence of 9 M urea (Figure 3.8d). Still, as
evident by the far-UV CD spectra, C-Cdc37Y298E retains some secondary structure (Figure
3.8e), while its 15N-HSQC spectrum displays very broad linewidths. Hence, loss of the native
structure by the phosphomimetic mutation does not result in domain disorder but rather in the
transition of C-Cdc37 to a conformationally heterogeneous, partially unfolded state. This effect
is not an artefact caused by domain truncation. Comparison of the 13C-HMQC or 15N-HSQC
spectra of full-length Cdc37 carrying the phosphomimetic mutation (Cdc37Y298E) to that of the
wild-type protein and of C-Cdc37Y298E (Figure 3.2b and Figure 3.9a) reveals a global loss of
dispersion for the signals of the C domain similar to that observed for the isolated CCdc37Y298E. The new signals that appear in the “unfolded” region of the spectrum of full-length
Cdc37Y298E show very good chemical shift correspondence to those of isolated C-Cdc37Y298E,
supporting a shift to the same partially unfolded state. In addition, partial unfolding is not
affected by the presence of Hsp90. Although Cdc37Y298E forms a stable complex with Hsp90
as reported by the large chemical shift change of I159, which lies at the vicinity of the Cdc3765

Hsp90 interface, the C-domain signals of I321 and I337 remain unperturbed at the unfolded
region (Figure 3.2b).
In order to assess whether partial unfolding due to the phosphomimetic mutation is genuine
and recapitulates the effect caused by the addition of a phospholyl group at position Y298, we
first monitored the Yes-mediated phosphorylation of Cdc37 by NMR. Although the reaction
was ~40% complete, the new signals that appear in the 13C-HMQC spectrum of Cdc37 overlay
well with the CH3δ signals of I321 and I337 of Cdc37Y298E, suggesting that the tyrosine-toglutamate substitution behaves as a faithful phosphomimetic in shifting the conformation of
the C domain to a partially unfolded state (Figure 3.2b). We also compared the molecular
dynamics simulations of wild-type, Y298E, and pY298 C-Cdc37, performed at two
temperatures (Figure 3.2c and Figure 3.9b). At 300K, C-Cdc37 remained folded in both
simulations, and native contacts between helices α1 and α2 were maintained. On the other hand,
for pY298, near the end of the simulations, helix α1 rotated toward the solvent, resulting in loss
of native contacts with helix α2, while in one of the Y298E simulations, α1 unfolded and native
contacts with α2 were lost. At 310 K, helix α1 unfolded and contacts between residue 298 and
helix α2 were lost, for both pY298 and Y298E C-Cdc37, while for C-Cdc37, unfolding of helix
α1 was only observed in the extended simulation, but without loss of native contacts and with
several short refolding events. In summary, the disruption of the hydrogen-bonding network of
Y298 and the addition of a negatively charged group have a synergistic effect on the
conformational properties of C-Cdc37, resulting in loss of native secondary and tertiary
structure.
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Figure 3.2. Phosphorylation of C-Cdc37 induces partial unfolding. a Overlay of the 15N-HSQC
of Y298E (green) and wild-type C-Cdc37 (purple) with selected expansions shown on the right.
b Selected regions (Ileδ) from 13C-HMQC spectra of Cdc37 constructs. Left: overlay of fulllength wild-type Cdc37 (black), full-length phosphomimetic mutant Cdc37Y298E (red), and Cdomain phosphomimetic mutant C-Cdc37Y298E (green). Middle: overlay of free Cdc37Y298E
(black) and in the presence of one equivalent deuterated Hsp90α (cyan). The red marks indicate
the positions of I321 and I337 signals in wild-type Cdc37. Right: overlay of Cdc37 (black) and
Cdc37 in the presence of 15-μg Yes acquired in “phosphorylation” buffer (red), together with
Cdc37Y298E (green). c Backbone rmsd for unmodified (top), phosphorylated (middle), and CCdc37Y298E (bottom). Simulations at 300 K are shown in dark and light blue, and at 310 K in
orange and red. Stars mark the time intervals from which snapshots were extracted.
C-Cdc37pY298 populates native-like folding intermediates. To understand the nature of the
unfolding transition triggered by the phosphorylation of Y298, we examined the unfolding of
C-Cdc37 under equilibrium conditions. The

15

N-HSQC spectra of CCdc37 acquired in the
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presence of increasing concentrations of urea show that, for most residues of the structured
core, unfolding occurs on the intermediate fast-exchange regime (Figure 3.10a). From those
resonances that are unambiguously traced at both low- and high-urea concentrations, it is
evident that the observed shift toward the unfolded state does not follow a linear, but either an
angular or a curved trajectory (Figure 3.3a). Therefore, the unfolding transition cannot be
described based on a simple two-state model where the native state (N) is in equilibrium with
the unfolded state (U), but intermediate species must be considered. Observing the indole
resonance of W342, which is well resolved and the only resonance that shifts on a slowexchange fashion without any apparent line broadening, reveals that during the course of the
titration at least two folding intermediate states, I1 and I2, become highly populated between
0.5 M and 5.5 M urea (Figure 3.3b). I1 appears at the beginning of the unfolding transition (0.5
M urea) and reaches a maximum fractional population of ~0.2, followed by I2 (1.5 M urea),
which reaches a maximum fractional population of ~0.7. Notably, during the early stage of
unfolding (~2.0 M urea), the sum of fractional populations is significantly lower than 1.0,
indicating that a fraction of C-Cdc37 (~0.4) populates alternate conformational states that are
invisible under the current experimental conditions, presumably because they interconvert on
a millisecond timescale. Comparison of the C-Cdc37 spectra acquired during the unfolding
transition to that of C-Cdc37Y298F and CCdc37Y298E provides further insights as to how the
composition of the conformational ensemble sampled by C-Cdc37 is altered in response to the
properties of the side chain at position 298 (Figure 3.10b and c). Most resonances in the
15

NHSQC spectrum of C-Cdc37Y298F overlay well with resonances of C-Cdc37’s spectrum

acquired in the presence of 1.5 M urea. Hence, disruption of Y298 hydrogen-bonding network
results in a population shift within the conformational ensemble to a state where I1 becomes
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populated. On the other hand, most resonances of C-Cdc37Y298E overlay well with resonances
of C-Cdc37’s spectrum acquired in the presence of 4.5 M urea, suggesting that the introduction
of a negative charge at position 298 produces a partially unfolded state, where folding
intermediate I2 is significantly populated. Backbone assignment of C-Cdc37Y298E reveals that
in the phosphorylated state, only helices α3 and α4 are fully formed, helix α2 shows a low
propensity of formation at very low confidence, and the sequence covered by helix α1 adopts a
coil conformation (Figure 3.1d and Figure 3.10d). This is further supported by the presence of
dNN(i,i + 1) NOEs for residues from helices α3 and α4, which are characteristic of αhelical
structure, and the absence of NOEs for residues forming helices α1 and α2 in the native state
(Figure 3.3c). In addition, for a set of eight residues (E298, E299, S300, E303, E304, I321,
L341, and V343), it was possible to unambiguously assign two signals, both of which exhibit
an irregular lineshape, indicating a higher degree of heterogeneity than what is reported by the
W342ε signal (Figure 3.2a). This set of residues is not clustered, but it is distributed throughout
the sequence and structure of the native state, as expected based on the global changes observed
in the spectrum. To obtain further insights into the structural properties of the partially unfolded
state, we acquired the methyl-NOESY of CCdc37Y298E. The observed CH3-CH3 NOE pattern
includes a small number of medium- and long-range NOEs from helices α3, α4, and residues
comprising helix α2, indicating that the phosphomimetic mutant samples a conformational
ensemble that is stabilized by native-like contacts between helices α2–α4 (Figure 3.3d).
Thus, phosphorylation of Cdc37 by Yes results in partial unfolding of C-Cdc37 and shift to a
heterogeneous conformational ensemble which comprises at least two equilibrium-folding
intermediates of near-native conformation.
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Figure 3.3 Phosphorylated C-Cdc37 populates folding intermediates. a The beginning (0.0–
1.5 M urea) and end (7.5–9.0 M urea) of the equilibrium unfolding of C-Cdc37 monitored by
15

N-HSQC. Arrows track the shift of signals from the native to the unfolded state. For I321 and

K330 for which the signals of both the native and unfolded states are visible in this expansion,
the superscripts N and U on the assignment denote native and unfolded states, respectively. For
E299 and H332, the signals of the unfolded state fall outside the present spectral window, but
show a “curved” change in chemical shift with increasing urea concentration. The spectrum of
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C-Cdc37Y298E is shown in red for comparison highlighting the position of I321 and K330
signals. b The indole H–N region of wild-type CCdc37, highlighting the signals that correspond
to W342 at different points of the equilibrium unfolding (left). Fractional populations of the
four visible species populated by C-Cdc37 during the equilibrium unfolding as a function of
urea concentration (right). c Selected strips from the amide region of the 15N-NOESY-HSQC
recorded for the wild-type C-Cdc37 (pink) and C-Cdc37Y298E (green). Representative residues
from all helices α1–α4 are included. d Selected strips from the HMQC–NOESY–HMQC
spectrum of C-Cdc37Y298E, highlighting unambiguous (black) and tentative (red) NOEs.

Coupled Cdc37Y298 and Hsp90Y197 tyrosine phosphorylation. Next, we investigated the
molecular mechanism by which partial unfolding of C-Cdc37 regulates the Hsp90 chaperone
cycle of protein kinases. Y298 phosphorylation has been implicated in the dissociation of
ErbB2, Cdk4, Raf-1, and v-Src from Cdc37, without affecting the interaction of Cdc37 with
Hsp90(42s). Since CCdc37 is directly involved in the formation of binary Cdc37 kinase
complexes130, 162, we used purified proteins to monitor the formation of binary and ternary
complexes of Cdc37 Y298 variants with bRaf and Hsp90. We found that the phosphomimetic
mutant Y298E forms stable binary complexes with both bRaf and Hsp90, and ternary
complexes with bRaf and Hsp90 that are indistinguishable from those formed by the wild-type
protein130, 163 (Figure 3.4a and Figure 3.11a, b). Despite the higher Kd value observed for the
interaction between Cdc37Y298E and bRaf as compared to wild- type Cdc37, this observation is
distinct from previously reported findings using co-immunoprecipitation from cell lysates133.
Therefore, we also tested complex formation with the single phosphomimetic mutant Y4E
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(Cdc37Y4E) or the double-phosphomimetic mutant Y4E/Y298E (Cdc37EE). Phosphorylation of
Y4, which is located at the N-terminal tail of Cdc37, was previously shown to have a more
limited impact, affecting the association of Cdc37 only with ErbB2 and v-Src. As for
Cdc37Y298E, both Cdc37Y4E and Cdc37EE formed stable binary complexes with bRaf and Hsp90,
and ternary complexes with bRaf and Hsp90 (Figure 3.4a and Figure 3.11a, b). Next, we tested
complex formation in an in vivo setting, where Flag-tagged bRaf was immunoprecipitated from
transiently transfected HEK293 cells and the associated HA-tagged Cdc37 variants were
visualized by western blotting. Similarly to the in vitro experiments, both phosphomimetic
Cdc37Y298E and the nonphosphomimetic mutant Cdc37Y298F were identified in bRaf complexes
to the same extent as was wild-type Cdc37 (Figure 3.4b and Figure 3.12).
In addition to Cdc37 phosphorylation at positions Y4 and Y298, Yes and other nRTKs
phosphorylate Hsp90 at positions Y197 and Y192 of the α and β isoforms, respectively. This
modification correlates with disassembly of Cdc37 from the substrate-recruitment complex and
promotes progression of the chaperone cycle133 In agreement with previous data133 Hsp90Y192E
did not form stable binary complexes with Cdc37 and/or ternary complexes with Cdc37 and
bRaf (Figure 3.4a and Figure 3.11a, b). Therefore, Cdc37 phosphorylation at Y298 does not
have a generalized impact on the formation of binary or ternary complexes with Hsp90 and the
client kinase, but instead, it is the phosphorylation of Hsp90 at Y192/Y197 which acts as the
molecular switch that triggers disassembly of the substrate-recruitment complex and
cochaperone dissociation. Importantly, modification of this residue has minimal impact on the
association of Hsp90 with other cochaperones, including that of Hsp70, Aha1, p23, Hop,
Fkbp59, Sugt1, and CHIP or with non-kinase clients, including the androgen and
glucocorticoid receptors (Figure 3.4c, d and Figure 11c, d and Figure 12).
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Since both Cdc37Y298 and Hsp90Y197 phosphorylation are mediated by Yes, we investigated
whether the functional consequence of Cdc37Y298 phosphorylation and C-Cdc37 partial
unfolding is to regulate Hsp90Y197 phosphorylation.

Figure 3.4. Assembly of complexes of Cdc37 and Hsp90 phosphomimetic variants with clients
and cochaperones. a Binary complex formation between Cdc37 variants and bRaf (left), and
between Hsp90β variants and Cdc37 (right), followed by ITC. The corresponding Kd values
are displayed in the inset. Error bars in the Kd values correspond to the errors resulted in fitting
of the data into a single binding site model. b HEK-293 cells were cotransfected with indicated
HA-tagged Cdc37 and FLAG-tagged bRaf plasmids. After cell lysis, proteins were
immunoprecipitated with anti-FLAG resin for 1 h at 4 °C with rotation. Bead pellets were
washed and analyzed for Cdc37 interaction by SDS-PAGE/western blot, using anti-HA
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antibody. c HEK-293 cells were transfected with FLAG-tagged Hsp90, Hsp90Y197E, or
Hsp90Y197F plasmids. After cell lysis, proteins were immunoprecipitated with anti-FLAG resin
for 1 h at 4 °C with rotation. Bead pellets were washed three times before analysis by SDSPAGE/western blot. Co-precipitating endogenous Hsp70, Aha1, p23, Hop, Fkbp59, and Cdk4
were detected with specific antibodies. d HEK-293 cells were transfected with the indicated
Hsp90, androgen receptor (AR), and glucocorticoid receptor (GR) plasmids. Proteins were
precipitated with GFP-Trap resin (left) or ANTI-FLAG M2 agarose (right) for 1 h at 4 °C with
rotation. Bead pellets were washed three times with lysis buffer before analysis by SDSPAGE/western blot as indicated. AR was visualized with anti-GFP antibody, GR was
visualized with a specific antibody, and Hsp90 was visualized with anti-FLAG antibody.

Purified variants of Cdc37 and Hsp90 were utilized to assemble binary and ternary complexes
formed with the client bRaf, and their tyrosine phosphorylation levels in the presence of added
Yes were quantified using mass spectrometry (Figure 3.5 and Figure 3.13). The highest level
of Yes-mediated Cdc37Y298 phosphorylation was detected in the free state or when in a binary
complex with bRaf, while reduced phosphorylation was observed for both a ternary complex
between Cdc37, Hsp90, and bRaf, and for a binary complex of Cdc37 with Hsp90 (Figure
3.13a). However, the total cellular pool of Cdc37 remains in a hypophosphorylated state, as
phosphorylation at either Y4 or Y298 is only detected after treatment with the potent
phosphotyrosine phosphatase inhibitor bpv(phen)133 Therefore, the significant difference in the
phosphorylation levels between the free and complexed states of Cdc37 observed in the current
in vitro setting is suppressed in the cell, presumably due to the action of protein phosphatases.
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On the other hand, Hsp90Y197 phosphorylation was markedly more efficient in the context of a
ternary complex with Cdc37 and bRaf, compared to either the free state or in a binary complex
with Cdc37 (Figure 3.5). Importantly, such dependence on a ternary complex for optimal
phosphorylation was not observed for other Hsp90 tyrosines that were detectably
phosphorylated in the presence of Yes. Similarly, Cdc37Y298 mutation did not have a marked
impact on Yesmediated phosphorylation of these additional sites (Figure 3.5). However, when
the non-phosphorylatable Y4F/Y298F double mutant (Cdc37FF) or the single nonphosphorylatable mutant Y298F (Cdc37F) were utilized to reconstitute ternary complexes,
Hsp90Y197 phosphorylation dropped by one order of magnitude (Figure 3.5). Intriguingly, in
ternary complexes of the doublephosphomimetic mutant Cdc37EE, Hsp90Y197 phosphorylation
was also compromised and still lower relative to ternary complexes of the wild-type protein
(Figure 3.5). These results suggest that Yes-mediated Cdc37Y298 phosphorylation uniquely
promotes Hsp90Y197 phosphorylation and that the Hsp90Y197dependent assembly and
disassembly of the recruitment complex are characterized by a coupled phosphorylation
mechanism. Therefore, coupled Hsp90Y197 phosphorylation does not merely depend on the
partial unfolding of C-Cdc37, but specifically requires that the amino acid at position 298 of
Cdc37 is a phosphorytable tyrosine.
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Figure 3.5 Phosphorylation of Hsp90 in the context of in vitro-assembled complexes. Mass
spectrometry intensity ratios of Yes-modified Hsp90α peptides over the corresponding
unmodified peptides for positions Y61, Y160, Y197, Y438, Y492, and Y604. Ratios are
normalized to the highest-detected phosphorylation levels among five different liganded states
of Hsp90α: free, in a binary complex with wild-type Cdc37 (C), or in a ternary complex with
bRaf and Cdc37 variants (wild type = C-K, doubly non-phosphorylatable = CFF-K, singly nonphosphorylatable = CF-K, and double phosphomimetic = CEE-K). Error bars are defined as s.d.
over two replicates.

C-Cdc37 unfolding unmasks a high-affinity SH2-binding motif. The dependence on Cdc37 in
uniquely facilitating Hsp90Y197 phosphorylation on a phosphotyrosine indicates that coupling
of the two phosphorylation events is characterized by high specificity for pY298. The vast
majority of nRTKs contain Nterminal SH2 and SH3 modular domains, among which the
former mediates protein–protein recognition through a specific interaction with short
polypeptide stretches that contain a phosphotyrosine. Thus, we tested the hypothesis that
promotion of Hsp90Y197 phosphorylation by Cdc37 phosphorylated at Y298 occurs through an
SH2-mediated recruitment of Yes to Hsp90. Scanning of the primary sequence of Cdc37 for
conserved motifs using highly stringent parameters164-165 identified the heptapeptide
296

EVYESLP302, which encompasses phosphotyrosine Y298, as an SH2 interaction motif,
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while using low-stringency parameters the tetrapeptide 359PGDP362 is identified as a potential
SH3 interaction motif. When a phosphotyrosine-modified decapeptide of Cdc37 (denoted as
pYESL) was tested for binding to the SH2 domain of Yes (YesSH2), it was indeed found to
exhibit high affinity (Kd= 0.41 ± 0.11 μM) (Figure 3.6a). The interaction is driven by
thermodynamically favorable contributions of both the enthalpic and the entropic terms, which
is similar to the thermodynamic signature of binding for the interaction of phosphopeptides to
Src SH2 domain (SrcSH2)166 (Figure 3.6a). Several structural studies of SH2 domains in
complex with phosphopeptides have revealed a conserved mode of recognition, where the
phosphotyrosine and the three residues immediately downstream are recognized by distinct
binding pockets. Although to date the mode of YesSH2-phosphopeptide interaction has not been
studied at a structural level, we used NMR to examine whether the YesSH2-pYESL interaction
maps on a surface common to other SH2-phosphopeptide complexes. Titration of pYESL to
15

N-labeled YesSH2, results in CSP of a large number of signals in an intermediate-slow

exchange fashion, consistent with the affinity measured by ITC (Figure 3.6b, c and Figure
3.14a). Mapping the CSP on the structure of YesSH2 shows that the most prominent changes are
observed for residues in the vicinity of the putative pTyr and pTyr + 3 binding pockets, showing
excellent correspondence with the residues involved in phosphopeptide recognition of other
SH2 domains (Figure 3.6d and Figure 3.14b). Furthermore, the addition of CCdc37Y298E in
which helix α1 is unfolded or wild-type C-Cdc37 in which helix a1 is fully formed cause only
minimal perturbation in the

15

N-HSQC of YesSH2 (Figure 3.14c). Therefore, Cdc37

phosphorylated at position Y298 is recognized by YesSH2 through a typical SH2-phoshopeptide
interaction.
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A potential mechanism by which Yes recruitment through the SH2-Cdc37pY298 recognition
affects Hsp90 phosphorylation is by increasing the local concentration of the modifying
enzyme at a particular location on Hsp90. To test this hypothesis, we assessed the total Hsp90
phosphorylation in the context of ternary complexes and in presence or absence of an excess
of SH2Yes or pYESL, using the Pro-Q Diamond stain to detect phosphotyrosines (Figure 3.6e).
Although addition of pYESL had a moderate impact on the overall levels of Hsp90
phosphorylation (7% drop), addition of SH2Yes resulted in a substantial 25% drop, consistent
with the concept that an excess of the isolated SH2 domain is able to compete with full-length
Yes for binding to Cdc37pY298 and exclude it from the chaperone complex, even though
Yesmediated phosphorylation of other Hsp90 tyrosine residues appear to be independent of
Cdc37.
Phosphorylation of Hsp90 at position Y197, as well as at positions Y313 and Y627 is not
carried out solely by Yes, since Yes knockdown fails to completely abolish phosphorylation of
these residues133 This indicates that other nRTKs can substitute for Yes in recognizing
Cdc37pY298 and may be recruited to the Hsp90 complex through a SH2-phoshopeptide
interaction. Thus, we examined the extent to which pYESL can be recognized by the SH2
domains of nRTKs of the Src kinase family other than Yes, including those of Src, Hck, and
Lyn. All domains show similar thermodynamic signatures of binding, with the SrcSH2 and
HckSH2 having Kd values comparable to those of YesSH2, while as expected based on the Kd,
addition of pYESL into 15N-labeled SrcSH2 results in large CSPs to its 15N-HSQC (Figure 3.6a
and Figure 3.14d). On the other hand, the interaction with LynSH2 is significantly weaker,
indicating that not all SH2 domains can effectively recognize pYESL and thus substitute for
Yes. Finally, we tested whether the

359

PGDP362 motif of C-Cdc37 is recognized by the SH3
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domain of Yes (SH3Yes) and therefore whether it provides additional specificity determinants
and stability to the Cdc37-Yes complex. Addition of excess Cdc37 to 15N-labeled SH3Yes only
marginally affects its

15

N-HSQC spectrum, with very small chemical shift changes and

broadening for a small number of signals, indicating a weak, transient interaction, which is
expected considering the lack of flanking proline or positively charged residues. Nevertheless,
perturbed residues map at the canonical SH3-binding site and include R105 and T106 of the
conserved RT loop of SH3 domains (Figure 3.14e).

Figure 3.6. Interaction of a pY298 phosphopeptide with the SH2 domains of Yes and other
nRTKs. a ITC isotherms for the interaction of pYESL with the SH2 domains of Yes, Src, Hck,
and Lyn (left), together with the enthalpic and entropic contributions to the free energy change
(middle) and the corresponding Kd values (right). Error bars in the Kd values correspond to the
errors resulted in fitting of the data into a single binding site model. b Overlay of the 15NHSQC
of YesSH2 in the absence (black) and presence (green) of one equivalent of pYESL. c CSP as a
function of YesSH2 primary sequence. The mean and one standard deviation above the mean are
marked by solid and broken lines, respectively. d Mapping of the observed CSPs on the
structure of SH2. The black broken line highlights the peptide-binding site as identified in other
SH2 domains. e The effect of competing concentrations of SH2Yes or pYESL (at 0.5 mM) on
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the overall phosphorylation levels of Hsp90 in the context of ternary complexes formed with
bRaf and Y4F/Y298F (lane 1) or wild-type Cdc37 (lanes 2–4), monitored by staining with ProQ Diamond (top) and coomassie (bottom).

In summary, the functional role of tyrosine phosphorylationinduced partial unfolding of CCdc37 is to unmask a highaffinity SH2-binding motif that serves to increase the local
concentration of nRTKs at Hsp90 and thus to potentiate Hsp90 tyrosine phosphorylation at
specific sites.

3.5

Discussion

Phosphorylation of Hsp90 and its composite machinery exerts key regulatory roles during
client maturation. Here, we show that during the kinase chaperone cycle, Cdc37
phosphorylated at Y298 acts as a platform for docking of non-receptor tyrosine kinases through
their regulatory domains to drive the coupled Hsp90 phosphorylation at Y197 and specifically
regulate kinase chaperoning (Figure 3.7).
Site-specific phosphorylation of Hsp90 has a differential impact on the maturation of different
classes of clients, including protein kinases and transcription factors138,

140, 167

. Our study

suggests that the cochaperone-mediated recruitment of modifying enzymes provides a
mechanism to generate highly specific Hsp90 modification patterns (Figure 3.5) that are
tailored to fine-tune the chaperone cycle in a client class-specific manner. We show that Hsp90
phosphorylation at Y197 does not compromise association of the Cdc37-independent nuclear
hormone receptor clients glucocorticoid receptor (GR) and androgen receptor (AR) with the
chaperone (Figure 3.4d), while a clear reduction in Cdk4 interaction with the phosphomimetic
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mutant Hsp90-Y197E is evident (Figure 3.4c). Further, Hsp90Y197E fails to associate with
Cdc37 (Figure 3.4a and Figure 3.11b), which during the early stages of the chaperone cycle
interacts exclusively with the N-terminal domain of Hsp90127, 131-132, 168, without losing its
ability to associate with a number of cochaperones (Figure 3.4c and Figure 3.11c, d) that
interact either with the C-terminal domain or with the middle and N-terminal domains of
Hsp90.
Phosphorylation of the Hsp90-Cdc37 chaperone pair has been largely explored; however, there
is only limited high-resolution information available to account for the functional outcome of
the observed modifications130,

132

. The addition of a phosphoryl group may alter protein

function through versatile mechanisms that include allosteric changes169, direct positive or
negative modulation of protein–protein and protein–DNA interactions170, availability of
cofactor-binding sites171, autoinhibition172, disorder-to-order173, and order-to-disorder174
transitions. Our NMR data suggest that C-Cdc37 acquires a partially unfolded state when
phosphorylated at Y298 (Figure 3.2 and Figure 3.9). This is a synergistic effect caused by the
disruption of the hydrogen bond network of Y298 side chain and the addition of the phosphoryl
group (Figs. 3.1, 3.2). The folding-unfolding transition of a small protein domain of the size of
C-Cdc37 occurs typically in a two state manner, where only the native and unfolded states are
populated. However, folding of C-Cdc37 through a highly populated folding intermediate
(Figure 3.3 and Figure 3.10) provides the cochaperone with two unique functional advantages.
First, helices α3 and α4 that form a hydrophobic patch previously shown to participate in
binding bRaf130, are fully formed (Figs. 3.1,3.3 and Figure 3.10d), allowing Cdc37 to interact
with clients and Hsp90 in the context of binary and/or ternary complexes (Figure 3.4 and Figure
3.1). Second, helix α1, which contains Y298, is unfolded in the phosphorylated state (Figs.
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3.2,3.3). This phosphorylation-stabilized extended conformation unmasks a high-affinity SH2binding phosphopeptide, which exhibits broad specificity over SH2 domains of nRTKs (Figure
3.6). These include the SH2 domain of the Cdc37- modifying enzyme Yes, as well as the SH2
domains of other nRTKs of the Src family that are capable of phosphorylating Hsp90Y197 133.
A common concern in using phosphomimetic mutants, particularly for tyrosine and less for
serine and threonine phosphorylation, is whether these serve as bona fide mimics of the
authentic phosphorylated state. Our results suggest that for Cdc37, Y298 phosphorylation
facilitates two distinct molecular events and functional outcomes. First, partial unfolding of
CCdc37, which results in the formation of an exposed phosphopeptide sequence, and second,
recognition of the resulting phosphopeptide by SH2 domains of nRTKs, which potentiates
Hsp90Y197 phosphorylation. We show that the partially unfolded state acquired by Cdc37Y298E
is the same as the one populated after Yes-mediated phosphorylation (Figure 3.2b). Therefore,
the phosphomimetic mutant is a faithful mimic in initiating the native conformational change
produced by the phosphorylation event. However, the “two-pronged plug into two-holed
socket” mode of SH2-phosphopeptide interactions imposes specific geometric and chemical
restraints for the binding pockets and particularly for the pY-binding pocket, which is
optimized for interacting with the phosphoryl group175-176. Evidently, the corresponding
phosphomimetic sequence in C-Cdc37Y298E fails to form a stable complex with SH2Yes (Figure
3.14c). Therefore, in this case, the Y298E phosphomimetic mutant is not a faithful mimic in
recruiting non-receptor tyrosine kinases to the chaperone complex via SH2-mediated
interactions, consistent with our data showing reduced Hsp90Y197 phosphorylation levels for
complexes reconstituted with the non-phosphorylatable mutants as compared to wild-type
Cdc37-reconstituted complexes (Figure 3.5).
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The binding of the Cdc37-derived phosphopeptide to SH2 domains is not the only non-kinase
domain interaction identified here, as C-Cdc37 interacts transiently also with the SH3
regulatory domain of Yes (Figure 3.14e). Although weak, it is expected that this interaction
brings a significant stabilizing contribution when coupled to the C-Cdc37pY298-SH2 interaction
in the context of a bipartite mode of binding. Thus, since Cdc37 provides kinase specificity to
the Hsp90 machinery, Cdc37pY298 may act as a platform for specific recruitment of modifying
nRTKs into the kinase chaperone cycle of Hsp90.
a

b

c
pY298

Yes

nRTK

f

e
pY197

d
pY197
pY298

pY298

Cdc37

Figure 3.7. Targeted-Hsp90 phosphorylation via a cochaperone-recruited kinase. a, b Client
kinases require Cdc37 to form stable complexes with Hsp90 in the beginning of the chaperone
cycle. c, d Partial unfolding of C-Cdc37 upon Y298Cdc37 phosphorylation creates a high-affinity
SH2-interacting motif, which recruits nRTKs to the Hsp90 complex. e, f nRTKs phosphorylate
Hsp90 at Y197, resulting in dissociation of Cdc37 and progression of the Hsp90 cycle.
Cochaperone-mediated recruitment of modifying enzymes may be a generalized mechanism to
create unique Hsp90 phosphorylation patterns in a client class-specific manner or alternatively
to modify clients (Hsp90, Cdc37, and client kinase are shown in blue, black outline, and green,
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respectively). The helical C-Cdc37 is shown in rainbow from blue to red. The kinase, SH2, and
SH3 domains of the modifying nRTK are shown in yellow, red, and gray, respectively.

The identification of multiple phosphorylation sites on both Hsp90 and its cochaperones
suggests that the chaperone cycle may be regulated at the level of the machinery via a
combinatorial phosphorylation pattern in a sequential and client class-specific manner. Support
for this hypothesis comes from previous observations, where the same nRTK (Yes) was able
to phosphorylate both Hsp90 and Cdc37, and from the current data showing a strong
Cdc37pY298-SH2Yes interaction (Figure 3.6). The phosphomimetic mutant Y192E of Hsp90β or
Y197E of Hsp90α prevents complex formation with Cdc37 and triggers the disassembly of the
recruiting ternary complex irrespective of the phosphorylation state of Cdc37 (Figure 3.4 and
Figure 3.11)133. Therefore, phosphorylation at this position of Hsp90 must be tightly regulated
and occur only after the client kinase has been loaded on the chaperone. In this respect, the
ability of Y197 to become phosphorylated in the context of ternary complexes, shows a very
strong correlation with the ability of Cdc37 to become phosphorylated at position Y298, since
in the presence of a non-phosphorylatable Cdc37Y298 variant, Y197 (hsp90α) phosphorylation
is greatly suppressed (Figure 3.5). Mechanistically, the presence of a phosphotyrosine at
position 298 and not the resulting C-Cdc37 domain unfolding is critical to promote
phosphorylation of Hsp90 at Y197 (Figure 3.5) and correlates with a higher effective
concentration of Yes at the chaperone complex (Figure 3.6e). In cis phosphorylation via SH2mediated kinase recruitment, where an nRTK utilizes a phosphotyrosine on its own substrate
as a docking site to further phosphorylate it on other accessible tyrosines is an efficient
mechanism for substrate hyperphosphorylation through processive or non-processive
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mechanisms177. In the context of a macromolecular complex such as the ternary Hsp90-Cdc37kinase complex, coupled phosphorylation occurs in trans, with the modifying kinase docked
on Cdc37 while phosphorylating Hsp90. As not all Hsp90 tyrosine phosphorylation events are
affected equally by Cdc37 phosphorylation (Figure 3.5 and Figure 3.13), in transmediated
coupled phosphorylation imprinted by Cdc37Y298 phosphorylation creates a unique
phosphorylation pattern on Hsp90, where Y197 becomes phosphorylated at high levels, and is
tailored for the progression of the kinase chaperone cycle. This highly regulated mechanism of
Hsp90 phosphorylation is unique to tyrosine modification, as SH2 domains are only found in
nRTKs. Therefore, it remains unknown how other phosphorylation events identified to impact
the kinase chaperone cycle, such as the modification of S365 (Hsp90β) by CK2152, are
regulated. Suppression of phosphorylation events by the action of phosphatases, combined with
the sequential masking and unmasking of the modification sites during different steps of the
chaperone cycle could provide alternative regulatory mechanisms.

85

3.6 Supplementary Information

Figure 3.8 Analysis of the sequence and biophysical properties of C-Cdc37. (a) A segment of
Cdc37’s multiple sequence alignment generated using JalView (left)178, covering helices
86

1

and

2

of C-Cdc37, which encompass Y298 and D310, respectively, together with a sequence

logo generated using WebLogo179 corresponding to the structured region (288-343) of the
domain (right). (b) C-Cdc37 residue pairs sorted by coevolution strength, where the strength
in covariance increases from green to red and with increasing radius. Only covarying residues
with sequence separation greater than three amino acids were considered. The last 20 amino
acids of Cdc37 were excluded from the analysis as the multiple sequence alignment for this
segment contained > 75% gaps. The Y298-D310 pair (boxed) shows the strongest covariation
within C-Cdc37. The coevolution matrix was generated using gremlin180. (c) Thermal
denaturation curves of wild-type (black), Y298F (orange) and Y298E (green) C-Cdc37
obtained by measuring molar ellipticity as a function of temperature. (d) Fluorescence emission
spectra of wild-type (black), Y298F (orange) and Y298E (green) C-Cdc37 acquired in native
buffer. For comparison, the spectrum of wild-type C-Cdc37 was also acquired under denaturing
conditions, in the presence of 9M urea. The frequency of maximum emission of each spectrum
is marked on the x-axis. C-Cdc37 contains a single tryptophan at position 342. (e) CD spectra
of wild-type (black), Y298F (orange) and Y298E (green) C-Cdc37 acquired in native buffer at
15 oC, and of wild-type C-Cdc37 acquired in the presence of 9M urea (purple). (f)
relaxation rates R2, R1 and 1H-15N NOE of wild-type (black) and Y298F CCdc37 (orange).
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15

N

Figure 3.9 Phosphorylation-induced unfolding of C-Cdc37. (a) Overlay of the 15N-HSQC spectra
of full-length wild-type Cdc37 (black), full-length Cdc37Y298E (red) and C-Cdc37Y298E (green). The
assignment of a set of dispersed C-Cdc37 signals is shown to highlight that the loss of dispersion
observed in the spectrum of C-Cdc37Y298E (Figure 2A) is also observed in the spectrum of full-
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length Cdc37Y298E. The expanded regions depicted on the right show that there is a very good
correspondence between the position of new peaks of full length Cdc37Y298E and C-Cdc37Y298E,
indicating that the phosphomimetic mutation causes the same conformational rearrangement to
full-length Cdc37 (partial unfolding) as to isolated C-Cdc37. (b) Heavy atom contacts within 4 Å
between residue 298 and helix

2

as derived from the molecular dynamics simulations performed

on wild-type (top), phosphorylated (Y298) (middle) or the Y298E phosphomimetic mutant of CCdc37 (bottom).
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Figure 3.10 Characterization of the partially unfolded state induced by the phosphomimetic
mutation (a) The unfolding transition of C-Cdc37 monitored using

15

N-HSQCs recorded in the

presence of different urea concentrations ranging from 0 to 9 M at 0.5 M steps. (b) Comparison of
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the 15N-HSQC spectra of wild-type C-Cdc37 under native conditions (black), Y298F under native
conditions (red) and wild-type C-Cdc37 in the presence of 1.5 M urea is shown on the left. The
same comparison is shown on the right, but for Y298E (green) and wild-type C-Cdc37 in the
presence of 4.5 M urea (purple). In the expansions of selected regions, the spectra acquired under
non-native conditions are shown at a lower threshold. (c) A comparison of the 15N-HSQC spectra
of Y298F (red) and Y298E (green) C-Cdc37. (d) Secondary structure propensity of Y298E derived
by analyzing the backbone Ca, Cb, N, C’ and HN chemical shifts using Talos-N4. Helical, extended
and coil conformations are shown as continuous lines in red, yellow and black respectively. The
confidence of prediction is shown as broken black line.
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Figure 3.11 The effect of phosphomimetic-related mutation on the assembly of Hsp90 and Cdc37
binary and ternary complexes with other cochaperones and the client kinase bRaf. (a) Size
exclusion chromatography traces and the corresponding gels of free bRaf, Cdc37 and Hsp90. The
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elution volume and the fractions analyzed by SDS-PAGE is shown for reference for Hsp90. (b)
Size exclusion chromatography traces and the corresponding SDS-PAGE images for binary
complexes of bRaf with Cdc37 variants (red), binary complexes of Hsp90 and Cdc37 variants
(blue) and ternary complexes of bRaf with Cdc37 and Hsp90 variants (green). All gels were loaded
according to the fraction scheme shown for Hsp90 in (marked in red in (a)), with the exception of
the Hsp90Y192E gels that were loaded with the fraction scheme marked in green in (a). The same
molecular weight marker as the one shown in the top panel of (a) was loaded on all gels. (c) The
interaction of Hsp90 and its phosphomimetic mutant Y197E with the cochaperones Cdc37, Aha1
and Hop, followed by ITC.
The corresponding Kds are shown in the inserts. (d) HEK-293 cells were transfected with indicated
plasmids and lysed in 20 mM Hepes pH 7.3, 100 mM NaCl, 1 mM MgCl2, 0.1% NP-40, 10 mM
sodium molybdate, plus protease and phosphatase inhibitors. Proteins were precipitated with
indicated antibody-conjugated resin for 1h at 4 oC with rotation. Bead pellets were washed three
times with lysis buffer before analysis via SDS-PAGE and western blot.
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Figure 3.12 Scans of uncropped gels shown in the main text and in the Supplemental information.
Fig. 4b (a-b), Fig. 4c (c-i), Fig. 4d (j-k), Supplementary Fig. 4 (l-m) and Fig. 6 (n-o).
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Figure 3.13 Cdc37 and Hsp90 phosphorylation sites identified in this study by mass spectrometry
at different liganded states. (a) MS/MS spectra of Cdc37 phosphopetides for Y298 and Y331 (left),
and ratios of modified over unmodified peptides for Y298 and Y331 of Cdc37. (b) The sequence
of Hsp90 (alpha isoform) highlighting in green the peptide coverage obtained in the current study
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and in red the tyrosine residues identified in the phosphorylated form. (c) MS/MS spectra of Hsp90
phosphopetides identified in the current study.

Figure 3.14 Interaction of SH2 and SH3 regulatory domains of nRTKs with Cdc37. (a) Expanded
regions of the

15

N-HSQC of YesSH2 (red) in the presence of 0.5 (cyan), 1.0 (magenta) and 1.2
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(blue) equivalents pYESL. (b) The electrostatic potential of SH2Yes mapped on its structure
(5MTJ). The orientation of the domain is the same as for Fig. 6d. (c) Overlay of the 15N-HSQC
spectra of free YesSH2 (black) and in the presence of two equivalents wild-type C-Cdc37 (cyan)
or C-Cdc37Y298E (red). The signals of T226, A228 and G246 which show the largest chemical
shift are found in the vicinity of the pY+3 binding pocket. (d) Overlay of the 15N-HSQC of SrcSH2
in the absence (blue) and presence (red) of one equivalent pYESL. (e) Left: overlay of the 15NHSQC of free YesSH3 (black) and the presence of five molar equivalents of full-length Cdc37
(red), acquired at 5 oC. Signal assignment is shown for those residues that experience a significant
drop in intensity in the presence of Cdc37. Middle: plot of intensities of SH3Yes signals in the
presence over the corresponding intensities in the absence of full-length Cdc37. The dotted line
marks a drop equal to one standard deviation higher than the average drop. Right: mapping of the
residues affected by Cdc37 on the crystal structure of SH3Yes.

Table 3.1: List of primers used in the present study
Mutant

PRIMER

F-yes-SH3

GGAATTCCATATGGGTGGTGTTACCATTTTTGTTG

R-yes-SH3

CGCGGATCCTTATTAGCTATCTGCCGGTGCAAC

F-Cdc37Y298E

GCCGCCGGGGCCAACCCGCTTCTTGCG

R-Cdc37Y298E

CGCAAGAAGCGGGTTGGCCCCGGCGGC

F-Cdc37Y298F

GGGAGGGACTCGAAGACCTCGACGG
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Table 3.1 Continued
R-Cdc37Y298F

CCGTCGAGGTCTTCGAGTCCCTCCC

F-Cdc37D310A

CATCTGCACGTCCTTCACCGCGAAGCACTTCTGGAGTTC

R-Cdc37D310A

GAACTCCAGAAGTGCTTCGCGGTGAAGGACGTGCAGATG

F-Cdc37-Y4E GTGGTCCCACACGCTTTCGTCCACCATATGGCC
R-Cdc37Y4E

GGCCATATGGTGGACGAAAGCGTGTGGGACCAC

F-Cdc37-Y4F GGTCCCACACGCTGAAGTCCACCATATGG
R-Cdc37-Y4F CCATATGGTTGGACTTCAGCGTGTGGGACC
F-Hsp90bY192E

TGACCCGCCTCTCTTCTAGTTCCCTTGTCTGATCTTCTTTA

R-Hsp90bY192E

TAAAGAAGATCAGACAGAGGAACTAGAAGAGAGGCGGGTCA

F-Hsp90aY197E

CTTTTATTCTTCGTTCCTCCAATTCCTCAGTTTGGTCTTCTTTCAGG

R-Hsp90aY197E

CCTGAAAGAAGACCAAACTGAGGAATTGGAGGAACGAAGAATAAA
GG

F-Hsp90aY197F

TTATTCTTCGTTCCTCCAAGAACTCAGTTTGGTCTTCTTTC

R-Hsp90aY197F

GAAAGAAGACCAAACTGAGTTCTTGGAGGAACGAAGAATAA
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Chapter Four

One-Bead−Two-Compound Thioether Bridged Macrocyclic γ‑AApeptide Screening Library
against EphA2

Note to Reader: This work was performed in collaboration with the Cai Group (Department of
Chemistry, University of South Florida), Qi Li (Department of Medical Oncology, Shuguang
Hospital, Shanghai University of Traditional Chinese Medicine) and Sridevi Challa (Moffit Cancer
Center). My contribution to this project was all molecular dynamics simulations. This chapter is
reprinted and adapted with permission from the above authors and Geoffrey M. Gray and Arjan
van der Vaart from Journal of Medicinal Chemistry, see Appendix C.

4.1

Abstract

Identification of molecular ligands that recognize peptides or proteins is significant but poses a
fundamental challenge in chemical biology and biomedical sciences. Development of cyclic
peptidomimetic library is scarce, and thus discovery of cyclic peptidomimetic ligands for protein
targets is rare. Herein we report the unprecedented one-bead− two-compound (OBTC)
combinatorial library based on a novel class of the macrocyclic peptidomimetics γ-AApeptides.
In the library, we utilized the coding peptide tags synthesized with Dde-protected α-amino acids,
which were orthogonal to solid phase synthesis of γ-AApeptides. Employing the thioether linkage,
the desired macrocyclic γ-AApeptides were found to be effective for ligand identification.
Screening the library against the receptor tyrosine kinase EphA2 led to the discovery of one lead
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compound that tightly bound to EphA2 (Kd = 81 nM) and potently antagonized EphA2-mediated
signaling. This new approach of macrocyclic peptidomimetic library may lead to a novel platform
for biomacromolecular surface recognition and function modulation.

4.2

Introduction

Chemical biology and biomedical sciences are undergoing a new era of vigorous development due
to the rapid discovery of new protein targets and unveiling of their biological importance.
Consequently, it is an unmet need to identify ligands that recognize peptide or protein targets with
high specificity and affinity,181 since such an effort could help in understanding function of
proteins and lead to potential therapeutic agents for diagnosis and treatment. Combinatorial
chemistry, which serves as a powerful tool for ligand screening in basic medicinal chemistry, has
emerged to meet this challenge.182 The diverse library of compounds provides concurrent but
independent chances for target screening. Since it provides the possibility to yield important
therapeutic agents from various target proteins, the progress of drug discovery has been largely
accelerated.183 As peptides are versatile molecules, which have modular chemical diversity and
favorable binding activity, they are natural building blocks for combinatorial libraries for screening
against various targets. Among them, macrocyclic peptides that have enhanced conformational
constraint and binding affinity are widely recognized for exploring ligand−receptor interactions.
Several general methods have been successfully developed to construct the macrocyclic ring
systems.184-190
Recent

efforts

have

contributed

to

the

creation

of

nonnatural

sequence-specific

peptidomimetics.191 These peptidomimetics are developed based on the mimicry of peptide
primary structure and possess a modified peptide backbone for the introduction of diverse
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functional side chains. Compared with natural peptides, peptidomimetics possess improved
protease resistance, chemodiversity, and bioavailability.192 The past decade has witnessed
noteworthy progress in the development of biomimetic oligomers, including β-peptides,193-195
peptoids,196-199 α-aminoxypeptides,24 α/β-peptides,200-201 azapeptides,202 and others. However, to
date only a handful of peptidomimetic combinatorial libraries were systematically investigated for
protein ligand identification.203 The development of the macrocyclic peptidomimetic
combinatorial library is even rarer.204-206 Motivated by these findings, we have recently developed
the new class of peptidomimetics, γ-AApeptides (oligomers of γ-substituted-N-acylated-Naminoethylamino acids), which were inspired by the backbone structure of the chiral PNA. 207-208
γ-AApeptides are highly resistant to proteolytic degradation and possess cellular translocation
capability and have enhanced chemodiversity, making them ideal candidates as molecular probes
or therapeutic agents.209 Indeed, these features have been demonstrated by our previously
developed one-bead−one-compound (OBOC) linear γ-AApeptides-based combinatorial libraries
capable of inhibiting Aβ aggregation and disrupting STAT3/DNA interaction.210-211 We thus
envisioned that the macrocyclic combinatorial library of γ-AApeptides would be endowed with
enhanced conformational rigidity and constraints compared with the linear counterparts and could
be even more beneficial in the identification of bioactive ligands.

4.3

Methods

Fmoc-protected amino acids were purchased from Chem-impex (Wood Dale, IL). TentaGel resin
(0.23 mmol/g) was purchased from RAPP Polymere (Tuebingen, Bermany). Rink amide-MBHA
resin (0.55 mmol/g) was purchased from GL Biochem (Shanghai, China). 1-Hydroxybenzotriazole
wetted with no less than 20% wt water (HOBt), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
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(EDC), 5,5-dimethyl-1,3-cyclohexanedione, and 4,4′-dimethoxytrityl chloride were purchased
from Oakwood Chemical (Estill, SC). 4-(Bromomethyl)benzoic acid was purchased from AKScientific (Union City, CA). 3-Mercaptopropionic acid was purchased from TCI (Tokyo, Japan).
Fluorescein isothiocyanate (FITC) was purchased from Chemodex (Gallen, Switzerland). Solid
phase synthesis was conducted in peptide synthesis vessels on a Burrell Wrist-Action shaker. γAApeptides were analyzed and purified on a Waters Breeze 2 HPLC system and then lyophilized
on a Labcono lyophilizer. The purity of the compounds was determined to be >95% by analytical
HPLC. Masses of γ-AApeptides and the MS/MS analysis were obtained on an Applied Biosystems
4700 Proteomics analyzer. 1H NMR spectra were recorded at 500 MHz using TMS as the internal
standard. 13C NMR spectra were recorded at 125 MHz using TMS as the internal standard. The
multiplicities are reported as follows: singlet (s), doublet (d), doublet of doublets (dd), triplet (t),
quartet (q), multiplet (m). Coupling constants are reported in hertz (Hz). High resolution mass
spectra were obtained on an Agilent 6220 using electrospray ionization timeof-flight (ESI-TOF).
Cell culture medium was purchased from Gibco (Rockford, IL), fetal bovine serum (FBS) was
purchased from Peak Serum (Fort Collins, CO), and penicillin−streptomycin was purchased from
Invitrogen (Carlsbad, CA). GST-EphA2 recombinant protein, poly(Glu-Tyr), and Alexa Fluor 594
goat anti-mouse antibody were purchased from Life Technologies (Carlsbad, CA) and SigmaAldrich (St. Louis, MO), respectively. Phosphotyrosine HRP conjugated antibody (pTyr) was
purchased from R&D Biosystems (Minneapolis, MN). pEphA2-Ser897 and EphA2 antibodies
were purchased from Cell Signaling Technologies (Danvers, MA). Anti-GST antibody was
purchased from Santa Cruz Biotechnology (Dallas, TX). All solvents and other chemical reagents
were obtained from Sigma-Aldrich (St. Louis, MO) and were used without further purification.
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Synthesis of the Dmt Protected Mercaptopropionic Acid (11). 4,4′-Dimethoxytrityl chloride (6.38
g, 18.82 mmol) was dissolved in 40 mL of CH2Cl2 containing 3-mercaptopropionic Acid (1.64
mL, 18.82 mmol) at room temperature. The triethylamine (3.93, 22.58 mmol) was slowly added
to the above solution. The solution was stirred at room temperature for 4−6 h. After that the mixture
was evaporated under reduced pressure, and the residue was washed with saturated citric acid and
extracted with ethyl acetate (30 mL ×3). The organic layer was dried over anhydrous Na2SO4, and
the solvent was evaporated. The residue was purified by flash column chromatography
(hexane/ethyl acetate 1:1) to afford the desired product as a light yellow solid (80% yield). 1H
NMR (500 MHz, CDCl3): δ 7.42−7.44 (d, J = 8.00 Hz, 2H), 7.34−7.35 (d, J = 9.00 Hz, 2H), 7.29(t,
J = 7.50 Hz, 2H), 7.21 (t, J = 7.50 Hz, 1H), 6.84−6.82 (d, J = 9.00 Hz, 2H), 3.79 (s, 6H), 2.49 (t, J
= 7.50 Hz, 2H), 2.30 (t, J = 7.50 Hz, 2H). 13C NMR (125 MHz, CDCl3): δ 178.2, 158.1, 145.2,
137.0, 130.7, 129.4, 127.9, 126.6, 113.2, 66.0, 55.2, 33.5, 26.6.
Synthesis of the 4-(Bromomethyl)benzoyl Chloride (12). The 4-(bromomethyl)benzoic acid (5 g,
23.25 mmol) was dissolved in 10 mL of thionyl chloride and reflux for 5 h. The excess thionyl
chloride was removed under reduced pressure to afford the desired product as a white solid and
directly use without purification (85% yield).51 1H NMR (500 MHz, CDCl3): δ 8.06 (d, J = 5.00
Hz, 2H), 7.52 (d, J = 10.00 Hz, 2H), 4.50 (s, 2H). 13C NMR (125 MHz, CDCl3): δ 167.7, 145.3,
132.9, 131.8, 129.6, 31.4.
Synthesis of 2-Acetyl-5,5-dimethylcyclohexane-1,3-dione (13). To a 100 mL round-bottom flask
was added 5,5-dimethylcyclohexane-1,3-dione (10 g, 71.34 mmol), N,N-diisopropylethylamine
(14.91 mL, 85.6 mmol), 4-dimethylaminopyridine (435.76 mg, 3.57 mmol), and 50 mL of DCM.
The mixture was stirred in an ice bath to which acetyl chloride (6.08 mL, 85.6 mmol) was added.
The reaction was warmed up to room temperature and allowed to stir for 8 h. The solvent was
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evaporated, and the residue was washed with 1 M HCl and then extracted with ethyl acetate (30
mL × 3). The organic layer was dried over anhydrous Na2SO4 and then removed in vacuo. The
residue was purified by flash column chromatography (hexane/ethyl acetate 1:1) to afford the 2acetyl-5,5-dimethylcyclohexane-1,3-dione as a yellowish solid (11 g, yield 85%).212[52] 1H NMR
(500 MHz, CDCl3): δ 2.54 (s, 3H), 2.48 (s, 3H), 2.3 (s, 2H), 1.01 (s, 6H). 13C NMR (125 MHz,
CDCl3): δ 202.3, 197.8, 195.1, 112.3, 52.4, 46.8, 30.6.
Synthesis of Dde Protected Amino Acids. The L-amino acid (1 equiv) was suspended in a solution
of the 2-acetyl-5,5-dimethylcyclohexane-1,3-dione (1.3 equiv) in absolute ethanol (∼50 mL).
Triethylamine (1.5 equiv) was added, and the reaction mixture was refluxed for 18 h. The resulting
yellow solution was cooled and concentrated under reduced pressure. The residue was dissolved
in CH2Cl2 (50 mL) and washed with 1 M HCl (50 mL × 2). The organic layer was dried over
Na2SO4, filtered, and concentrated in vacuo. Addition of Et2O (∼40 mL) to the residue resulted in
immediate white precipitate, which was filtered and washed with cold Et2O to afford the title
compound as an off-white crystalline solid (∼70%).213
Dde-Ala-OH (14). White solid. 1H NMR (500 MHz, DMSO-d6): δ
13.51 (d, J = 5.00 Hz, 1H), 4.61 (t, J = 5.00 Hz, 1H), 2.48 (s, 3H), 2.27 (s, 4H), 1.41 (d, J = 5.00
Hz, 3H), 0.92 (s, 6H). 13C NMR (125
MHz, CDCl3): δ 197.4, 172.9, 172.5, 107.6, 52.8, 51.6, 30.3, 28.3,19.1, 18.1. HRMS (ESI) ([M +
H]+) calcd for C13H20NO4, 254.1392; found, 254.1396.
Dde-Val-OH (15). White solid. 1H NMR (500 MHz, CDCl3): δ 13.6 (d, J = 5.00 Hz, 1H), 10.97
(s, 1H), 4.61 (t, J = 5.00 Hz, 1H), 2.5 (s, 3H),2.39 (s, 4H), 2.36 (m, 1H), 1.08 (d, J = 5.00 Hz, 3H),
1.04 (d, J = 5.00 Hz, 3H), 1.0 (s, 6H). 13C NMR (125 MHz, CDCl3): δ 174.3, 171.6, 107.9, 62.3,
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51.9, 31.1, 30.1, 28.1, 19.1, 18.7, 17.0. HRMS (ESI) ([M + H]+) calcd for C15H24NO4, 282.1705;
found, 282.1717.
Dde-Phe-OH (16). White solid. 1H NMR (500 MHz, CDCl3): δ
13.71 (d, J = 5.00 Hz, 1H), 7.18−7.27 (m, 5H), 4.57−4.61(m, 1H), 3.05−3.09 (m, 2H), 2.36 (s,
4H), 2.20 (s, 3H), 1.00 (s, 6H). 13C NMR (125 MHz, CDCl3): δ 198.1, 173.6, 171.0,135.5, 129.4,
128.6, 127.4, 107.9, 58.3, 52.4, 45.5, 39.3, 30.1, 28.0, 18.1, 8.5. HRMS (ESI) ([M +
H]+) calcd for C19H24NO4, 330.1705; found, 330.1714.
Dde-Leu-OH (17). White solid. 1H NMR (500 MHz, CDCl3): δ 13.60 (d, J = 10.00 Hz, 1H), 10.01
(s, 1H), 4.57−4.61 (m, 1H), 2.50 (s, 3H), 2.37 (s, 4H), 1.82 (m, 2H), 1.77 (m, 1H), 0.99 (s, 6H),
0.95 (d, J = 5.00 Hz, 3H), 0.89 (d, J = 5.00 Hz, 3H). 13C NMR (125 MHz, CDCl3): δ 198.9, 173.9,
107.9, 54.9, 52.3, 45.6, 41.3, 30.1, 28.2, 24.8,
22.7, 21.7, 18.7, 8.4. HRMS (ESI) ([M + H]+) calcd for C16H26NO4, 296.1862; found, 296.1873.
Dde-Glu(OBn)-OH (18). Pale yellow solid. 1H NMR (500 MHz, DMSO-d6): δ 13.77 (d, J = 5.00
Hz, 1H), 10.50 (s, 1H), 7.33 (s, 5H), 5.10 (s, 2H), 4.55 (m, 1H), 2.53−2.59 (m, 2H), 2.51 (s, 3H),
2.39 (s, 4H), 2.21−2.25 (m, 2H), 1.01 (s, 6H). 13C NMR (125 MHz, CDCl3): δ 174.3, 171.9, 171.2,
135.4, 128.6, 128.4, 128.3, 128.2, 66.7, 55.4, 52.3, 30.2, 29.6, 28.2, 27.7, 18.7. HRMS (ESI) ([M
+ H]+) calcd for
C22H28NO6, 402.1917; found, 402.1925.
Dde-Asp-OH (19). White solid. 1H NMR (500 MHz, DMSO-d6): δ 13.56 (d, J = 10.00 Hz, 1H),
4.84 (m, 1H), 2.90 (dd, J = 15.00, 5.00 Hz, 1H), 2.78 (dd, J = 15.00, 5.00 Hz, 1H), 2.46 (s, 3H),
2.27 (s, 4H), 1.36 (s, 9H), 0.92 (s, 6H). 13C NMR (125 MHz, CDCl3): δ 172.3, 170.7, 168.7, 107.7,
81.5, 52.5, 38.2, 30.1, 38.3, 28.0, 17.9. HRMS (ESI) ([M + H]+) calcd for C18H28NO6, 354.1917;
found, 354.1929.
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Dde-Glu-OH (20). White solid. 1H NMR (500 MHz, DMSO-d6): δ
13.54 (d, J = 10.00 Hz, 1H), 4.26 (q, J = 5.00 Hz, 1H), 2.43 (s, 3H),
2.28 (s, 4H), 2.24−2.26 (m, 2H), 1.90−2.10 (m, 2H), 1.36 (s, 9H),
0.93 (s, 6H). 13C NMR (125 MHz, CDCl3): δ 172.7, 171.8, 107.4, 80.3, 54.2, 52.1, 45.2, 30.8, 30.1,
28.3, 28.1, 27.8. HRMS (ESI) ([M +
H]+) calcd for C19H30NO6, 368.2073; found, 368.2075.
Dde-Lys-OH (21). White solid. 1H NMR (500 MHz, CDCl3): δ 13.69 (m, 1H), 10.24 (s, 1H), 4.80
(m, 1H), 4.40 (m, 2H), 3.09 (m, 2H), 2.50 (s, 3H), 2.34 (s, 4H), 1.95 (m, 2H), 1.50 (m, 2H), 1.40
(s, 9H), 1.01 (s, 6H). 13C NMR (125 MHz, CDCl3): δ 173.3, 172.9,
172.0, 171.6, 155.9, 107.6, 80.9, 78.9, 60.1, 56.1, 40.9, 39.8, 32.1, 30.3, 29.1, 27.9, 21.6, 18.4,
13.9. HRMS (ESI) ([M + H]+) calcd for
C21H35N2O6, 411.2495; found, 411.2497.
Fmoc-Lys(Dde)-OH (22).214[54] Pale yellow solid. 1H NMR (500 MHz, CDCl3): δ 13.29 (s, 1H),
7.73−7.74 (d, J = 5.00 Hz, 2H), 7.58 (t, J = 5.00 Hz, 2H), 7.37 (t, J = 5.00 Hz, 2H), 7.27 (t, J =
5.00 Hz, 2H), 5.79 (d, J = 10.00 Hz, 1H), 4.42−4.46 (m, 1H), 4.35−4.37 (d, J = 10.00 Hz, 2H),
4.18 (t, J = 5.00 Hz, 1H), 3.38−3.39 (m, 2H), 2.53 (s, 3H), 2.35 (s, 4H), 1.78−1.80 (m, 2H),
1.70−1.72 (m, 2H), 1.47−1.57 (m, 2H), 1.00 (s, 6H). 13C NMR (125 MHz, CDCl3): δ 198.5, 174.7,
174.3, 156.2, 143.8, 143.7, 141.3, 127.7, 127.0, 125.1, 119.9, 107.8, 67.1, 53.4, 52.2, 47.1, 43.4,
31.9, 30.2, 28.3, 28.2, 22.4, 21.1, 18.3, 14.2. HRMS (ESI) ([M + H]+) calcd for C 31H37N2O6,
533.2652; found,
533.2661.
After structures of putative hits were determined by MALDI MS/MS, the hits and its FITC labeled
analogues were resynthesized on the Rink amide resin and confirmed by Applied Biosystems 4700
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Proteomics analyzer (Scheme 4.2) For the synthesis of the fluorescent cyclic peptide, the FmocLys(Dde)-OH was first attached to the Rink amide resin. The Fmoc protection group was then
removed, followed by the desired building blocks needed for the sequence synthesis. After the
γAApeptides were cyclized, the Dde group was removed. Then FITC (2 equiv) and DIPEA (6
equiv) in DMF were added to the resin and shaken for 12 h at room temperature. The FITC labeled
cyclic γpeptide was cleaved by 1:1 (v/v) DCM/TFA containing 2% triisopropylsilane. The crude
was purified by the Waters HPLC system with flow rate of 0.8 mL/min with a linear gradient from
5% to 100% (CH3CN in water) in 40 min (Figure 10).
Fluorescence Polarization (FP). The binding affinity (Kd) of the hits was obtained by fluorescence
polarization (FP). The FP experiment was performed by incubating 50 nM FITC labeled
AApeptide with EphA2 (0.0625−2 μM) in 1× PBS. The binding affinity of the lead compound to
the GST protein (Kd) was obtained by incubating 50 nM FITC labeled AApeptide in GST ranging
from 0.3125 to 55 μM. Dissociation constants (Kd) were determined by plotting the fluorescence
anisotropy values as a function of protein concentration, and the plots were fitted to the following
equation (Figures 12 and 13).215
𝑌 = [𝐹𝑃𝑚𝑖𝑛 + (𝐹𝑃𝑚𝑖𝑛 − 𝐹𝑃𝑚𝑖𝑛 )]

(𝐾𝑑 + 𝐿𝑠𝑡 + 𝑥) − √(𝐾𝑑 + 𝐿𝑠𝑡 + 𝑥)2 − 4𝐿𝑠𝑡 𝑥
2𝐿𝑠𝑡

The Lst is the concentration of the AApeptide and the x stands for the concentration of the protein.
The experiments were conducted in triplicates and repeated three times.
In Vitro Kinase Assays and Immunoblotting. In vitro kinase assay to evaluate EphA2 kinase
activity was performed as described before.216[46] Briefly, 50 μL of kinase reaction containing 50
ng of recombinant EphA2, 50 μg of poly(Glu-Tyr) and 200 μM ATP, and 2 μM 1 and 9 (negative
control) were incubated at 30 °C for 40 min. The reaction was stopped by addition of gel loading
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buffer. The samples were boiled for 5 min and SDS−PAGE was performed. Immunoblotting with
pTyr-HRP antibody (1:2000 dilution) was performed to detect substrate phosphorylation. The
extent of phosphorylation was quantified using ImageJ software. For studying the activity of the
compounds in cells, C13 cells were treated at indicated doses for 24 h. The cells were lysed in lysis
buffer, and immunoblot analysis was performed. Densitometric analysis was performed by SPSS.
The experiments were conducted in triplicates and repeated three times.
Scratch-Wound Motility Assay. C13 cells were trypsinized, and 105 cells were reseeded on a 12well tissue culture plate. After 12 h, the attached cells were scratched with a 200 mL pipet tip and
cell migration was observed for up to 24 h. 0 h images were captured using a Nikon ECLIPSE
microscope. The plates were placed back at 37 °C and 5% CO2 for 24 h, and another set of images
were captured of the same wounds. The wound widths were measured by ImageJ (version 1.50).
The experiments were conducted in triplicates and repeated three times.
Matrigel-Coated Transwell Assays. The assays were performed by transfected the C13 cell line
with control EphA2 for 48 h. After that the cells were plated into the top chambers and treated
with either vehicle or 10 μM 1. Twenty-four hours later cells in the top chamber were scraped and
migrated cells were fixed with crystal violet staining. Transwell data were determined by the
number of the migrated cells, and the value from parental cells was arbitrarily set at 100%. The
experiments were conducted in triplicates and repeated three times.

4.4

RESULTS AND DISCUSSION

Design of the Cyclic Library. The thioether moiety is widely found in nature. For instance,
methionine has a thioether side chain and is virtually present in all proteins. Other natural products
such as antibiotic lanthipeptides directly utilize thioether bridges to form multimacrocylic ring

108

structures. Heinis et al. also adopted the thioether linkage to develop phage-display mediated
bicyclic peptide libraries.184-185, 217 This thioether-bridge mediated cyclization has proven to be
highly efficient in cyclization, leading to cyclic peptides with not only rigidified conformational
freedom but also enhanced metabolic stability. These features make them promising affinitive
candidates for biological applications. By employment of a thioether-bridge approach, a novel
cyclic γ-AApeptide library could be synthesized and tested against target proteins. To test our
hypothesis, we embarked on the design of the cyclic γ-AApeptide library by introducing a Dmt
(4,4′-dimethoxytrityl) protected mercaptoethyl carbonyl group to the secondary amine in the first
γ-AApeptide building block (Figure 4.1) on the solid phase. After another three γ-AApeptide
building blocks were assembled subsequently, the 4(bromomethyl)benzoyl group was attached to
the N-terminal amino group of the sequence. Next, the Dmt group was removed, and the γAApeptide could be cyclized under nearly neutral conditions with virtually quantitative yield due
to the high efficiency of sulfur-mediated SN2 reaction.
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Figure 4.1. Synthesis of the thioether bridged one-bead−two-compound macrocyclic γ-AApeptide
library. See Supporting Data for details.

Molecular Dynamics (MD). In order to assess the potential conformational rigidity of this class of
cyclic γ-AApeptides, we conducted molecular dynamics (MD) simulations of the cyclic backbone
and linear backbone in explicit water (Figures 4.10). Consistent with our hypothesis, MD
simulation (Figure 4.10) suggested the backbone of thioether bridged cyclic γ-AApeptides is much
more conformationally rigid than that of the linear one, leading to possibility of identification of
novel ligands with high affinity. Library Diversity and Decoding. To ensure the development of
relatively unbiased cyclic library, a diverse set of hydrophobic, cationic, and negatively charged
side chains were chosen. Briefly, due to the structural nature of γ-AApeptides, four chiral side
chains came from the side chains of five different N-Alloc protected γ-AApeptide building blocks
(R, Figure 4.1). The other three side chains were introduced by acylating the secondary amino
group with six different carboxylic acids or acyl chlorides after deprotection of the alloc group (R′,
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Figure 4.1). Thus, by using the split and pool method, the theoretical diversity of the library was
expected to be 135 000 (Figure 4.1), and 405 000 beads were used for the preparation of the library.
Unlike linear γ-AApeptide library,210-211 the direct sequencing of cyclic γ-AApeptides was no
longer feasible using MS/MS. Instead, the strategy of a one-bead−two-compound (OBTC) library
containing both ligands and analyzable coding sequences on the same bead was desired.215, 218
Peptides consisting of αamino acids could serve well as coding sequences since the MS/MS pattern
of amino acid fragments is unambiguous. To this end, we developed a highly effective approach
to synthesize coding peptides by using Dde ((1-(4,4-dimethyl-2,6-dioxacyclohexylidene)ethyl)
protected α-amino acids. The deprotection of Dde was very mild using NH2OH·HCl and
imidazole219 and fully orthogonal to chemistry engaged in the synthesis of thioether-bridged cyclic
γ-AApeptides.
To prepare the desired OBTC cyclic γ-AApeptide combinatorial library, TentaGel beads (200−250
μm; 1.5 nmol/bead)) were soaked overnight in water and then exposed to 1:1 (v/v) DCM/Et2O
containing 0.5 equiv of di-tert-butyl decarbonate (Boc2O) (Figure 4.1). This was expected to
possess Boc protection of amino groups on the outer surface of the beads since the interior of the
beads still remains in water. After washing with DMF, the interior of the beads was allowed to
react with the Met, the amino acid facilitating coding peptide cleavage upon cyanogen bromide
(CNBr) treatment. After removal of the Fmoc protecting group, the beads were split into five equal
aliquots and reacted with five different Dde protected amino acids, respectively, so as to establish
a coding tag representing the first γ-AApeptide building block on the outer layer. Subsequently,
the Boc group of the outer layer was removed by TFA, followed by the attachment of five Alloc
γ-AApeptide protected building blocks.
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Next, the Alloc group was removed by Pd(PPh3)4 and Me2NH· BH3, and the Dmt protected 3mercaptopropanoic acid was added to react with the secondary amino group. The beads were
pooled and split into five aliquots again. After the Dde group was removed, the second set of the
Dde protected amino acids was added to introduce the coding tag for the second γAApeptide
building block on the outer layer of the beads. These steps were repeated 3 more times. Compared
with the cycle of the first building block, the only difference in the subsequent synthetic process
on the outer layer was that after the Alloc group was removed, the N group of the γ-AApeptide
building block was reacted with a different carboxylic acid or acyl chloride to introduce diverse
side chains. Since each γAApeptide building block bears two side chains, two Dde protected amino
acids were used to code each building block (Figure 4.1). Finally, the 4-(bromomethyl)benzoyl
chloride was used to cap the N-terminus of γ-AApeptides on the outer layer, followed by selective
removal of the Dmt group on the thiol linker with 2% TFA in DCM. The cyclization of γAApeptides was achieved in the presence of the ammonium carbonate ((NH4)2CO3), which
occurred on the surface of the beads only due to the lack of cyclization linker in the interior of the
beads. The deprotection of side chain protecting groups was finally conducted in 94% TFA, 2%
triisopropylsilane, 2% water, and 2% thioanisole (v:v:v:v). Quality of the beads was excellent, as
evidenced by the fact that 8 out 10 randomly selected beads showed unambiguous MS/MS
fragmentation patterns by MALDI and were able to provide information on the coding peptide
sequence almost instantly.
With the success of obtaining the cyclic γ-AApeptide combinatorial library, we moved forward to
examine its potential for identification of valuable biological ligands. EphA2 (ephrin type-A
receptor 2) was chosen due to its prominent role in the pathogenesis of various tumors.220 EphA2
(Figure 4.2) belongs to the family of Eph receptor tyrosine kinases that regulate tissue development
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and patterning of the visual system and play a critical role in mediating the cell−cell
communication and angiogenesis.221-222 Recent findings suggest that EphA2 overexpression is a
key factor contributing to multiple cancers such as melanoma, ovarian, lung, and breast.216, 223-224
Therefore, EphA2 is a promising target for cancer therapeutic development. Considerable efforts
have started to be made to identify inhibitors that block the capability of EphA2 for the
phosphorylation of its downstream protein substrates, thereby dampening EphA2 mediated cell
signaling. However, to date, only limited success was achieved.225 Thus, it is compelling to identify
ligands from our macrocyclic γ-AApeptide library that bind to EphA2 with high affinity.

Figure 4.2. EphA2 signaling and inhibition pathway.

To conduct the library screening, we first incubated beads with GST tagged intracellular domain
of EphA2 protein (Figure 4.3A and Supporting Data). After the thorough wash and the following
incubation with the mouse anti-GST antibody, the beads were washed again and treated with the
Alexa Fluor 594 labeled goat-anti mouse secondary antibody. Ten beads emitting red fluorescence
were identified under the fluorescence microscope and picked up as the putative positive hits.
Subsequently, these beads were incubated with guanidium chloride (GdmCl) to denature any
potential proteins stuck on the surfaces of the beads. The coding peptides in the inner layers of the
beads were then cleaved off the beads by treatment with CNBr and subsequently sequenced by
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tandem MS/MS of MALDI. Among the 10 hits, seven different peptide structures could be
determined unambiguously. (The rest ot the three hits had poor fragmentation which were very
difficult for us to work out the structures. This may be caused by the cleavage step.) Next, the
corresponding sequences of the seven cyclic γAApeptides conjugated with fluorescein
isothiocyanate (FITC) labels were resynthesized and measured for their binding affinity toward
EphA2 by fluorescence polarization (FP) assay. Fortunately, the most potent hit, AApeptide 2
(FITC labeled AApeptide 1) (Figure 4.3B), exhibited excellent binding affinity to EphA2 with a
Kd value of 81 nM (Figure 4.3C). The potential binding to the GST tag was excluded as 2 only
showed negligible binding affinity to GST protein with a Kd of 14.2 μM, which is ∼170-fold
weaker than that of EphA2 binding (Figure 4.3D). Besides, the GST protein, another two kinases
AKT1PKBα and NFKBIA were chosen to test the selectivity of the 1, which showed Kd of 3.62
μM and 0.741 μM (Figure 4.13), respectively, demonstrating the binding of 1 toward EphA2 is
selective. Moreover, we treated C13 cells with 1 μM and 5 μM 2, and the diffuse fluorescence was
clearly visible in 1 h (Figure 4.9), suggesting the compound is cell permeable.
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Figure 4.3. (A) Screening of the γ-AApeptide library. (B) Structure of 2 (FITC labeled lead
compound 1). (C) Kd of the compounds to the EphA2. (D) Kd of the compounds to the GST.

Given the strong binding affinity of 1 (Figure 4.4A) toward EphA2, we next performed assays to
evaluate its biological activity. The initial in vitro kinase assay (Figure 4.4B) showed that 2 μM 1
could completely inhibit EphA2 kinase activity by preventing phosphorylation of its substrate
poly(Glu-Tyr). Another compound 9 (Figure 4.6), with the same molecular scaffold, failed to
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inhibit activity of EphA2, suggesting that recognition of 1 toward EphA2 was specific. At the same
concentration, 1 also greatly suppressed the autocatalytic activity of EphA2 (Figure 4.4C). Both
abovementioned in vitro kinase assays suggested 1 is a potent inhibitor of EphA2 kinase activity.
Inspired by the results, we further investigated the ability of 1 for the regulation of catalytic activity
in an ovarian cancer cell line C13 cells which displays high expression of EphA2.226 As shown in
Figure 4.4D, the phosphorylation level of EphA2 was inhibited in a dosedependent fashion with
the increased concentrations of 1. The IC50 of 1 for the inhibition of EphA2 inhibition was
approximately 5 μM.

Figure 4.4. (A) Structure of lead compound 1. (B) In vitro kinase assay was performed using 50
ng of EphA2 and 50 μg of poly(Glu-Tyr) as a substrate containing 2 μM 1. Quantification of
substrate phosphorylation was shown. (C) Autophosphorylation of EphA2 was detected by
incubating 50 ng of EphA2 with 2 μM 1 in the kinase assay buffer. Immunoblot analysis with pTyr
antibody was performed. (D) C13 cells were treated with the indicated concentrations of 1 for 24
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h. Immunoblot analysis of EphA2-Ser897 was performed. Total EphA2 was used as a control. The
extent of phosphorylation was quantified using ImageJ software. Densitometric analysis was
performed by SPSS.

Since EphA2 was shown to play a critical role in cell migration,227 we next tested the effect of 1
on cell migration and invasion. 1 was applied to C13 cells and analyzed using a scratch-wound
motility assay. The data in Figure 4.5A showed a time- and dose-dependent downregulation of cell
migration in response 1 treatment, as shown by as much as 70% delay in wound closure at 24 h
post-treatment with the highest dose of 1 (Figure 4.5A). Similar results were seen in Matrigelcoated Transwell assays, treatment of 10 μM 1 led to around 70% and 80% decrease in cell
migration (Figure 4.5B) and invasion (Figure 4.5C), respectively, suggesting EphA2 mediated cell
signaling was significantly suppressed. The inactive compound 9 was also tested for comparison
(Figure 4.7), which as expected did not show capability to prevent migration. A linear compound
AApeptide 10 was also tested (Figure 8), and the result was consistent with the MD simulation
because 10 was much less potent. Taken together, the ability of 1 for the strong inhibition of EphA2
activity in cells suggests that cyclic γ-AApeptides possess excellent cell permeability, augmenting
their future development in biomedical sciences.
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Figure 4.5. (A) Wound-healing assay. Images were taken 0, 12, and 24 h after wound formation.
Data are presented as the mean ± SD of triplicate experiments and using image J software. C13
cells treated with 10 μM 1 or vehicle and were subjected to migration (B) and invasion (C) assays.
Transwell data were determined by the number of the migrated cells, and the value from parental
cells was arbitrarily set at 100%.

4.5

Conclusion

In summary, a new class of macrocyclic peptidomimetic combinatorial library has been developed.
With the unique γAApeptide backbone, which ensures the chemodiversity in the library, this new
method has great potential to be a rich source in protein/peptide ligands identification. In addition,
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compared with previous linear peptide library developed by our group, the thioether bridged
macrocyclic γ-AApeptide library has the dual advantages of significantly enhanced conformal
rigidity of the backbones and cell permeability. This led to higher promise in the identification of
more potent and useful ligands/molecular probes. Furthermore, the new encoding approach of Dde
peptide tags also greatly increases the possibility and ease of the structural elucidation of putative
hits. The promise of this macrocyclic library was manifested by the identification of potent ligands
that specifically target the EphA2 receptor tyrosine kinase. With a Kd value of 81 nM, compound
1 was found to be a potent inhibitor of the EphA2 signaling in both in vitro and cellular assays.
Currently, the library is being used as a new platform for screening against various targets in our
group, and the in vivo study of compound 1 is underway.

4.6

Supporting Information

Fmoc-protected amino acids were purchased from Chem-impex (Wood Dale, IL). TentaGel resin
(0.23 mmol/g) was purchased from RAPP Polymere (Tuebingen, Bermany). Rink Amide-MBHA
resin

(0.55

mmol/g)

was

purchased

from

GL

Biochem

(Shanghai,

China).

1-

Hydroxybenzotriazole wetted with no less than 20% wt. water (HOBt), 1-Ethyl-3-(3dimethylaminopropyl) carbodiimide (EDC), 5,5-Dimethyl-1,3-cyclohexanedione and 4,4'Dimethoxytrityl Chloride were purchased from Oakwood Chemical (Estill, SC). 4(Bromomethyl)benzoic acid was purchased from AKScientific (Union City, CA). 3Mercaptopropionic Acid was purchased from TCI (Tokyo, Japan). Fluorescein isothiocyanate
(FITC) was purchased from Chemodex (Gallen, Switzerland). Solid phase synthesis was
conducted in peptide synthesis vessels on a Burrell Wrist-Action shaker. γAApeptides were
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analyzed and purified on a Waters Breeze 2 HPLC system, and then lyophilized on a Labcono
lyophilizer, the purity of the compounds was determined to be >95% by analytical
HPLC. Masses of γ-AApeptides and the MS/MS analysis were obtained on an Applied
Biosystems 4700 Proteomics Analyzer. 1H NMR spectra were recorded at 500 MHz using TMS
as the internal standard. 13C NMR spectra were recorded at 125MHz using TMS as the internal
standard. The multiplicities are reported as follows: singlet (s), doublet (d), doublet of doublets
(dd), triplet (t), quartet (q), multiplet (m). Coupling constants are reported in Hertz (Hz). High
resolution mass spectra were obtained on an Agilent 6220 using electrospray ionization time-offlight (ESI-TOF). Cell culture media was purchased from Gibco (Rockford, IL), fetal bovine
serum (FBS) was purchased from Peak Serum (Fort Collins, CO), penicillin-streptomycin was
purchased from Invitrogen (Carlsbad, CA). GST-EphA2 recombinant protein, Poly(Glu-Tyr) and
Alexa Fluor 594 goat anti-mouse antibody were purchased from Life Technologies (Carlsbad,
CA) and SigmaAldrich (St. Louis, MO) respectively. Phospho-Tyrosine HRP conjugated
antibody (pTyr) was purchased from R&D Biosystems (Minneapolis, MN). pEphA2-Ser897 and
EphA2 antibodies were purchased from Cell signaling technologies (Danvers, MA). Anti-GST
antibody was purchased from Santa Cruz Biotechnology (Dallas, TX). All solvents and other
chemical reagents were obtained from Sigma-Aldrich (St. Louis, MO) and were used without
further purification. The One-bead Two-compound cyclic γ-AApeptide library was prepared on
TentaGel NH2 resin (2.64g, 0.61mmol, 405000 beads) using split and pool method at room
temperature. Theoretically each bead of the library had two layers, with inner layer containing a
coding peptide and outer layer composed of the cyclic γ-AApeptide ligand. Please refer the next
paragraph for details of library preparation. Unless otherwise noted, in the outer layer, the Fmoc
protecting group was removed by 20% (v/v) piperidine in DMF (10 min × 2). The Alloc protecting
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group was removed by Pd(PPh3)4 (8 mg, 0.007 mmol) and Me2NH·BH3 (25 mg, 0.42 mmol) in 3
mL DCM (10 min × 2). All the Alloc protected γ-AApeptide building blocks (2 equiv) and
carboxylic acids (2 equiv) were coupled to desired amino groups on the solid phase using
HOBt/DIC (4:4 equiv.) as the coupling reagents in DMF for 6 h twice. All the acyl chlorides (2
equiv.) were coupled to desired amino groups in DCM containing DIPEA (4 equiv.) for 30 min
twice. In the inner layer of the beads, the Dde protected amino acids (5.5 equiv.) were coupled to
the desired amino groups in DMF for 3 h in the presence of PyBop (5 equiv.) and NEM (11
equiv.). Dde deprotection solution was prepared by suspending 1.25 g (0.180 mmol) of
NH2OH·HCl and 0.918 g (0.135 mmol) of imidazole in 5 mL NMP, and the mixture was sonicated
until complete dissolution. The deprotection solution was added 1 mL CH2Cl2 before use.219 The
formation of bi-layers on the beads was achieved by following previously reported protocols
(Scheme 4.1, Table 4.1).215, 218 Briefly, the resin was soaked in water overnight. After being
transferred into the peptide reaction vessel, the resin was quickly drained and washed with 1:1
(v/v) DCM/diethyl ether. A solution of (Boc)2O (0.5 equiv.) in 1:1 (v/v) DCM/diethyl ether was
added, and the mixture was shaken on the Burrell Wrist-Action shaker for 3 h, followed by the
wash with DCM (3×) and DMF (3×) (Scheme S1). Next, Fmoc-Met-OH (0.5 equiv.), HOBt (2
equiv.) and DIC (2 equiv.) were added to react with the inner layer of the resin. The Fmoc group
was removed and the beads were split into 5 portions, which were reacted with The Dde-Ala-OH,
Dde-Phe-OH, Dde-Leu-OH, Dde-Val-OH, and Dde-Glu(OBn)-OH in 5 peptide synthesis vessels,
respectively.

Subsequently, the Boc protecting group on the outer layer was removed by using 94% TFA, 2%
TIS (triisopropylsilane), 2% H2O and 2% Thioanisole, and the exposed amine was coupled with
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the corresponding γ-AApeptide building blocks. Following that, the Alloc protecting group on the
γ-AApeptide building blocks was removed, and the Dmt protected mercaptopropionic acid was
added to react with the secondary amine. Subsequently, all the beads were pooled and mixed
thoroughly and then split into 5 portions again. The Dde group of the coding peptides in the inner
layer was removed and 5 Dde protected amino acids were added to react as the previous step
(Table 4.1). Then the Fmoc group of the γ-AApeptides in the outer layer was removed and the
sequence was coupled with desired γ-AApeptide building blocks. The beads were pooled and split
again, and the synthetic cycle was repeated three more times. The last Dde protecting group was
remained in the decoding layer, while the Fmoc group of the outer layer was removed then the
beads were coupled with the 4-(bromomethyl)benzoyl chloride. Following that, the Dmt
protecting group was removed by 2% TFA, 2% triisopropylsilane and 96% CH2Cl2 for 2 min (×5)
until the deprotecting solution became colorless. The cyclization of γ-AApeptide was achieved by
adding the solution of
(NH4)2CO3 (10 equiv) in 1:1 (v/v) DMF/H2O to the resin and shaking the mixture for 8 h. The
resin was washed with DMF (3×) and DCM (3×). Finally, protecting groups on the sidechains
were removed with 94% TFA, 2% triisopropylsilane, 2% H2O and 2% Thioanisole for 1 h.
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Scheme 4.1. The Preparation of the thioether bridged cyclic library.
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Table 4.1. Encoding map.

4.6.1.

Library Screening

The EphA2-GST protein was used as a target for the combinatorial library screening. The beads
were screened and picked up under a Zeiss inverted fluorescence microscope installed with a
10x43HE filter. To avoid any possible nonspecific binding, EphA2 and antibodies solution were
all made in 1% BSA/TBST blocking buffer.
4.6.2

Beads Screening

The TentaGel beads (2.64 g, 405000 beads, 135000 compounds) were swelled in DMF for 1 h.
After being washed with Tris buffer for five times, the beads were equilibrated in Tris buffer
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overnight at room temperature, followed by incubation with the blocking buffer (1% BSA in Tris
buffer with a 1000× excess of cleared E. coli lysate) for 1 h.
Prescreening: The blocked beads were incubated with the mouse anti-GST antibody (1:1000
dilution) for 2h at room temperature. After a thorough wash with 1× Tris buffer, the beads were
then incubated with the goat anti-mouse IgG conjugated with Alexa Fluor 594 (1:1000 dilution)
for 2 h at room temperature. The beads were washed with the Tris buffer (3×), and then transferred
into a 6-well plate to be observed under Zeiss inverted fluorescence microscope installed with the
10×43HE filter. The beads emitting red fluorescence were picked up and excluded from formal
screening.
The rest of the beads were pooled together into the peptide vessel, washed with Tris buffer, and
then treated with 8 M guandine∙HCl at room temperature for 1h to remove any bound proteins.
The guandine∙HCl was washed away subsequently with both water (10×) and Tris buffer (5×).
The beads were then incubated in DMF for 1 h, followed by washing and equilibration in Tris
buffer overnight.
Screening: The beads were incubated in 1% BSA/Tris buffer and 1000× excess of E. coli lysate
for 1 h at room temperature. After wash with Tris buffer for 5 times, the beads were incubated
with EphA2-GST protein at a concentration of 50 nM for 4 h at room temperature with a 1000×
excess of E. coli lysate. After the thorough wash with Tris buffer, the library beads were incubated
in 10 mL mouse anti-GST antibody for 2 h at room temperature. The beads were washed by Tris
buffer for 5 times with caution and incubated with 10 mL goat anti-mouse IgG conjugated with
Alexa Fluor 594 for 1 h at room temperature. The beads were washed and then transferred into
the 6-well plate with Tris buffer, and observed under the Zeiss inverted fluorescence microscope.
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The beads emitting read fluorescence were picked up as putative hits for further validation. Each
hit was transferred to an Eppendorf microtube, and denatured in 100 µL 8M guanidine•HCl for
1h at room temperature, respectively. The bead was rinsed with Tris buffer 3 × 10 min, water 3 ×
10 min, DMF 3 × 10 min, and ACN 3 × 10 min. At last the resin was placed in ACN overnight in
each microtube and then ACN was evaporated. The bead was incubated in the cocktail of 5:4:1
(v:v:v) of ACN: glacial acetic acid: H2O containing cyanogen bromide (CNBr) at a concentration
of 50 mg/mL overnight at room temperature. The cleavage solution was then evaporated, and the
cleaved peptide was dissolved in ACN : H2O (4:1) and subject to MALDI TOF-TOF analysis.

4.6.3

Synthesis of the FITC-labeled Hits

After structures of putative hits were determined by MALDI MS/MS, the FITC labeled hits were
re-synthesized on the Rink Amide resin and confirmed by Applied Biosystems 4700 Proteomics
Analyzer (Scheme S2). Briefly, the Fmoc-Lys(Dde)-OH was first attached to the Rink amide
resin. The Fmoc protection group was then removed, followed by the desired building blocks
needed for the sequence synthesis. After the γ-AApeptides were cyclized, the Dde group was
removed. Then FITC (2 equiv.) and DIPEA (6 equiv.) in DMF were added to the resin and shaken
for 12 h at room temperature. The FITC labeled cyclic γ-peptide was cleaved by 1:1 (v/v)
DCM/TFA containing 2% triisopropylsilane. The crude was purified by the Waters HPLC system
with flow rate of 0.8 mL/min with a linear gradient from 5% to 100% (CH3CN in water) in 40
min (Figure S10).
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4.6.4

Fluorescence Polarization (FP)

The binding affinity (Kd) of the hits was obtained by fluorescence polarization (FP). The FP
experiment was performed by incubating 50 nM FITC labeled AApeptide with EphA2 (0.0625 to
2 μM) in 1×PBS. The binding affinity of the lead compound to the GST protein (Kd) was obtained
by incubating 50 nM FITC labeled AApeptide in GST ranging from 0.3125 to 55 μM. Dissociation
constants (Kd) were determined by plotting the fluorescence anisotropy values as a function of
protein concentration, and the plots were fitted to the following equation (Figure S7-8).215 The Lst
is the concentration of the AApeptide and the x stands for the concentration of the protein. The
experiments were conducted in triplicates and repeated for three times.

𝑌 = [FPmin + (𝐹𝑃𝑚𝑖𝑛 − 𝐹𝑃𝑚𝑖𝑛)
2𝐿𝑠𝑡
4.6.5

in vitro Kinase assays and immunoblotting

in vitro kinase assay to evaluate EphA2 kinase activity was performed as described before. 216
Briefly, 50µl kinase reaction containing 50 ng recombinant EphA2, 50 µg Poly(Glu-Tyr) and 200
µM ATP and 2 µM of 1 and 9 (Negative Control) were incubated at 30 oC for 40 min. The reaction
was stopped by addition of gel loading buffer. The samples were boiled for 5 min and SDS PAGE
was performed. Immunoblotting with pTyr-HRP antibody (1:2000 dilution) was performed to
detect substrate phosphorylation. The extent of phosphorylation was quantified using ImageJ
software. For studying the activity of the compounds in cells, C13 cells were treated at indicated
doses for 24 h. The cells were lysed in lysis buffer and immunoblot analysis was performed.
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Densitometric analysis was performed and using the image J software. The experiments were
conducted in triplicates and repeated for three times.

Figure 4.6. A). Structure of lead compound 9 (Exact Mass: 1224.6769, Found (MALDI-TOF, M+H+): 1225.9114).
B). in vitro kinase assay was performed using 50 ng EphA2 and 50 µg Poly(Glu-Tyr) as a substrate containing 2µM
1 and 9. Quantification of substrate phosphorylation was shown.

4.6.6

Migration and invasion assays

Scratch-wound motility assay. C13 cells were trypsinized and 105 cells were reseeded on a
twelve-well tissue culture plate. After 12 h, the attached cells were scratched with a 200 ml pipette
tip and cell migration was observed for up to 24h. 0 h images were captured using a Nikon
ECLIPSE microscope. The plates were placed back at 37 ºC and 5% CO2 for 24h, and another set
of images were captured of the same wounds. The wound widths were measured by ImageJ
(version 1.50). The experiments were conducted in triplicates and repeated for three times.
Matrigel-coated transwell assay. Assays were performed by transfected the C13 cell line with
control EphA2 for 48 h. After that the cells were plated into the top chambers and treated with
either vehicle or 10µM 1. 24 hours later cells in top chamber were scraped and migrated cells
were fixed with crystal violet staining. Transwell data was determined by the number of the
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migrated cells and the value from parental cells was arbitrarily set at 100%. The experiments were
conducted in triplicates and repeated for three times.

Figure 4.7. Wound-healing assay of negative control AApeptide 9. Images were taken 0, 12 and
24 hours after wound formation. Data are presented as mean ± SD of triplicate experiments. C13
cells treated with 10 µM 9 or vehicle were subjected to migration.
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Figure 4.8. Wound-healing assay of linear AApeptide 10. Images were taken 0, 12 and 24 hours
after wound formation. Data are presented as mean ± SD of triplicate experiments. C13 cells
treated with 10 µM 10 or vehicle were subjected to migration.
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Figure 4.9. Fluorescent microscopy images of C-13 cells treated with 1 μM and 5 μM of 2 for 1
hour.
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4.6.7. Molecular dynamics simulations

Figure 4.10. MD simulations of linear γ-AApeptide L1 and cyclic γ-AApeptide C1. A) Heavy
atom RMSD (in Å) with averaged structure for L1 (top) and C1 (bottom) as a function of simulation time (in μs). Each simulation is indicated by a different color. B) Free energy (in kcal/mol)
of conformational clusters for L1 (black) and C1 (red). Clusters are indexed by population (free
energy); a total of 69 clusters were identified for L1, and 63 for C1. C) RMSD between
conformational clusters (in Å), with legend to the colors on the right. Upper triangular matrix for
L1, lower triangular matrix for C1. D-E) Structures of the conformational clusters for L1 (D) and
C1(E). From left to right, these structures correspond to clusters 1, 20, 40, and 60, respectively.
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Systems were built using CHARMM17 and parameterized in the CHARMM General Force Field7,
228

using Paramchem.229-230 Several torsions with high penalties were further optimized using a

potential energy scan with the Gaussian software231 at the MP2/6-31G* level. Simulations were
run using OpenMM74 in the NPT ensemble, with Langevin dynamics27 and a Monte Carlo
barostat32 at 1 bar. A nonbonded cutoff of 12 Å was used. Long range electrostatics were treated
using Particle Mesh Ewald.4-5 Systems were solvated in TIP3 water104 with a 15 Å shell on all
sides of the solute.
After minimization, systems were heated without restraints from 150 to 300 K for 800 ps.
Equilibration was then performed at 300 K for a further 2 ns, followed by a 500 ns production
run. Five independent simulations were run per system using different random number seeds for
the initial velocities, yielding a total 2.5 μs of production run per peptide. Snapshots were recorded
every 10 ps. Analysis was performed with AmberTools16160 and CHARMM.17 Clustering was
performed on the aggregate simulations using an RMSD based metric with a 0.1 Å cutoff and the
Art-2 neural network algorithm,232 with RMSDs relative to the averaged structures. Relative free
energies were calculated from the number of frames assigned to each cluster.
In order to assess the potential conformational rigidity of this class of cyclic γ-AApeptides, we
conducted molecular dynamics (MD) simulations of the cyclic backbone C1 in explicit water
(Figure 4.10). For comparison, simulations were also run for the corresponding linear structure
L1 (Figure 4.10); five independent simulations were per-formed for each, with a total production
time of 5 μs. Heavy atom root mean square deviations (RMSDs) with the averaged structure were
significantly higher for L1 (Figure 4.10A), indicating higher rigidity of C1. A conformational
clustering showed more accessible conformations for L1 within any free energy bound (Figure
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4.10B). Moreover, the clusters were geometrically more diverse for L1 (Figure 4.10C-E). This
was especially apparent at low free energies, as indicated by the fact that the RMSDs between
cluster centers 1-50 was significantly lower for C1 (lower triangular part of Figure 4.10C) than
for L1 (upper triangular part of Figure 4.10C). For both γ-AApeptides, the remaining clusters were
higher in free energy, especially for C1, and structurally more dissimilar from the lower clusters.
RMSDs between these and other cluster centers were also higher for L1 than C1 (Figure 4.10C).
Overall, consistent with our speculation, the MD simulation suggested the backbone of thioether
bridged cyclic γ-AApeptides is much more conformationally rigid that that of the linear one,
leading to possibility of identification of novel ligands with higher affinity.
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Scheme 4.2. The list of the hits (FITC)
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AApeptide 1 Dde-Ala-Phe-Asp-Glu-Glu-Glu-Phe-H*

AApeptide 7 Dde-Phe-Phe-Asp-Glu-Glu-Glu-Phe-H*

AApeptide 2 Dde-Leu-Lys-Ala-Phe-Lys-Glu-Leu-H*
Figure 4.11. The determination of decoding sequences. H* stands for the homoserine lactone.
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AApeptide 3 Dde-Lys-Lys-Leu-Leu-Asp-Glu-Phe-H*

AApeptide 4 Dde-Phe-Leu-Lys-Glu-Lys-Ala-Ala-H*
Figure 4.11 Continued
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AApeptide 5 Dde-Lys-Ala-Phe-Leu-Phe-Lys-Glu-H*

AApeptide 6 Dde-Lys-Leu-Ala-Phe-Phe-Glu-Ala-H*
Figure 4.11 Continued
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Figure 4.11 Continued
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Figure 4.13 The Kd data of AApeptide 2 to AKT1-PKB
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and NFKBIA

Compound 11

Figure 4.14. The NMR Spectrum of compounds 11-22.
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12

Figure 4.14 Continued
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Figure 4.14 Continued
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Figure 4.14 Continued

145

15

Figure 4.14 Continued
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Figure 4.14 Continued

150

20

Figure 4.14 Continued
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Figure 4.14 Continued
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Figure 4.14 Continued
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22

Figure 4.14 Continued
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Compound Name

Purity (based on analytical HPLC)

1

97.3%

2

99.1%

3

99.3%

4

96.5%

5

98.2%

6

97.6%

7

98.7%

8

98.9%

9

99.7%

10

99.2%

Figure 4.15. The purity of the compounds and HPLC trace of the hits
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Figure 4.15 Continued
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Chapter Five
Secondary Structure Adopted by the Gly-Gly-X Repetitive Regions of Dragline Silk
Note to Reader: This work was performed in collaboration with the Yarger Group (School of
Molecular Sciences and the Magnetic Resonance Research Center, Arizona State University), the
Holland Group (Department of Chemistry and Biochemistry, San Diego State University) and the
Lewis Group (Department of Biology and Synthetic Biomanufacturing, Utah State University).
My contribution to this project was all replica exchange simulations. This chapter is reprinted and
adapted with permission from the above authors and Geoffrey M. Gray and Arjan van der Vaart
from International Journal of Molecular Sciences, see Appendix D.

5.1

Abstract

Solid-state NMR and molecular dynamics (MD) simulations are presented to help elucidate the
molecular secondary structure of poly(Gly-Gly-X), which is one of the most common structural
repetitive motifs found in orb-weaving dragline spider silk proteins. The combination of NMR
and computational experiments provides insight into the molecular secondary structure of
poly(Gly-Gly-X) segments and provides further support that these regions are disordered and
primarily non-β-sheet. Furthermore, the combination of NMR and MD simulations illustrate the
possibility for several secondary structural elements in the poly(Gly-Gly-X) regions of dragline
silks, including β-turns, 310-helicies, and coil structures with a negligible population of α-helix
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observed. Keywords: spider silk; NMR; solid-state NMR; molecular dynamics; secondary
structure

5.2

Introduction

Dragline spider silks have been extensively studied with the long-term goal often being
biomimicry233-235. Dragline spider silks are protein-based biopolymers and understanding the
proteins’ primary and secondary structures are critical steps in the goal of reproducing synthetic
versions of this extraordinary fiber236. The technology and ability to determine primary sequences
through DNA analysis has provided numerous amino acid sequences for a large number of
dragline silks as well as the diversity of other silks that spiders produce237-238. Hence, the next step
is to determine the molecular secondary structure and dynamics of these sequenced proteins in
spider dragline silk. Protein structural elucidation experimental tools such as nuclear magnetic
resonance (NMR) spectroscopy and X-ray Diffraction (XRD) have been extensively used to probe
the secondary structures of the proteins that make-up spider dragline silk239-247. They have
provided many insights into the molecular structure and organization of the silk proteins.
However, a complete picture of the structure and dynamics within spider dragline silk is still
lacking due to the complex and amorphous nature of the biopolymer. The goal of determining a
comprehensive protein secondary structure for spider dragline silk protein-based biopolymers is
aided by molecular dynamics (MD) simulations, which can play a critical role in connecting
experimental restraints with potentially plausible molecular structures248-250. Much of the
complexities in both the structure and dynamics of biopolymers such as spider’s dragline silk will
require a synergistic effort between computational/theoretical biophysics and experimental
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structural biology to obtain a true molecular level structural and dynamic understanding251. This
is a first effort on the part of the authors to combine recent solid-state NMR results and MD
simulations to help elucidate the secondary structures found in the poly(Gly-Gly-X) of orbweaving spider dragline silk.
Major ampullate spider silk (dragline) is a protein-rich biopolymer that is commonly made up of
repetitive amino acid segments (or motifs) from two proteins, major ampullate spidroin 1 (MaSp1)
and major ampullate spidroin 2 (MaSp2) in orb-weaving spiders252. Common repetitive segments
or motifs include poly(Ala), poly(Gly-Ala), poly(Gly-Gly-X), and poly(Gly-Pro-Gly-X-X)236.
The general picture that has emerged to describe major ampullate spider silk is that the poly(Ala)
and flanking poly(Gly-Ala) segments form nanocrystalline β-sheet structures and the rest is an
amorphous glycine-rich flexible linking region, where poly(Gly-Gly-X) is the common motif
found in MaSp1 and poly(Gly-Pro-Gly-X-X) is the common motif found in MaSp2250. Previous
NMR studies have shown that poly(Gly-Pro-Gly-X-X) found in MaSp2 forms type II β-turn
structures253. Additionally, solid-state NMR has provided evidence that poly(Gly-Gly-X) found
in MaSp1 forms 31-helical structures similar to polyglycine II254-261 . The poly(Gly-Gly-X)
sequence is also found in minor ampullate and flagelliform (capture spiral) silk. This sequence is
of particular interest as the X residue is always from a restricted set of amino acids 262-263 and is
frequently in the same order in each protein. In major and minor ampullate silks they are Leu, Tyr,
Ala, and Gln and in flagelliform they are Ala, Val, Ser, and Tyr. In this paper, we combine
experimental solid-state NMR results that focus on the X-residues and molecular dynamics
simulations to better understand the molecular secondary structure of poly(Gly-Gly-X) found in
MaSp1 which will provide a starting point for understanding the structure of this motif in the other
silks.
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5.3

Methods

5.3.1

Materials

Mature female N. clavipes spiders were fed with tap water and crickets once per week. Spiders
were forcibly silked at a speed of 2 cm/s for 1 h every other day. The major ampullate silk (dragline
silk) was separated from the minor ampullate silk under an optical microscope (Olympus,
Waltham, MA, USA). To prepare isotope enriched dragline silk, the spiders were fed a 200 µL
saturated solution of U-[13C,

15

N]-L-alanine, U-[13C,

15

N]-L-leucine, U-[13C,

15

N]-L-glutamine,

and U-[13C, 15N]-L-phenylalanine over four feedings during silk collection. A total of 10 mg of
isotope-enriched dragline silk was collected. Isotopes were purchased from Cambridge Isotopes
Laboratories, Inc. and used as received.
5.3.2

Solid-State NMR Measurements

Solid-state NMR spectra were collected on a Varian VNMRS 400 MHz spectrometer equipped
with a 1.6 mm triple-resonance cross polarization magic angle spinning (CP-MAS) probe
operating in triple resonance mode (1H/13C/15N). One-dimensional (1D) 1H→13C CP-MAS and
two-dimensional (2D) 13C–13C through-space correlation NMR experiments with dipolar-assisted
rotational resonance (DARR) experiments261 were performed at a spinning speed of 35 kHz. The
CP condition consisted of a 1.6 µs 1H π/2 pulse, followed by a 1.0 ms ramped (6%) 1H spin-lock
pulse with a radio frequency (rf) field strength of 155 kHz at the ramp maximum and the 13C
channel matched to the −1 spinning sideband condition (rf field strength of 120 kHz). Typical
experimental conditions included a 25 kHz sweep width, and a recycle delay of 3.0 s, with twopulse phase-modulated (TPPM) 1H decoupling applied during acquisition with a rf field strength
of 130 kHz. In 2D 13C–13C through-space correlation experiments, the spectra were collected with
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1024 points in the direct dimension, 320 t1 complex points in the indirect dimension, and 32 scans
averages with spectral widths in the direct and indirect dimension of 25 and 35 kHz, respectively.
During the DARR mixing period, continuous wave (CW) irradiation was applied on the 1H
channel at n = 1 (ωR = ω1) rotary resonance condition with mixing times (τm) of 50, 150 ms, and
1 s. The 2D spectra were processed with exponential line broadening of 100 Hz in the direct
dimension and a Gaussian function of the form exp(−(t/gf)2) in the indirect dimension with the
constant, gf, equal to 0.0025. The

13

C isotropic chemical shift was indirectly referenced to

adamantane (38.56 ppm).
5.3.3

Molecular Dynamics Simulations

Simulations of spider silk mini-fibrils consisting of MaSp1 residues 71–121 with primary
sequence

GQGAGAAAAA-AGGAGQGGYG-GLGSQGAGRG-GLGGQGAGAA-

AAAAAGGAGQ-G were performed. Each strand consisted of two poly(Ala) regions, separated
by a spacer region. The individual strands were capped by acetyl and amine groups. The minifibrils were constructed from 3 planes of 5 strands, for a total of 15 identical strands. Each of these
strands was initially constructed in an extended β-sheet conformation. Two different systems were
simulated in which the strands were oriented antiparallel within the planes, and parallel or
antiparallel between the planes. These systems are designated AA (antiparallel within planes,
antiparallel between planes) and AP (antiparallel within planes, parallel between planes),
respectively.
In order to significantly enhance the amount of sampled space, temperature replica exchange
molecular dynamics (TREX-MD)42,

264

simulations were performed. In TREX-MD, multiple

independent copies of the system (replicas) are run at different temperatures. At regular time
intervals, attempts are made to swap coordinates between the replicas with neighboring

161

temperatures. The success of these attempts is based on an energy criterion that preserves detailed
balance. In order to equilibrate the replicas at their chosen temperatures, molecular dynamics
(MD) simulations were performed. These simulations used distance restraints between the Cα
atoms of opposing sheets of poly(Ala) regions; these distances were restrained by a flat bottom
potential with a force constant of 20 kcal/(mol Å), active beyond a distance of 6.0 Å. Each system
was first heated from 120 to 400 K over a period of 1 ns. Replicas of the system were then cooled
to their TREX-MD starting temperature over a period of 1 ns. The temperatures for the TREXMD simulations were selected from unrestrained TREX-MD trial runs so as to optimize the
swapping of replicas. In the trial runs, systems were simulated at temperature intervals of 10 K
between 300 and 400 K. The heat capacity was then calculated from these exploratory simulations
and the temperature of the phase transition corresponding to the melting of the noncrystalline area
was identified (between 350 and 365 K). Because phase transitions represent bottlenecks for
replica exchange40 , smaller spacings were used near the phase transition. Swapping was
monitored in further trial runs, and extra replicas were inserted where needed. This optimization
resulted in 37 common replicas at temperatures of 300, 302, 304, 307, 309, 311, 313, 315, 317,
319, 322, 324, 326, 329, 333, 334.5, 336, 339, 341, 343, 345, 347, 350, 352, 355, 357, 359, 361,
363, 365, 367, 369, 371, 373, 375, 377, and 380 K. Additional replicas were added at 305.5, 320,
327.5, 331, 337, 348.5, and 353 K for AP, and 305.5, 321, 327.5, 331, 337.5, 353.5, and 378.5 K
for AA, resulting in a total of 44 replicas for each system.
After temperature equilibration, a 5 ns per replica TREX-MD equilibration was performed, during
which the use of positional restraints on the poly(Ala) region was removed. All simulations were
performed with the Amber12 GPU35 code and the Amber99SB265 force field, using a generalized
Born implicit solvent model266, and Langevin dynamics with a friction coefficient of 5 ps−1.
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Bonds involving hydrogen atoms were constrained using the SHAKE algorithm33, which
permitted the use of a 2 fs timestep. Swapping was attempted every 2 ps for all systems, with an
average success rate between 50% and 70% for each replica. Coordinates were saved every 2 ps.
After equilibration, an unrestrained production run of 60 ns per replica was performed for AP, and
45 ns for AA, for a total production simulation time of 2.6 and 1.9 µs, respectively. Simulations
were run until all replicas had visited all temperatures; this took somewhat longer for the AP
system. Secondary structures for all but the 31-helices were calculated using STRIDE107, which
uses the Kabsch and Sander rules267 with stricter hydrogen bond definitions for assigning α- and
310-helices and β-sheets, and Thornton’s definitions268-269 for turns. For this analysis, all β-turn
types were grouped together, but type III (which equals a 310-helix) was excluded. STRIDE
assignments were verified by visual inspections. Since 31-helices are not identified by STRIDE,
visual inspections were performed on samples of three consecutive residues, of which at least two
residues had |ϕ| between 70◦ and 90◦, and |ψ| between 140◦ and 150◦; absolute values were chosen
to include both right- and left-handed helices. A total of 400 randomly selected structures were
visually inspected for the occurrence of 31-helices; the sample statistics were used to calculate the
overall occurrence of 31-helices, and boot strapping was used to estimate errors. All structural
analyses were performed for the 300 K replicas.

5.4

Results

5.4.1

Solid-State NMR

The consensus primary amino acid sequence for MaSp1 along with the

13

C cross polarization

magic angle spinning (CP-MAS) NMR spectrum of 13C-labeled N. clavipes spider dragline silk is
shown in Figure 1a,b, respectively. The N. clavipes silk is a MaSp1-rich silk with a low MaSp2
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content (~80:20, MaSp1:MaSp2). Thus, when investigating this silk it is the MaSp1 protein that
is primarily characterized. However, it should be noted that although the N. clavipes dragline silk
is primarily MaSp1, minor contributions from amino acids present in the MaSp2 protein cannot
be discounted. The contribution from MaSp2 amino acids in non-Gly-Gly-X motifs is believed to
be mostly negligible for the X amino acids, since Leu is entirely absent from MaSp2 and Tyr is
present in the same Gly-Gly-X motif in MaSp2238. Gln is present in a non-Gly-Gly-X Gln-Gln
motif in MaSp2 and could contribute to a minor extent. The spider dragline silk is 13C enriched at
Ala, Gly, Leu, Gln, and Tyr. The Ala methyl, Cβ, resonance has been shown in previous studies
to be heterogeneous with a minimum of two-components at 17.4 and 20.9 ppm that has been
assigned to Ala present in a disordered 31-helix similar to polyglycine II and ordered
nanocrystalline β-sheet structures, respectively261. The Ala in 31-helical structures have been
ascribed to Ala located in the repetitive Gly-Gly-X motif while, the Ala in β-sheet structures are
located in the poly(Ala) and flanking poly(Gly-Ala) motifs in the primary amino acid sequence.
By 13C labeling the common X amino acids (Gln, Tyr, Leu) found in Gly-Gly-X, we have been
able to further probe the secondary structure of this disordered domain.
The

13

C isotope enrichment permits 2D

13

C–13C correlation experiments with dipolar assisted

rotational resonance (DARR) to extract the conformation dependent

13

C chemical shifts for the

various amino acids that are found in the Gly-Gly-X motif. This 2D method is particularly useful
for extracting all

13

C chemical shifts for each site including the CO chemical shifts that are

completely overlapped in the 1D 13C CP-MAS spectrum (see Figure 1). The 13C chemical shifts
are tabulated in Table 1. The results for Ala and Gly are similar to previously reported solid-state
NMR studies where components for β-sheet and 31-helix were observed with nearly identical
chemical shifts261. For the other 13C labeled X amino acids including Gln and Tyr, the chemical
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shifts indicate that these amino acids are present in non-β-sheet conformations; however, the shifts
do not match α-helical structures and shifts similar to those observed for Ala in a model 31-helix
for the most part (see Table 1)254, 270-273. Specifically, the observed shifts for Cα and CO sites shift
to the β-sheet side of random coil (to lower ppm) and the Cβ sites are close to random coil. This
is similar to the observations observed for Ala in the model 31-helical structure, but are also similar
to β-turn chemical shift trends depending on the amino acid position in the turn274. Lastly, for Leu,
the 13C chemical shift trends most closely match the random coil conformation. Overall, the solidstate NMR results illustrate that the structure of the Gly-Gly-X motif is not β-sheet or α-helix and
is best interpreted as a disordered structure with evidence for 31-helix, β-turn, and/or random coil
conformations.

MaSp1: GGAGQGGYGGLGSQGAGRGGLGGQGAGAAAAAA
(a)

(b)
Figure 5.1. (a) Consensus primary amino acid sequence for N. clavipes MaSp1. Gly-Gly-X
regions where X = A, Y, L and Q are indicated in green, orange, red, and blue; and (b) 1H→13C
cross polarization magic angle spinning (CP-MAS) NMR spectrum of
dragline silk.
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13

C-labeled N. clavipes

Table 5.1.

13

C NMR isotropic chemical shifts in ppm from tetramethylsilane (TMS) for N.

clavipes dragline silk, random coil, and polypeptides with defined secondary structures.
a (AGG)10 model peptide with (ϕ, ψ) values near (−90◦, 150◦).
Residue

N. clavipes

α-helix

β-sheet

Random Coil

31-helix

Gly C

43.2

46.0

43.2-44.3

43.4

41.4-42.5

Gly CO

169.7

174.9

168.4-169.7

173.2

Ala Cα

49.3

52.3-52.8

48.2-49.3

50.8

48.9

14.8-16.0

19.9-20.7

17.4

17.4

176.2-176.8

171.6-172.2

176.1

174.6

50.3
Ala Cβ

17.4
20.9

Ala CO

172.8
174.5

Gln CO

172.6

175.4-175.9

171.9-172.2

174.3

-

Gln Cα

52.7

56.4-57.0

51.0-51.4

54.0

-

Gln Cβ

25.8

25.6-26.3

29.0-29.9

27.7

-

Gln Cγ

30.6

29.7-29.8

29.7-29.9

32.0

-

Gln Cδ

176.6

-

-

178.8

-

Tyr CO

172.7

176.7

169.7

174.2

-

Tyr Cα

55.1

54.8-58.6

52.1

56.2

-

Tyr Cβ

37.7

36.1

39.3

37.1

-

Tyr Cγ

128.6

129.7

128.0

128.9

-

Tyr Cδ

130.9

129.7

128.0

131.6

-
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Table 5.1 Continued
Tyr Cε

116.1

116.1

115.0

116.5

-

Tyr Cζ

156.2

154.2

155.2

155.6

-

Leu CO

176.0

175.7

170.5-171.3

175.9

-

Leu Cα

53.8

55.7

50.5-51.2

53.4

-

Leu Cβ

41.6

39.5

43.3

40.7

-

Leu Cγ

24.0

-

-

25.2

-

Leu Cδ

23.3

24.4

24.9

24.3

-

The 13C–13C correlation method with long (1 s) DARR mixing permits observation of long range
contacts between adjacent amino acids. This allows one to identify the location of amino acids in
different motifs. For Gln, Tyr, and Leu, long-range contacts to Gly are observed at 42.1, 41.2, and
42.5 ppm, respectively, which is consistent with these amino acids present in the Gly-rich GlyGly-X motif (see Figure 2). Importantly, the Gly correlations observed are consistent with Gly
present in 31-helix (41.4–42.5) indicating that the common X-amino acids in Gly-Gly-X exhibit
correlations consistent with this conformation. However, as discussed above, although the shift
trends agree with the 31-helical structure for the most part, the shifts for the X amino acids show
some inconsistencies and closely overlap with β-turn and coil conformations. The MD simulations
discussed in the next section help to clarify this ambiguity and assist in characterizing the structure
of Gly-Gly-X.
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(a)

(b)
Figure 5.2.

13

C–13C correlation spectrum collected with a long dipolar assisted rotational

resonance (DARR) mixing period of 1 s. Short range (intra-residue) and long range (inter-residue)
dipolar contacts are indicated with dashed black lines. Long range dipolar contacts for (a) LeuGly and (b) Tyr-Gly present in Gly-Gly-X repeats are indicated in red.
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5.4.2

Molecular Dynamics Simulations

Simulations were performed of two MaSp1 mini-fibrils that consisted of three planes of five
identical strands. The systems differed in the arrangement of strands: in the anti-parallel/parallel
(AP) system, the strands were oriented anti-parallel within the planes and parallel between the
planes, while in the anti-parallel/anti-parallel (AA) system, the strands were arranged in an antiparallel manner within the planes and between the planes. Representative temperature replica
exchange molecular dynamics (TREX-MD) structures at 300 K are shown in Figure 3. In all
systems, the poly(Ala) regions were in the β-sheet configuration, but the length of the β-sheets
varied among the systems. AP had the longest β-sheets, with more residues in this conformation
than AA. Root mean square deviations (RMSD) of the backbone atomic positions were calculated
using the averaged system as a reference (Table 2). AP showed lower average RMSD values than
AA, indicating less structural variation of AP. RMSD values for the spacer region were similar to
the overall RMSD for AP and AA, indicating significantly higher mobility of the spacer regions.
In both systems, a bend between the two poly(Ala) regions was observed (Figure 3, Table 2). This
bending was decomposed into in-plane bending (within the plane of the sheets) and out-of-plane
bending (out of the plane of the sheets). The AP bending was small for all three angles; AA had
larger bending angles, particularly for out-of-plane bending. The lower bending angle for the AP
system suggests that it can be packed more efficiently into larger structures as opposed to the AA
system.
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Figure 5.3. Representative TREX-MD structures at 300 K, with poly(Ala) region in red, rest in
blue. (a) AP; (b) AA system.

170

Table 5.2. Structural data of 300 K replica. Root-mean-square deviation (RMSD) in Å and angles
in degrees. Secondary structural elements in the spacer regions (residues 82–107) are given as a
percentage of all spacer residues; π-helices and bridges are not reported.
Region

Overall

Property

AP

AA

RMSD

9.2 ± 1.0

11.5 ± 0.8

Total bending angle

13.2 ± 7.5

55.5 ± 18.7

In-plane bending

6.5 ± 0.7

16.0 ± 5.6

5.4 ± 4.2

31.3 ± 18.9

RMSD

9.6 ± 1.5

11.4 ± 3.4

% 310-helix

4.1

4.3

% 31-helix

0.1

0.1

% β-turn

30.6

35.6

% Coil

32.5

33.4

% β-sheet

26.4

18.9

% α-helix

0.7

0.9

angle
Out-of-plane
bending angle

Space Region

The secondary structure of the spacer region in the TREX simulations is shown in Table 2, and
the Ramachandran plot for the spacer region is shown in Figure 4. The spacer regions were rich
in β-turns and coils, but a significant fraction of β-sheets was found as well. A large fraction of
the poly(Ala) β-sheets extended into the first 5 residues of the spacer region. Typically only a few
isolated β-sheets were found in the center of the spacer regions; these generally consisted of a few
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residues and 2 to 3 strands. This means that the high population of β-sheets stemmed from a
continuation of the poly(Ala) β-sheets; apart from these extensions, the spacer had few β-sheets.
The spacer was also poor in α-helices, with less than 1% of the spacer residues in α-helical
conformation. The low abundance of α-helices and β-sheets in the spacer region is in agreement
with the NMR results reported above and in the literature for the Gly-Gly-X region254-261.

Figure 5.4. Ramachandran plots for the spacer region (residues 82–107) for (a) AP and (b) AA
simulations. Data is shown for the 300 K replicas. Three basins (and their mirror images,
indicated by primes) were found. Basin I corresponds to β-turns and β-sheets, basin II
corresponds to β-turns, 31-helices, and coils, and III corresponds to 310-helices and α-helices.
Based on NMR chemical shifts, it has previously been reported and also indicated in this study
that the spacer region is rich in 31-helices with (ϕ, ψ) values near (−90◦, 150◦)254-261. We indeed
saw a large population of secondary structure elements with these dihedral angles in the
simulations, but these were classified as β-turns in our MD analysis. In contrast to the NMR
findings, very low 31-helical content was found in the spacer region (~1 per 6 simulation frames).
The 31-helices that formed were rich in Gly (Table 3), and were 3 residues in length. Structures
of representative 31-helices are shown in Figure 5. The helices formed inter-strand hydrogen
bonds, mostly with β-turns. Although NMR chemical shifts of 31-helices show overlap with
chemical shifts for β-turns, and the dihedral angles of 31-helices and β-turns overlap, the low
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occurrence of 31-helices in the simulations likely indicates a force field deficiency in describing
Gly-rich areas.

Table 5.3. Sequence composition of 31-helices in the 300 K replicas. X indicates a residue with
|ϕ| between 70 and 90 degrees, and |ψ| between 140 and 150 degrees; Y indicates any combination
of dihedral angles.
% Residue

AP

AA

XX

XYX

XX

XYX

G

60.0 ± 4.9

58.5 ± 3.3

61.5 ± 4.8

60.0 ± 3.0

A

9.6 ± 4.4

5.2 ± 2.7

12.1 ± 4.8

8.0 ± 3.2

Q

8.5 ± 3.9

12.2 ± 3.5

10.1 ± 4.5

10.0 ± 3.3

L

9.2 ± 4.2

8.0 ± 3.1

7.9 ± 3.7

8.9 ± 3.2

Y

3.7 ± 1.9

6.1 ± 2.7

5.3 ± 2.7

7.3 ± 3.1

R

9.4 ± 4.3

6.6 ± 2.8

4.9 ± 2.5

3.4 ± 1.8

S

3.6 ± 1.7

4.2 ± 2.1

2.6 ± 0.4

3.5 ± 1.9
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Figure 5.5. Representative structures of 31-helices in the simulations. (a) shows the motifs with
hydrogen-bonding partners; while (b) shows the backbone atoms along the helical axis.
Hydrogen, oxygen, nitrogen, and carbon are indicated in grey, red, blue and green, respectively.
Hydrogen bonds with neighboring strands are indicated by dotted lines, and their lengths are
given.
In the simulations, 310-helices also formed (4%); mostly consisting of three residues, and
sometimes four (~10%). The (ϕ, ψ) distribution for the 310-helices peaked at (−70◦, −25◦) and
(70◦, 25◦), which is close to the (−60◦, −30◦) and (60◦, 30◦) values for the ideal right and lefthanded 310-helix, respectively275. The (ϕ, ψ) dihedral distribution of the 310-helices partly
overlapped with the dihedral distribution for β-turns, in particular type I and its mirror image
type I’275. β-turns and 310-helices both have i→i + 3 hydrogen bonding patterns, and their
chemical shifts largely overlap. There are other structural similarities as well267-269; in fact, type
III β-turns (which are excluded from our β-turn definition) correspond to a 310-helix275. In the
simulations, the interconversion of β-turns and 310-helices was frequently observed, including βturns with (ϕ, ψ) angles that match those of the 31-helix (especially in the higher temperature
replicas) although they were short turns only comprised of a few residues and not continuous
extended helices. Of interest was the relatively large occurrence of left-handed 310-helices (Table
4). The backbone (ϕ, ψ) angle distribution of these helices peaked at (70, 25) degrees, which
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differs from the (−70, −25) degrees of right-handed 310-helices. Left-handed 310-helices are rare
in ordinary proteins, and typically involve Gly [37]. The high occurrence of Gly in the MaSp1
spacer region is atypical for proteins; moreover, the absence of tertiary structure in the
amorphous spacer region might further contribute to its high formation. Representative structures
of the 310-helices are shown in Figure 6. α-helical motifs were rare; when they occurred, they
were on average 2–3 residues longer than the 310-helical motifs. Formation of α-helices occurred
only in the central spacer region, except for the (Ala)n α-helices in AA, which were due to
refolding of the poly(Ala) region. Since refolding of the poly(Ala) region is unlikely to occur,
the AA system is likely not representative of a spider silk mini-fibril. Ser-Gln-Gly (SQG) was
present in most of the motifs, and a large percentage of α-helices contained Leu-Gly-Ser (LGS)
motifs. Both LGS and SQG sequences also formed 310-helices, suggesting potential
interconversion between these structures.

Table 5.4. 310-helices in the 300 K replicas. %G, %A, and %S indicate the occurrence of Gly,
Ala, or Ser, respectively, given as a percentage of all residues in 310-helices. The average length
of hydrogen bonds in the 310-helices (in Å) is also shown.
Occurrence

AP

AA

Overall

Left

Right

Overall

Left

Right

%G

50.9

41.5

58.5

49.0

53.3

46.7

%A

36.6

47.3

52.7

17.6

67.3

32.7

%S

13.8

21.6

78.4

11.8

46.6

53.4

310 hydrogen bond length

2.1 ± 0.2

2.1 ± 0.2
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Figure 5.6. Structure of the most commonly formed 310-helices. Top panels (A) show righthanded 310-helices, bottom panels (B) show left-handed helices. Hydrogen, oxygen, nitrogen, and
carbon are indicated in grey, red, blue and green, respectively. Hydrogen-bond lengths are
indicated by dotted lines, and their lengths are given.

5.5

Discussion

TREX-MD simulations of two MaSp1 mini-fibrils that differed in the arrangement of strands
indicated higher stability of the AP system in which the strands were arranged in an anti-parallel
manner within and parallel between the planes. The simulations showed that the β-sheets of the
poly(Ala) region extend into the first residues of the spacer region. The secondary structure of the
remaining spacer region was poor in α-helices and β-sheets, and predominantly consisted of βturns and coils. The simulations showed very low 31-helical content though, which might point to
deficiencies in the force field. A minor fraction of 310-helices was found, with a high occurrence
of left-handed 310-helices, which rarely occur in other proteins. It is thought that the high Gly
content and the absence of tertiary structure is responsible for the high formation of left-handed
310-helices in the disordered spacer region. Only short 31- and 310-helices were found, with all 31-
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and most 310-helices consisting of three residues. Conversions between these two structural
elements and β-turns were frequently observed. The variation in turns and 31 and 310-helices
appear possible due to the high Gly content and the absence of tertiary structure restraints.
In principle, combining solid-state NMR with MD simulation is a powerful approach for
determining the secondary structure for spider dragline silk and the various repetitive motifs that
comprise the silk proteins. The solid-state NMR data provided convincing evidence that the GlyGly-X motif does not form α-helical or β-sheet structures, with some evidence for the polyglycine
II 31-helical conformation. However, some of the observed chemical shifts also overlap with 310helical, β-turn, and random coil chemical shifts, making the interpretation somewhat ambiguous.
The MD simulation provided evidence for the presence of all of these structures, illustrating the
disorder of the Gly-Gly-X spacer region and helping with the NMR interpretation. While 31helical content is currently underestimated in the MD, tuning of the Gly force field parameters
and the use of chemical shift restraints in the simulations will improve the accuracy of the
simulations. In this way, it is anticipated that combining solid-state NMR and MD will greatly
enhance our ability to characterize the conformational structure of the various repetitive motifs
that comprise spider and other types of animal silks.

5.6

Conclusions

Solid-state NMR and MD simulations were used in conjunction to illuminate the conformational
structure of poly(Gly-Gly-X), one of the most common repetitive motifs found in dragline spider
silk proteins. The combination of NMR and MD results provides new insight into the secondary
structure of poly(Gly-Gly-X) segments and provides further support that these regions are
disordered and primarily non-β-sheet. Further, the combination of NMR and MD simulations
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illustrate the possibility for several secondary structural domains in the poly(Gly-Gly-X) regions
of dragline silks including β-turns, 310-helices, and coil structures with an insignificant population
of α-helix observed. These solid-state NMR results and MD simulations highlight the complexity
of this common spider silk protein motif. It is envisioned that this combined NMR experimental
and MD computational method will be powerful moving forward for elucidating the
conformational structure and hierarchical organization of other silk motifs that remain under
determined.
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Chapter Six

Secondary structure of Gly-rich motifs of major ampullate spidroin 1 and 2 proteins

6.1

Abstract

Spider dragline silk has highly desirable material properties, possessing high extensibility and
strength, along with biocompatibility. However, attempts to artificially reproduce dragline silk
result in inferior materials. To elucidate the structural properties of silk under dope and fiber
conditions, as well as the effects of spinning, multiple replica exchange with solute tempering,
molecular dynamics and pulling simulations were performed on model peptides extracted from the
N. clavipes gene. Analysis of the secondary structure found predominantly turns, bends and coils
in the dope under low concentration. 31-helices formed under intermediate concentrations while
high dope concentrations contained almost no 31-helices. Both pulling and simulation under fiberlike conditions resulted in formation of a high fraction of 31-helices (~30%). These results indicate
that both the unidirectional extension experienced during the spinning process and the low
dielectric of the fiber facilitate the unique secondary structure identified in silk.
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6.2

Introduction

Spider dragline silk is remarkably tough due to a combination of high extensibility and strength.236,
249, 276

Dragline silk fibers are predominantly composed of two large proteins, major ampullate

spidroin 1 (MaSp1) and major ampullate spidroin 2 (MaSp2).277-278 The sequence of these proteins
consist of non-repetitive termini, which are separated by a highly repetitive core that makes up the
majority (~90%) of the sequence. The repetitive core consists of blocks of 40 to 200 residues that
are repeated between 20 and 100 times; each block consists of a 4 to 10 residue poly-Ala or polyGly-Ala region that is adjacent to a Gly-rich region. In the fiber, the poly-Ala and poly-Gly-Ala
regions form 2×5×7 nm crystallites consisting of antiparallel β-sheets.279-280 These crystallites are
aligned to the fiber axis and embedded in an amorphous matrix.276 The crystallites are responsible
for the fiber's strength, while the amorphous Gly-rich regions provide its elasticity.281 In MaSp1
the Gly-rich regions consist of GGX motifs,277 and in MaSp2 they consist of GPGXX motifs278
(where X=Ala, Gly, Leu, Gln, Tyr). The GGX motifs adopt 31-helical structures, also known as
polyproline II (PPII) helices (Figure 6.1),85, 254-261, 282-283 while the GPGXX motifs adopt type II βturn structures253 that collectively enables formation of β-spirals.284

Before spider silk is spun into a fiber by a specialized organ (spinneret), the constituent proteins
are stored in a highly concentrated solution in an abdominal gland.285 Depending on the species,
this gland consists of two or three different zones.286 The A zone at the start of the gland is neutral
or slightly alkaline and secretes and stores MaSp1 and MaSp2, while the other zones towards the
spinnerets are acidic, secrete protein coating, and have a role in preprocessing of the fiber.287 At
concentrations that range between 30-50%,288-290 the proteins are believed to form micellar
structures in the A zone, that congregate to form liquid crystal intermediates.291-292 This viscous,
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gel-like solution is void of fibrils, through an unknown mechanism that is controlled by the pH.287,
292

Insights into the protein microstructure in the A zone dope would aid the understanding of this
mechanism, but so far, experimental data is somewhat conflicting. Early NMR, FTIR and CD
measurements indicated that the dope lacks β-sheets, and consists of a dynamical ensemble of
loosely formed α and 31-helices,290 while other CD measurements indicated a structure poor in αhelices and β-sheets.293 CD indicated that the proteins are in a random coil with some β-sheet
structure in the gland,287 and in random coil in aqueous solution.294-295 NMR indicated that the
dope is dynamically disordered without well-defined secondary structure296-298 with fast backbone
dynamics on the sub-nanosecond time scale.297 Raman confocal spectromicroscopy and
vibrational CD indicated a mixture of random coil and 31-helical segments, with some α-helical
structures.299-300 Other Raman spectromicroscopy experiments indicated that the GGX and
GPGXX motifs have indistinguishable conformations in the dope, which both form a disordered
random coil with some α-helical contribution.301

Here, we present simulations to further assess the structural propensities of several peptide
sequence motifs of the Gly-rich regions of Nephila clavipes MaSp1 and MaSp2 at various
concentrations. Here, simulations of five peptide sequences from the amorphous region of N.
clavipes under differing peptide concentrations, solvents and model spinning conditions reveal the
contributing factors to the formation of 31-helices. Peptide concentration is found to decrease the
prevalence of 31-helices. Simulation in octanol (used to model the solid state), resulted in an
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increase in the formation of 31-helices. Extension of the peptide using a pulling force resulted in
the highest fraction of 31-helices.

Figure 6.1. (A) Fischer projection of the carbonyl vectors along the peptide axis. Each carbonyl
is rotated by 120° relative to the other. (B) View of the backbone of a model 31-helix down the
peptide axis. (C) View of backbone along the side of the peptide.

6.3

Methods

A total of five peptide sequences representative of the Gly-rich regions in MaSp1277 and MaSp2278
of Nephila clavipes were studied (Table 6.1). The MaSp1 sequences will be indicated by 1a-c, the
MaSp2 sequences by 2a-b. Systems were simulated in water104 and, in order to mimic the low
dielectric environment of a highly concentrated peptide solution, also in octanol.7 For the water
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solvated systems, three concentrations were simulated: a low concentration of one strand per box,
a medium concentration of three strands per box, and a high concentration of 30 strands per box,
while a single strand was simulated in octanol. A solvent layer of 20 Å was used for the monomeric
simulations in water and octanol, as well as for the trimeric simulations in water.

Table 6.1. Studied peptide sequences.
Name

Source

Sequence

1a

MaSp1

GGAGQGGYGGLGSQG

1b

MaSp1

GGAGQGGYGGLGSGG

1c

MaSp1

GGAGQGGYGGLGNGG

2a

MaSp2

PGGYGPGQQGPGGYGPGQQGP

2b

MaSp2

GPGGYGPGQQGPGGYAPGQQGP

Sampling of the low and intermediate concentrations was performed with multiple scaling replica
exchange (MREST)40, 56 simulations. In MREST, simulations are run of multiple independent
copies of the system, each with a different temperature and biasing potential. At preset intervals
(here: 5 ps), attempts are made to swap coordinates between the systems in a way that preserves
detailed balance. The biasing potential consist of a temperature-scaled potential for the solventsolvent and solvent-protein interactions,51 combined with Tsallis biasing53 of all degrees of
freedom. The temperature-scaled potential allows for the use of a small number of replicas for
large systems, while the Tsallis biasing potential and increased temperature favor barrier crossing.
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Details of the method can be found in the original paper.56 The MREST simulations were
performed with CHARMM,17 using six replicas for water and with temperature and Tsallis q
factors of (T, q) = (300 K, 1), (332 K, 1.00001), (368 K, 1.00002), (407 K, 1.00003), (451 K,
1.00004), (500 K, 1.00005). For octanol systems, 10 replicas were used with temperature and
Tsallus q factors of (T,q) = (300 K, 1), (317 K, 1.000025), (336 K, 1.000030), (355 K, 1.000040),
(376 K, 1.000045), (398 K, 1.000050), (421 K, 1.000055), (446 K, 1.000065), (472 K, 1.000075),
(500 K, 1.000080). For the trimeric systems, 8 replicas were run using temperature and q factors
of (T,q) = (300 K, 1), (312 K, 1.000010), (325 K, 1.000020), (339 K, 1.000030), (353 K,
1.000040), (368 K, 1.000050), (383 K, 1.000055), (400 K, 1.000060).
Systems were heated in the NPT ensemble from 150 to 300 K in 50 K increments over a period of
400 ps, further heated (using 10 K increments of 100 ps) if needed, and equilibrated in the NVT
ensemble for 2000 ps. After a further equilibration using MREST for 1 ns, production runs were
performed using 6 replicas and 40 ns per replica for the low concentration water system, and 10
replicas and 40 ns per replica for the octanol and medium concentration water systems.

While swapping rates were satisfactory for the low and medium concentrations (40%-60%),
swapping was very low in test MREST simulations of the high concentration system indicating
low efficiency of sampling. The high concentration systems were therefore simulated with MD
using OpenMM .74 The MD simulations were run in triplicate using different seeds for temperature
initialization; systems were first heated to 600 K and then cooled to 300 K in order to generate
sufficiently randomized starting configurations. Systems were then run for 250 ns, printing
snapshots every 5 ps. MD and MREST simulations were run until the distribution of variables
measured (RMSD, secondary structure, Ramachandran plots) did not change with additional
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simulation. Because of the high frustration of the high-peptide concentration systems, further tests
of convergence are required.

All simulations in CHARMM were performed using the Langevin integrator.

27

Bonds with

hydrogen atoms were constrained using SHAKE allowing a timestep of 0.002 ps.33 A nonbonded
cutoff of 12 Å with a switching function was used, and long-range electrostatics were handled
using the particle-mesh Ewald method.5 Snapshots were saved every 5 ps.

Pulling simulations were performed using CHARMM17 and applying a force of 80 pN between
the terminal N and C atoms in the x-direction. Systems were clustered, and the centroids used as
the starting points for the simulation. Systems were resolvated to add additional water molecules
in the direction of pulling, corresponding to a layer of 30 Å in the x-direction and 20 Å in the y
and z-directions. Systems were then heated for 100 ps in 50 K increments from 150 K to 300 K
for a total heating time of 400 ps. Distance restraints were applied between the terminal N and C
atoms. Pulling was then performed over a period of 5 ns and snapshots were saved every 2 ps.

Simulations of the snow-flea antifreeze protein were performed using OpenMM74 in the
CHARMM 36 protein force field.6 The starting structure was taken from PDB ID 2PNE.302 A
solvent layer of 20 Å of TIP3104 water was added beyond the protein. The system was then
minimized and heated with backbone restraints of 5 kcal/mol from 150 K to 300 K in 50 K
increments. Each heating step was 1 ns. Equilibration was then performed, and the restraints
gradually released from 5 kcal/mol, 2.5 kcal/mol, 1 kcal/mol, 0.5 kcal/mol, 0.1 kcal/mol and the
unrestrained. Each equilibration step was performed for 2 ns. 100 ns of production was then
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performed. All simulations were performed with periodic boundary conditions in the NPT
ensemble using Langevin dynamics27 and a Monte Carlo barostat.32 A 12 Å cutoff was used for
nonbonded interaction with a switching potential. Long-range electrostatics were treated using
Particle-Mesh Ewald.5 Snapshots were saved every 5 ps.

Secondary structure was calculated using DSSP.107 Since 31-helices are not recognized as a
secondary structure by this method, an internal script was used to calculate the angle between
adjacent C=O backbone vectors. Angles of 120° ± 20° were then classified as 31-helices.

6.4

Results

In order to assure sufficient sampling, swapping was checked for all replicas. Simulations were
run until each replica visited all other replicas at least once. For all simulations, this occurred
within 1 ns of sampling. Sampling was then continued until each replica went from the lowest
replica to the highest and then back down to the lowest. Further tests for convergence are still
required for the MD simulations.

Water/1 1a-1c peptides had similar Ramachandran plots (Figure 6.2), with major populations
centered around (φ,ψ) = -60°, 150°).The region of the plot between (φ,ψ) = (-60°, 150°) to (φ,ψ)
= (-90°, 135°) is typically associated with PPII helices. The largest populations were centered at
(φ,ψ) = (-60°, 150°), corresponding to right-handed PPII helices. Small populations were observed
around the helical regions (corresponding to α-helices and 310-helices) of the Ramachandran plots
as well, however these structures were not observed. 2a-2b had similar large population centered
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at (φ,ψ) = (-60°, 150°). The shape of this population differed from 1a-1c systems, with density
observed around (φ,ψ) = (-50°, 180°). Populations at (φ,ψ) = (60°, ±150°) were not present in 2a
and were reduced in 2b.

Peptides in Water/3 simulations all showed peaks around (φ,ψ) = (-60°, 150°). 1a also had
populations around (φ,ψ) = (60°, 150°). Peaks around (φ,ψ) = (-60°, -180°) were also observed,
and are connected to the (φ,ψ) = (-60°, 150°) populations. The population at (φ,ψ) = (60°, 150°)
was not present for 1b-1c and 2a-2b. Similar small populations for helices were observed for all
Water/3 systems.

Water/30 systems showed large populations at (φ,ψ) = (-60°, 150°), as well as the connecting
populations at (φ,ψ) = (-60°, -180°). These populations were more substantial for 2a-2b than for
1a-c. Additionally, all Water/30 systems had multiple small populations in both the right and lefthanded α-helical regions. The population for the left-handed helical region is shifted up, centered
around (φ,ψ) = (40°, 60°). This corresponds to 310-helices. The formation of left-handed structures
is due to the high Gly content.
Several differences between Ramachandran populations for Water/1 and Water/3 systems were
observed. For 1a-1c systems, the increase in concentration reduced the population of left-handed
structures. This is evidenced by the loss of density at (φ,ψ) = (60°, 150°). This loss was also
observed for 2b. Increasing concentration also reduced the population in the helical region for 2a.
Ultimately, this suggests a mild cooperative effect for the formation of right-handed PPII helices
between peptide strand. Increasing the concentration by an order or magnitude (i.e. Water/30)
revealed larger changes structural effects. While right-handed PPII helices still formed, the basins
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become more restricted around (φ,ψ) = (-60°, 150°). Additionally, the helical regions of the plot
were also more populated. Interestingly, 2a-2b had larger population in (φ,ψ) = (60°, 150°).

All sequences had large populations in (φ,ψ) = (-60°, 150°). Generally, Water/1 1a-1c systems had
higher populations in the (φ,ψ) = (60°, 150°) region, while 2a-2b did not. This may be in part due
to the presence of Pro in 2a-2b and not 1a-1c, resulting in conformational restriction. This effect
became less prominent for Water/3 systems, in which only 1a retained a larger population than 2a2b, and the trend was reversed for Water/30, with 1a-1b having smaller populations in this region
and 1c having a similar population as 2a-2b. While 2a had a slightly higher population located in
the helical/turn region for Water/1, similar populations were observed for all sequences in Water/3
and Water/30.
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Figure 6.2. Ramachandran plot for each system.

Secondary structure analysis revealed high propensities for turns/bends and coils for Water/1
systems, with relatively small populations of 31-helices (Figure 6.3). Very few sheet and α-helices
were identified. 1a-1c systems had ~30-40% turns/bends, 20-30% coils and ~10% 31-helices.
Typically, structural formation was local and did not result in the formation of large structural
motifs. Systems 2a-2b showed a shift in the population, having a higher percentage of turns/bends.
31-helices were still ~10%, however, coils were reduced. The population shift from coil to turn for
2a-2b is likely a reflection of the presence of Pro in these sequences. Additionally, several of the
residues for 2a-2b had noticeable sheet populations (~5%). Water/3 secondary structures had
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higher populations of 31-helices. Coils still comprised ~20-30%, and turns/bends ranged form 3040%. While helices did not form, there was an increase in sheets. This was more pronounced for
2a-2b, than for 1a-1c. Water/30 systems had almost no 31-helices, and small populations of sheets.
These systems were almost exclusively turns/bends and coils.

Effects of sequence and structure for secondary structure were identified. The largest role in
secondary structure was the concentration, with shifts in structural population. Populations of 31helices increased 2-fold going from Water/1 to Water/3, indicating a cooperative formation of this
structure. The same result was observed for β-sheets. Little effect on turns/bend and coils was
observed. High concentration (Water/30) resulted in an overall increase in turns/bends, with loss
of 31-helices and a reduction in β-sheets. Sequence effects were observed for Water/1 and Water/2,
with 2a-2b having higher populations of turns/bends and β-sheets. Propensity for 31-helices were
relatively similar for all sequences. Populations in Water/30 indicate little sequence dependent,
with systems most just composed of turns/bends and coils.
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Figure 6.3. Fraction of secondary structure of silk peptides in water and octanol. Sequences have
a slight propensity to form turns in water, with mostly random coil structures indicated. Sequences
have a much higher propensity to form turns in octanol. Additionally, significant formation of
helices are identified in several sequences.

Because of the relative scarcity of 31-helices in nature, simulations were performed test the ability
of the CHARMM 36 force field to replicate this structural motif. Simulations of the snow flea
antifreeze protein, a protein with a high content of 31-helices, was performed. RMS values are
given in (Figure 6.4). The simulation is stable in the force field, and does not experience any
significant structural changes. A small spike in RMS is observed ~75 ns, which corresponds to a
twist in the structure. Calculation of the fraction of 31-helices from the crystal structure and
comparison to average obtained from the simulation gave values of 25% and 27%, respectively.
This is in excellent agreement and shows the CHARMM 36 force field is able to replicate this
structural motif with high fidelity.
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Figure 6.4. RMSD for the snow-flea antifreeze protein relative to the crystal structure.

Octanol systems 1a-1b showed high helical content in the (φ,ψ) = (-60°, -45°), which correspond
to α-helices. Both also had populations around (φ,ψ) = (40°, 20°), suggesting the presence of lefthanded 310-helices. Small populations around (φ,ψ) = (-60°, 150°) was observed for 1b. 1c and 2a
had shifted helical populations closer to (φ,ψ) = (-40°, 0°), indicating a greater 310-helical content.
1c also had a similar left-handed helical population. 1c had a large population of (φ,ψ) = (-60°,
150°) and (φ,ψ) = (-90°, 135°), both indicative of right-handed PPII helices. Similar populations
were observed in 2a and the (φ,ψ) = (-60°, 150°) was observed in 2b. 2b had small populations in
the helical regions of the plot, with larger population at (φ,ψ) = (-60°, 180°) and (φ,ψ) = (60°,
150°).

Peptides showed population shifts towards helices in octanol (Figure, 6.3). 1a had ~20-30% helix
content and 1b had ~10-20% helix content. 1c had similar coil and turns/bends as the Water/1
system but had a slight increase in sheet content and ~2-fold increase in 31-helices. 2a-2b also
showed in increase in helical content and 31-helices.
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In order to understand the effects of spinning on the formation of 31-helices, pulling experiments
were performed on the centroids obtained for clustering Water/1 and Water/3 trajectories (here
labeled Pull/1 and Pull/3, respectively). Ramachandran plots for Pull/1 systems (Figure 6.5) reveal
large populations centered at (φ,ψ) = (-60°, 150°). Systems 1a-1c had smaller adjacent populations
at (φ,ψ) = (-135°, 150°). The latter region corresponds to β-sheets. Besides this, there are very
small populations at (φ,ψ) = (-40°, -60°) for Water/1 1a-1c. This suggests potentially transient
helical populations and may serve as an intermediate in the transition from turns/bend/coils to βsheets and 31-helices. These regions were not observed for systems 2a-2b. Water/3 systems also
had large populations at (φ,ψ) = (-60°, 150°). Additionally, small populations at (φ,ψ) = (60°, 150°)
were also present. Both Water/1 and Water/3 systems had major populations in the PPII region.
Sequence dependence on the pulling Ramachandran plots was not observed, however, slight
differences in concentration dependence were present, specifically in the possible transient helical
populations for 1a-1c observed in the Water/1 but not the Water/3.
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Figure 6.5. Ramachandran plot for the pulled monomer (top panel) and the trimer (bottom panel).

Secondary structures analysis revealed an almost complete loss of turns/bends upon pulling for
Water/1 (Figure 6.6). An ~3-fold increase in 31-helices was observed for all systems,
corresponding to the density on the Ramachandran plot. β-sheets were not observed for Water/1.
Systems 2a-2b maintained a slightly higher fraction of turns and helices than 1a-1c. Loss of
secondary structure was also observed for Water/3 systems, however, to a lesser degree. Slightly
higher populations of turns/bends were also present. Additionally, a higher population of β-sheets
was also present, especially for 2a-2b.

Figure 6.6. Secondary structure for pulled sequences.
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RMS histograms show several differences between the environments (Figure 6.7). Water/1
systems had the highest mean RMS, showing that they had the greatest conformational flexibility.
1a-1c had similar RMS distributions, centered around 0.3, while 2a-2b also had similar
distributions, but shifted to ~0.25. Water/3 systems were all shifted, with 1a centered around 0.2.
1b and 1c were centered around 0.15, while 2a-2b were both centered around 0.1. Water/30
systems had lower distribution means, with 1a-1c centered near 0.4 and 2a-2b centered near 0.2.
In addition to the shifting means of the distributions for Water/1, Water/3 and Water/30, the
variance decreases as well. Octanol distribution means were less than Water/1, with 1a-1c centered
from 0.15-0.2 and 2a-2b centered near 0.1. Distributions had a higher RMS than Water/3 for 1a1c, while octanol distributions overlapped with Water/3 distributions for 2a-2b. Pull/1 systems had
a reduced RMS compared to Water/1. This corresponded to a shift of ~0.2 for 1a-1c and of ~0.1
for 2a-2b. Interestingly, RMS values increased for some Pull/3 systems compared to Water/3. This
occurred for 1a and 1c. 1b, and 2a-2b had overlapping distributions for Pull/3 and Water/3.
Increasing concentration results in decreasing RMS. This is observed for all systems in the
Water/1, Water3 and Water/30.

All peptides showed a decrease in RMS with increasing concentration. Octanol systems also had
a decrease in the RMS distributions compared to Water/1 systems. Pulling also resulted in a
decreased RMS, with Pull/1 and Pull/3 systems centered at similar locations. Systems 1a-1c had
similar RMS distributions for Water/1, Water/3, Water/30. Systems 1a-1c show larger decreases
than 2a-2b. This may be due to the higher conformational flexibility of these sequences compared
to 2a-2b. Octanol also reduces the RMS. Interestingly, pulling has mixed effects. For low
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concentration, pulling reduced the conformational flexibility of all sequences. However, for higher
concentration, the flexibility is increased for some sequences. This indicates that some sequences
may have a cooperative effect in which the presence of other sequences enhances sampling.

The compactness of structures was also measured using radius of gyration (ROG) (Figure 6.7).
Water/1 systems had the highest ROG values and the broadest distribution. 1a-1c had similarly
centered distributions at 0.45. 2a-2b had similar distributions as well, with lower means than those
for 1a-1c, centered at 0.4. Water/3 systems had lower ROG distributions. 1a-1c were centered
around 0.25, while 2a-2b were centered around 0.2. Water/30 systems had the lowest means and
narrowest distributions. 1a-1c were centered near 0.5 and 2a-2b were centered around 0.3. Systems
in octanol had narrowed distributions with reduced means compared to Water/1. Pull/1
distributions were effectively flat, indicating high changes in extension during the simulation.
Pull/3 systems showed an increase in ROG compared to Water/3, due to the increased extension
during the simulation. Overall, compactness of the structures decreased with increasing
concentration. This follows similar trends as the RMS, again supporting the idea that higher protein
concentration restricts sampling. Structures were more compact in octanol. Compactness
decreased with extension, with Pull/1 increasing more than Pull/3, relative to Water/1 and Water/3,
respectively.

Hydrogen bonding (Figure 6.7) for Water/1 had one-tailed distributions, centered at 0 for 1a-1c.
2a-2b had distributions centered around 0.1. Water/3 distributions were increased compared to
Water/1. 1a was centered around 0.1 and 1b-1c were centered around 0.2 and 0.15, respectively.
2a-2b were both centered around 0.2. Water/30 distributions were centered around 0.2 for 1a, 0.25
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for 1b-1c and 2a-2b. Octanol distributions had the highest hydrogen bonding mean, as well as the
broadest distributions. 1a-1b were centered around 0.3, 1c was centered around 0.5 and 2a-2b were
centered around 0.4. Pull/1 all had a similar distribution centered around 0, but the variance was
reduced compared to Water/1, indicating fewer states with hydrogen bonding. Pull/3 distributions
had similar variances as the Water/3 counterparts. 1a had a similar distribution, but 1b-1c and 2a2b had a slight decrease in the mean, indicating some loss of hydrogen bonding upon extension.
Ultimately, octanol had the highest number of hydrogen bonds, likely a result of the decreased
dielectric resulting in increasing strength of hydrogen bonds.
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Figure 6.7. Histograms of the RMS, radius of gyration and number of hydrogen bonds, all
normalized by total number of residues.
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6.5

Discussion

Simulations of the snow-flea antifreeze protein indicate that the force field is able to accurately
replicate 31-helical secondary structures. Comparison of secondary structures obtained from the
dope show small fractions of 31-helices. These are maximized under medium protein
concentration. At this concentration, the peptides may form intermolecular hydrogen bonds, which
stabilize 31-helices, and are also more extended, allowing this structure to form. The inability of
Water/1 systems to form intermolecular hydrogen bonds and the relative decrease in the ROG
(extension) of Water/30 systems preclude the formation of this structure. This data supports the
findings that under dope-like conditions, the peptides are mostly turns and coils. Formation of 31helices is observed to be highest under spinning or fiber-like conditions. Thus, this unique
secondary structure is a direct result of the spinning process and subsequent environment of the
silk fiber. Other secondary structural elements also form under the fiber-like conditions, however,
the spinning process (i.e. pulling) would likely eliminate these structures. The formation of 31helices may be slightly cooperative, as the Pull/3 forms a higher fraction of this secondary structure
than Pull/1. Sequence effects were also observed, with MaSp2 sequences having a higher fraction
of 31-helices that MaSp1. This may be due to the presence of Pro in these sequences. This suggests
that sequences rich in MaSp2 may have a higher 31-helical content, along with turn content.
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Chapter Seven

Molecular dynamics simulations and molecular flooding studies of the retinoid X-receptor
ligand binding domain

Note to Reader: This chapter is reprinted and adapted with permission from Geoffrey M. Gray,
Ning Ma and Arjan van der Vaart from Journal of Molecular Modeling, see Appendix E. My
contribution to this project was parameterization and simulation of bexarotene and fluorinated
analogues and simulation of the apo-state aqueous proteins.

7.1

Abstract

Bexarotene is an FDA approved retinoid X receptor (RXR) agonist for the treatment of cutaneous
T-cell lymphoma, and its use in other cancers and Alzheimer’s disease is being investigated. The
drug causes serious side effects, which might be reduced by chemical modifications of the
molecule. To rationalize known agonists and to help identify sites for potential substitutions we
present molecular simulations in which the RXR ligand-binding domain was flooded with a large
number of drug-like molecules, and molecular dynamics simulations of a series of bexarotene-like
ligands bound to the RXR ligand-binding domain. Based on the flooding simulations, two regions
of interest for ligand modifications were identified: a hydrophobic area near the bridgehead and
another near the fused ring. In addition, positional fluctuations of the phenyl ring were generally
smaller than fluctuations of the fused ring of the ligands. Together, these observations suggest that
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the fused ring might be a good target for the design of higher affinity bexarotene-like ligands,
while the phenyl ring is already optimized. In addition, notable differences in ligand position and
interactions between the RXRα and RXRβ were observed, as well as differences in hydrogen
bonding and solvation, which might be exploited in the development of subspecies-specific
ligands.

7.2

Introduction

The retinoid X receptor (RXR) is a promiscuous member of the superfamily of nuclear receptors
(NRs), serving as the master partner in many NR heterodimer complexes as well as forming
homodimers303-305. These dimer complexes function predominantly as transcription factors,
controlling metabolism, cell growth, differentiation, and death. Three subtypes for RXR have been
reported306. The major type is RXRα, present in the kidney, liver, intestine, lung, and skin. RXRβ
is found in all tissues, while RXRγ is found in the brain, muscles, and pituitary gland. RXR binds
retinoids in the L-shaped hydrophobic pocket of its ligand-binding domain (LBD), but the identity
of its natural ligand remains unclear. Candidates traditionally included 9-cis-retinoic acid307-308
(which has not been observed in vivo309 and was ruled out based on pharmacological data310), as
well as docosahexaneoic acid311-312, arachidonic acid312, oleic acid312, lithocholic acid311, phytanic
acid311, and β-apo-14′-carotenal313.
In the absence of ligands, the RXR heterodimers bind corepressors and their cognate DNA
response elements (REs)314. Dependent on the identity of the binding partner, the REs are usually
direct, inverted, everted, or palindromic repeats of two G(G/T)TCA half-sites, separated by 1 to 5
base pairs303. The corepressor complexes have histone-deacetylase activity and hence maintain a
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repressed transcriptional state. Transcriptional activation is reached by the binding of ligands and
depends on RXR subordination, whether the heterodimer is permissive or non-permissive315. In
permissive heterodimers, activation is achieved by binding of an RXR agonist or ligand of the
binding partner. RXR ligands alone cannot activate non-permissive dimers, and the presence of
the partner ligand is required. Permissive partners include peroxisome proliferator-activated
receptor (PPAR), farnesoid X receptor (FXR), and liver X receptor (LXR), while non-permissive
partners include retinoic acid receptor (RAR), 3,5,3′-triiodothyronine receptor (T3R), and vitamin
D receptor (VDR)304, 316. The latter class can be further subdivided into conditional non-permissive
heterodimers, which superactivate transcription in presence of RXR agonists, and nonconditional
nonpermissive heterodimers for which RXR agonists have no effect, even in the presence of the
partner agonist. Activation of the dimer complex induces a conformational change leading to the
release of corepressor, the binding of coactivators, and the active transcriptional state314,
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.

Examples that do not conform to this model have been found as well: the binding of the LG100268
RXR agonist to the RXR/FXR heterodimer leads to antagonism and a decrease in DNA affinity318.
RXR also interacts with other proteins304, for example with NPAS2 and Clock, which regulate the
circadian cycle319.
Despite the promiscuity of RXR, its involvement in a variety of transcriptional pathways, and the
cross-talk between various NRs, the RXR has served as a drug target for a variety of diseases 303,
316

. While its therapeutic potential includes atherosclerosis, diabetes, obesity, eczema, and certain

immune diseases, the greatest successes have been in cancer303, 320. Bexarotene321 (1) is an FDA
approved RXR agonist for the treatment of cutaneous T-cell lymphoma (CTCL), a rare and
incurable cancer of the immune system characterized by skin rashes, tumors, and lesions 322.
Bexarotene induces apoptosis in CTCL cells323, and it inhibits metastasis and angiogenesis in solid
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tumors324. Bexarotene is also being explored for treatment of lung, breast, and colon cancers320.
Additionally, it has shown promise for the treatment of Alzheimer’s disease through RXR
mediated apoE induced degradation and clearance of β-amyloid in the brains of mice325.
Administration of bexarotene in mouse models also demonstrated a reversal of Alzheimer deficits
and the improvement of cognitive and social skills325-326, but the extent of plaque clearance and
efficacy is being debated326-330.
Bexarotene has severe side effects, including hyperlipidemia for 100% of the patients and
secondary hypothyroidism for 40-100%331-333. This observation motivated us to design, synthesize,
and test new RXR agonists based on the bexarotene scaffold with potentially reduced side effects86,
334

. A potential lucrative route is the design of agonists with higher binding affinities, which might

result in increased selectivity and a decrease of dosage. We previously identified several RXR
selective ligands that induce apoptosis with EC50 values similar to bexarotene, no mutagenicity,
and low cytotoxicity86, 334. To rationalize these new ligands and to support the efforts in designing
improved RXR agonists, we performed simulation studies of bexarotene (1) and promising
bexarotene-like leads (2-11; Figure 7.1). Ligands 2-11 are modified versions of 1; for most of the
ligands these modifications consist of various degrees of ortho-halogenation (with 2 and 5 the
exceptions). 2, 4, and 7 also have a modified bridgehead, in which the vinyl bridging group has
been substituted for a ketone group. Analogs 3, 4, 5, 6, 7, 8, 9, and 10 demonstrated EC50 values
within one order of magnitude from bexarotene and some (3 and 6) a higher agonist activity than
bexarotene. All ligands were shown to cause apoptosis at levels similar to 1 in a human CTCL cell
line. In addition, 6 showed extremely highRXR transcription activationin separate tests,and 7
demonstrated high RXR specificity86,

334

. Molecular dynamics (MD) simulations of 1-11 in

complex with the RXR LBD were performed. In addition, molecular flooding simulations of the
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LBD were performed to help identify and characterize available patches in the binding pocket that
are currently not optimally used for binding. Our simulations reveal important structural trends
and indicate new opportunities to increase binding by extending the fused hydrophobic ring of the
bexarotene scaffold.

7.3

Methods

We used the site identification by ligand competitive saturation (SILCS) method 66 to identify
binding sites for polar, hydrophobic,and aromaticgroupsinthe RXR binding pocket. In this
molecular flooding simulation method, the protein is simulated in a high molar aqueous solution
of small organic molecules that represent fragments of drug-like molecules. The high molarity
increases the number of binding events between the solvent and protein, which is needed for good
statistics. The simulations are used to calculate "FragMaps", probability density mapsthat indicate
wherefunctional groups prefer to bind on the protein surface. The SILCS method is considered a
molecular flooding method, since the binding pocket is flooded with a large number of identical
drug-like molecules. Since the protein potential is not altered, sampling of the protein
conformational substates is not enhanced, however. FragMaps were calculated using the volmap
utility in VMD 1.9.1110. The FragMap occupancies were calculated using a bin size of 1.0 Å and
cut off of 0.5 Å, and averaged over the 40 ns trajectories. Initial coordinates of the RXRα and
RXRβ LBDs were taken from the protein data bank, access codes 1MVC335 and 1H9U336,
respectively. These structures were chosen because they contain bexarotene-like agonists in the
LBD (BMS649 and LG100268, respectively, (Figure 7.1), and because the structures capture two
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different conformations of helix H12. In 1MVC, H12 is in the canonical active conformation, while
it is in an intermediate position in 1H9U. For each LBD, three simulations were performed: the
apo LBD solvated in a rectangular box of 1 M benzene, 1 M propane, and water. Benzene and
propane tend to aggregate in water if their concentrations are too high; therefore, to avoid
aggregation, repulsive benzene-benzene and propane-propane Lennard-Jones potentials were
introduced66.A massless dummy atom was built at the center of mass of both benzene and propane,
and a Lennard-Jones potential with ε and σ values of -0.01 kcal mol-1 and 12.0 Å, respectively,
and subject to a cut off distance of 8.0 Å was introduced between the dummy atoms to prevent
aggregation66. The distance between the protein and the nearest edge of the water box was at least
12 Å, and 0.15 M NaCl was added to each system. After heating from 150 K to 300 K over 400 ps
using mass-weighted constraints on the LBD backbone with a force constant of 1.0 kcal mol-1,
each system was equilibrated for 700 ps during which the constraints were gradually released.
Equilibration was followed by a 40 ns production run; the aggregate length of the production runs
was 240 ns. Snapshots were taken every 0.2 ps and used to calculate water, benzene, and propane
FragMaps.
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Figure 7.1. Bexarotene and bexarotene-like analogs
Each ligand was simulated in complex with the RXRα and the RXRβ LBDs, for a total of 22
simulations. The initial structures corresponded to the top binding poses of our previous docking
studies86, 334. Each system was heated from 150 K to 300 K over 400 ps with 1.0 kcal mol-1
constraints centered on the protein backbone and the non-hydrogen atoms of the ligand; constraints
were also used for the Arg 316 and Ile 268 side chains (residue numbering as in RXRα, here and
in the remainder of the article), which were treated as flexible residues in the docking studies.
Heating was followed by an equilibration of 700 ps, during which the constraints were gradually
released. Each equilibration was followed by a 40 ns production run; the aggregate length of the
production runs was 880 ns.
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All simulations were carried out with the CHARMM program17 and CHARMM 36 force field159;
parameters for the ligands were obtained from the CHARMM General Force Field using the
CGenFF website7. Protonation states at pH 7 were identified using the H++ server337. SHAKE33
was used for all bonds involving hydrogen atoms, and a 2 fs integration time step was employed.
Simulations were performed in the NPT ensemble338 and long-range electrostatic interactions were
handled with the particle-mesh Ewald method4. In all of our simulations, the RXR LBD was
simulated in the monomeric state, since we were merely interested in the binding pocket. Visual
analyses were performed with VMD110.
The docking studies used AutoDock63 and followed our previously established protocol86. Because
AutoDock charges can overpolarize charges86 , a second set of docking was performed with
OpenBabel 2.3.0339 charges. In the docking, Arg316, Ile 268, and the ligand were treated as
flexible, and the Lamarckian genetic algorithm was used for a maximum of 25 million energy
evaluations per dock. A total of 400 docks were performed per ligand, and AutoDock binding free
energies were used to score the ligands.
7.4

Results

FragMaps were obtained from molecular flooding simulations of the apo LBD; these maps are
shown in Figure 7.2 and indicate regions of high probability for the binding of polar and
hydrophobic groups. To indicate these positions with respect to the position of the ligands, the
averaged position of bexarotene in the LBD as obtained from MD is shown as an overlay in each
of the panels; bexarotene was not present in the flooding simulations, however. The FragMaps for
the RXRα and RXRβ showed several differences between the binding pockets. The first was the
RXRβ had higher occupancy of hydrophobic regions in the pocket surrounding the fused ring
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system than the RXRα. There was also a region of high hydrophobic occupancy at the bridgehead
in RXRβ, which was not found in RXRα. The RXRα did have high hydrophobic occupancy around
the fused ring, although the hydrophobic occupancy in this area was higher for RXRβ. Hydrophilic
occupancy occurred near the fused ring system for both proteins. In the RXRβ, this region was
isolated to the carboxylate group, close to the entrance of the LBD. In the RXRα, the hydrophilic
occupancy extended to surround one side of the fused ring.
Propane and benzene FragMaps revealed a hydrophobic region around the fused-ring system for
both RXRα and RXRβ. This region was in contact with Phe 313, Ile 324, Ile 345, Phe 346, Val
349, and Ile 428. While overlays of the ligands in the MD simulations with the high hydrophobic
occupancy regions of the SILCS simulations showed that the fused ring of the ligands partly
overlapped with the hydrophobic occupancy region, the SILCS simulations showed that there is
extra space available for the extension of hydrophobic moieties. In addition, a region of high
hydrophobic occupancy was seen around the bridgehead region for RXRβ. Protein residues close
to this area include Trp 305, Asn 306, Ile 310, Cys 432, and Leu 436. This occupancy is indicative
of another target region for chemical modification to enhance ligand binding by the addition of
hydrophobic regions to the bridgehead. The SILCS simulations of the RXRβ LBD revealed a
region of high hydrophobic occupancy near the entrance of the binding pocket (helix H12),
surrounding Val 265, Val 342, Phe 438, and Phe 439. Since RXR antagonists act to bind and
prevent helix H12 from closing over the LBD entrance, extension of groups to form contacts with
this region would likely result in antagonistic properties340.
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Figure 7.2. FragMaps for benzene (light gray), water (gray), and propane (black) in the RXRα (a)
and the RXRβ (b). Arrows show regions of high occupancy surrounding the ligand. Only part of
the binding pocket is shown with the side chain of Ile drawn as licorice for reference. For clarity,
the overlays of the averaged binding position of bexarotene in the separate MD studies are shown
as sticks; bexarotene was not present in the molecular flooding simulations, however.
Protein backbone RMSDs of the ligand-bound RXR MD trajectories are shown in Figure 7.3.

Figure 7.3. Protein backbone RMSD of ligand-bound MD trajectories.
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Analyses of the ligand-bound RXR MD trajectories showed that water was present in the ligandbound LBDs as well (Figure 7.4). Solvent occupancy for the bound systems was generally higher
in the RXRα than the RXRβ (Table 7.1); this was also the case for the apo state simulations. For
RXRα, 1, 2, 3, 4, 6, and 7 all had water occupancy in the binding pocket. This occurred near the
bridgehead for 2, 4, and 7, which are ligands with a ketone bridgehead. For 1, higher occupancy
was observed near the fused ring in the vicinity of Ile 310. This suggests that the presence of water
may in part interfere with the hydrophobic interactions between H5 and the fused ring. High water
occupancy also occurred near Ile 310 for 2, 4, and 7. For these ligands, water occupancy formed
around Asn 306, and water molecules interacted with the ketone bridgeheads. This resulted in
more favorable interactions and better overlap of hydrophilic moieties with hydrophilic residues
for these ligands. Water occupancy in RXRβ occurred only for 4 and 7. In both cases, water
occupancy occurred around Cys 432. Both ligands have a ketone bridgehead and formed hydrogen
bonds with the water at this site. The other ligand with a ketone bridgehead was 2, but for this
ligand no water occupancy was observed near the bridgehead. This resulted in a distinctive shift
of 2 in order to reposition the ketone bridgehead away from the hydrophobic area formed by Trp
305, Asn 306, Ile 310, Cys 432, and Leu 436. The differences in ligand-bound solvation patterns
suggest that the desolvation step of ligand binding differs between carbon bridgeheads and ketone
bridgeheads within the RXRα and RXRβ. Additionally it suggests that the desolvation penalty for
the RXRα is different from the RXRβ.
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Figure 7.4. Water occupancy of 1 during simulation of 1 RXRα (a), and 7 in water occupancy
occurred near the carboxylate group. For 1, there was RXRα (b) and in RXRβ (c). Helices are
labeled for reference. Arrows high occupancy surrounding part of the fused ring system (arrow).
For 7, show regions of high occupancy surrounding the bridgehead. In all cases, high occupancy
occurred near the bridgehead.
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Table 7.1 Average number of water molecules in the ligand-bound LBD.
Compound

RXRα

RXRβ

1

6.5 ± 1.4

4.7 ± 1.3

2

7.9 ± 1.4

7.5 ± 1.4

3

6.7 ± 1.3

5.4 ± 1.3

4

8.2 ± 1.4

8.5 ± 1.5

5

8.3 ± 1.4

4.4 ± 1.2

6

9.0 ± 1.9

6.7 ± 1.3

7

6.3 ± 1.3

6.1 ± 1.3

8

5.8 ± 1.4

6.9 ± 1.4

9

2.7 ± 0.9

6.8 ± 1.4

10

6.8 ± 1.5

9.2 ± 1.6

11

7.5 ± 1.6

6.3 ± 1.6

Insight into the dynamical behavior of the ligands was obtained from MD simulations. The starting
configurations for the MD were taken from the top poses of docking experiments86, 334. Binding
energies were dominated by the electrostatics, which was between 1.5 and 3 times the van der
Waals energy. Shifts from the docked poses occurred for halogenated compounds. The largest shift
in RXRα was for 6, resulting in a displacement of ∼1.7 Å toward H11 for the fused ring (Figure
7.5). This resulted in more hydrophobic contacts between the fused ring and H11, in the regions
identified by the flooding simulations. The shift resulted in exclusion of some of the water in the
fused ring region in order to facilitate closer contacts with H11. However, water surrounding the
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carboxylate moiety were unperturbed. Due to hydrogen bonding of the ketone bridgehead with
water, 7 did not experience large shifts. Other ligands experience some shifts of the fused ring, but
these shifts were smaller than 1.0 Å. It was noted that single ortho-fluorination resulted in a similar,
but smaller, positional shift than double fluorination. Shifts were smaller for RXRβ. The fused ring
of 7 shifted by ∼1.6 Å, but the rest of the system remained at the docking position. This may in
part be due to the hydrophobic pocket near the bridgehead. While the ligands shifted, the protein
binding pockets remained highly similar between all systems, with backbone root mean square
deviations (RMSDs) of 0.8 Å for each of the H3, H5, and H11 helices. Overall, the different ligand
shifts for RXRα and RXRβ led to somewhat different ligand positions and interactions in the two
proteins. These slightly different preferences might be exploited for the development of
subspecies-specific ligands.

Figure 7.5. Ligand shift of 6 in RXRα, with close-up in inset
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Table 7.2 shows the RMSDs for the phenyl and fused ring regions of each ligand; these values
were averaged over all frames of the MD production trajectories. RMSD values for the fused ring
were generally higher than for the phenyl ring. Averaged structures generated from the trajectories
are overlaid in Figure 7.6. While the phenyl ring maintained only a few distinct binding poses, the
fused ring sampled a wider range of positions and was more mobile. These findings indicate that
the protein is well adjusted to the position of the phenyl ring, whereas contacts with the fused ring
were less optimal. These observations hint that stronger binding might be obtained by chemical
modification of the fused ring.

Figure 7.6. Overlay of the averaged structures of all ligands within the binding pocket. The
fused ring is shown in black and the phenyl ring is shown in white
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Table 7.2. Average root mean square deviationsa.
Compound

a

RXRα

RXRβ

Phenyl ring

Fused ring

Phenyl ring

Fused ring

1

1.05 (0.38)

1.58 (0.28)

2.06 (0.61)

3.20 (0.96)

2

1.74 (0.31)

3.27 (0.46)

3.28 (0.57)

3.20 (0.54)

3

0.50 (0.18)

0.68 (0.25)

0.68 (0.27)

0.76 (0.32)

4

0.60 (0.23)

0.72 (0.34)

0.95 (0.33)

1.28 (0.49)

5

0.77 (0.25)

0.85 (0.24)

0.74 (0.25)

0.81 (0.34)

6

1.48 (0.44)

1.84 (0.55)

1.04 (0.32)

1.12 (0.45)

7

0.48 (0.17)

0.67 (0.25)

0.70 (0.31)

0.87 (0.38)

8

0.93 (0.27)

1.05 (0.35)

1.58 (0.92)

2.32 (1.28)

9

0.51 (0.19)

0.77 (0.31)

1.78 (0.45)

1.78 (0.36)

10

0.78 (0.19)

1.11 (0.39)

2.00 (0.43)

2.64 (0.53)

11

0.82 (0.22)

1.15 (0.35)

1.84 (0.55)

2.14 (0.54)

In Å, with standard deviation in parentheses.

Table 7.3 shows the hydrogen bonding frequency for the ligands in both RXRα and RXRβ.
Three residues from the protein were found to actively engage in hydrogen bonding: Gln 275, Arg
316, and Ala 327. Distinct differences in hydrogen bonding frequencies were observed for RXRα
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and RXRβ. Of all simulated ligands, only 7 and 10 frequently hydrogen bonded to both RXRα and
RXRβ. It is interesting to note that these were the two ligands with greater specificity for the RXR
over the RAR in experimental studies86. Studies of indenoisoquinoline-based RXR agonists have
concluded that the Arg 316 residue is not necessary for the activation of the RXR341. Our
simulations seem to confirm this observation. For example, in simulations of ligand 6, which had
the highest experimental activation of RXR86, no significant hydrogen bonding with Arg 316 was
observed. Other fluorinated compounds displaying high RXR activation also had minimal
hydrogen bonding with Arg 316. No discernible trend was apparent for either Gln 275 or Ala 327,
indicating that these may not be suitable targets for enhancing RXR selectivity.
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Table 7.3. Hydrogen bond frequency
RXRα

RXRβ

Gln 275

Arg 316

Ala 327

Gln 275

Arg 316

Ala 327

1

20.0%

72.0%

26.3%

23.0%

0.0%

33.9%

2

19.0%

0.1%

27.8%

24.1%

0.0%

42.0%

3

4.1%

0.0%

32.9%

32.9%

85.9%

58.2%

4

13.6%

0.0%

23.3%

23.3%

0.0%

44.0%

5

22.5%

0.0%

21.5%

21.5%

74.8%

18.3%

6

8.5%

0.0%

6.2%

6.2%

18.6%

26.8%

7

7.1%

74.8%

15.9%

15.9%

69.7%

20.4%

8

22.6%

8.3%

38.8%

38.8%

0.0%

35.3%

9

33.2%

10.2%

47.1%

47.1%

0.0%

4.9%

10

26.5%

63.2%

40.4%

40.4%

31.3%

48.3%

11

24.7%

14.3%

32.0%

32.0%

0.0%

28.4%

Overall, the flooding and MD simulations suggested that hydrophobic modifications of the fused
ring might be a promising route toward ligands with improved binding affinity. The presence of
hydrophobic pockets surrounding the ketone bridgehead and the fused rings, as well as ligand
motions, indicate the presence of available space. This might allow for the addition of hydrophobic
groups to these regions to enhance binding affinity. To further support this suggestion, we
performed proof-of-concept docking of several ligands with added hydrophobic groups. These
ligands specifically targeted the areas of high hydrophobic occupancy identified in the SILCS
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studies and the areas of weak interactions identified in the MD simulations, but synthetic organic
feasibility or Lipinski’s rules342 were not considered at this stage. Several modifications were
found to significantly increase binding, as measured from calculated binding free energies.
Examples are given in Figure 7.7 and the corresponding Autodock binding free energies are given
in Table 7.4. Binding poses with the highest docking score show that the modified fused-ring
system occupied more of the surrounding region, covering the targeted hydrophobic regions. The
binding modes and protein-ligand contacts were preserved in subsequent MD simulations, with
the van der Waals interactions about 10 kcal mol-1 more favorable than for ligands 1-11. These
studies suggest that tighter binding can be achieved by the targeted addition of hydrophobic groups
to the fused ring.

Figure 7.7. Modified ligands.

Table 7.4. Docking free energies of the modified ligandsa

a

1

12

13

14

RXRα

-8.21; -8.94

-9.62; -10.23

-10.33; -10.84

-11.43; -11.85

RXRβ

-8.13; -8.92

-9.69; -10.10

-10.42; -11.00

-11.00; -11.46

In kcal mol-1. The first listed number is for Autodock charges, the second for OpenBabel

charges
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While these ligands were not designed as drug leads and merely served to illustrate that the targeted
hydrophobic regions may indeed increase binding, ADMET calculations showed a few drug-like
properties. ADMETSAR calculations343 predicted good blood-brain barrier permeability, good
intestinal absorption, no AMES toxicity and no carcinogenity; rat LD50s were predicted as 2.2119
mol/kg for bexarotene, 2.7425 for 12, 2.6984 for 13, and 2.4752 mol/kg for 14. As expected, not
all ADMET properties were promising, however; for example, SwissADME344 predicted low
solubility, like bexarotene, for all, with Log Po/w values of 5.84 for bexarotene, 6.59 for 12, 8.04
for 13, and 7.31 for 14, and violation of Lipinski’s rules because of molecular mass and Log Po/w
for ligands 13 and 14.

7.5

Conclusions

MD simulations of the RXR LBD in presence of bexarotene like ligands and molecular flooding
simulations of the RXR LBD were performed. Occupation probability maps generated from the
simulation of the apo-state protein indicate the presence of a region of high hydrophobic
occupancy close to where the fused rings bind the LBD. From the occupancy maps of the holostate protein, this same region was shown to be mostly unoccupied by bexarotene-like ligands.
This indicates that chemical modifications targeting this region might enhance binding affinity.
Another region of interest was found near the bridgehead, but occupancy maps showed that there
is little available space around the phenyl ring. Chemical modification of the phenyl ring would
likely perturb optimal binding poses within the LBD in order to avoid steric clashes with added
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groups. This possibly explains why the addition of nitro-groups and other hydrogen bond acceptor
groups ortho to the carboxylate group diminished binding affinity, as found by our previous
docking and experimental studies.86, 334 Moreover, the smaller positional fluctuations of the phenyl
ring compared to the fused ring suggest that interactions with the phenyl ring are already optimized
for the ligands. Our simulations also showed differences in hydrogen bonding patterns and
solvation between RXRα and RXRβ, which might benefit the development of subspecies-specific
ligands.
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Chapter Eight

Conclusion

Conformational fluctuations of biomolecules regulate their biological function. Changes in
conformational fluctuations result in changes in the structural ensemble for a biomolecule. This in
turn changes the microscopic behavior of the system and the macroscopic obserables. My research
has shed light on several interesting cases. Simulation of the HPV type 6 E2 protein (chapter 2)
revealed the importance of the β2-β3 loop fluctuations that act to drive the higher affinity of the
ΔLL mutant for noncognate DNA sequences. Via rearrangements, this loop forms contacts with
the DNA, which had previously not been identified experimentally. Formation of these novel
contacts helped drive the increase in the binding affinity of the mutant protein. It was further
discovered that the removal of the terminal Leu perturbed the β-barrel fluctuations, allowing for a
quasiharmonic mode motion in the mutant systems and the WT system bound to the cognate
sequence, which was not present in the WT bound to the noncognate sequence. This in turn helped
facilitate the rearrangement of the loop. Additionally, my simulations validated the previous
hypothesis that the cognate DNA sequences exist in a prebent conformation compared to
nongcognate sequence. This results in a lower deformation energy for the binding of a cognate
sequence.
Simulations of the C-terminal domain of Cdc37 (chapter 3) in which Y298 was unphosphorylated,
phosphorylated and mutated to a phosphomimetic residue, revealed the importance of
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conformational fluctuations in the regulation of the Hsp90 chaperone cycle. Both the
phosphomimetic and phosphorylated systems resulted in the loss of native like contacts and
hydrogen bonding for that residue. This resulted in an unfolding of α1 helix and an exposure of an
SH2-binding domain. This domain is important for the recognition of client chaperones.
Contrastingly, while α1 helix did unfold for the WT system, native-contacts were maintained
throughout the simulation and the exposure (as measured by the solvent-accessible surface area)
of the SH2-domain remained lower than the other two systems. This reveals the structural effects
of Y298 phosphorylation on the Cdc37 domain and the regulatory effects of this post-translational
modification on the Hsp90 chaperone cycle.
The effects of the conformational fluctuations of cyclization were investigated on a novel γAApeptide library (chapter 4). Previous results have indicated that there are fewer low energy
conformers for cyclical peptoids resulting in a reduction in conformer space. This in turn results
in a higher statistical weight for relevant binding configurations, making them better choices for
drug compounds than linear libraries. Simulations of a model linear and cyclic γ-AApeptide
supported this idea, finding that the fluctuations of the cyclic compounds were reduced.
Additionally, clustering followed by free energy calculations based on cluster populations showed
that the free energy of less populated clusters rose more steeply for the cyclic than the linear. This
shows that the ensemble does indeed favor lower energy configurations. Vibrational entropies
obtained by quasiharmonic analysis for each cluster also showed that the entropy values within
clusters was also lower for cyclic peptoids. These findings show that not only are conformers
confined to fewer clusters for the cyclic peptoids, but they are more confined within clusters as
well.
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Temperature replica exchange of mini silk-fibrils (chapter 5) revealed the conformational
fluctuations involved in spider dragline silk. These simulations showed the formation and
fluctuations of secondary structure in a native-like ensemble. The stability of the β-sheets and the
residue-composition were found to best match experiment when the strands were anti-parallel
within plane and parallel between planes. GGX secondary structural motifs were identified to be
primarily random coils with small populations of 310-helices and 31-helices. Both left and righthanded helices were identified.
The conformational fluctuations of the amorphuous region of spider dragline silk was further
investigated in chapter 6, using multiple replica exchange with solute tempering (MREST), MD
and pulling experiments. A higher fraction of 31-helices were observed. Additionally, the fraction
of this secondary structure was increased through increasing concentration, simulation in a fiberlike environment and extension of the structure (pulling). Ultimately, the highest fraction of these
helices was identified under the fiber-like conditions and extension. This indicates that this
secondary structure forms during the spinning process and is favored by conversion to a fiber state.
Finally, the conformational fluctuations of ligands bound to the retinoid X-receptor (chapter 7)
were also investigated. Differences in water occupancy in the LBD along with shifts in the ligand
binding positions suggested that these changes contribute to the binding affinity of bexarotene
analogues. Differences in water occupancy between RXRα and RXRβ indicated interactions that
may be used to tailor compounds specific to either subtype. Finally, a hydrophobic binding pocket
was identified that represent a region of potential ligand optimization to enhance the binding free
energy to RXR.
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Summarily, my research has contributed to the understanding of conformational fluctuations and
changes that occur in protein-DNA binding systems, drug-binding, regulation of chaperones via
post-translations modifications and spider dragline silk.
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